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PREFACE 
Intrauterine growth retardation is frequently observed in clinical practice. Small-
for-gestational-age newborns are not merely small but they exhibit many signs of 
abnormal intrauterine development. They represent a group of newborns which 
are at risk, especially during the perinatal period. Without treatment neonatal hy-
poglycemia often occurs. To prevent hypoglycemia, glucose infusions are given to 
these infants almost on a routine basis. Treatment by glucose administration is, 
however, only symptomatic. The pathogenesis of hypoglycemia after intrauterine 
growth retardation is not fully elucidated. This investigation was initiated to study 
this aspect. Because of the limitations, connected to investigations in human 
babies, an animal model had to be used. The rat was selected to induce experi-
mental intrauterine growth retardation. Several aspects of carbohydrate metabo-
lism were studied during the first 6 hours after delivery of these intrauterine 
growth-retarded animals. 
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Chapter 1. 
THE SMALL-FOR-GESTATIONAL-AGE NEWBORN INFANT 
1.1. Introduction 
Intrauterine growth retardation can result from a variety of maternal, placental or 
fetal factors. It is associated with a clinical picture in which low birth weight with 
respect to gestational age is the most prominent feature. Many terms have been 
used to denote the state of being undersized at birth: pseudoprematurity, dysma-
turity, underdevelopment, fetal malnutrition, small-for-date, small-for-gesta-
tional-age, intrauterine growth retardation. From these, the terms small-for-
gestational-age and small-for-date are generally used in clinical practice be-
cause they give the most clear description of the primary result of intrauterine 
growth retardation: a small body with respect to the duration of gestation. In The 
Netherlands the term dysmaturity is frequently used as well. 
1.2. Definition 
From the early history of mankind, children with an unusually low birth weight 
have been born. For many years this was thought to be the result of premature 
delivery. In 1950, the World Health Organization defined children with a birth 
weight of 2,500 g or less as being "premature", regardless of the estimated 
gestational period. 
It was realized in the fifties that previously called premature babies were not 
always prematurely born and some of them were more mature than estimated 
from the birth weight (Söderling, 1953; Rumbolz and Mc.Googan, 1953; Jarvi-
nen et al., 1957). Therefore, the W.H.O.'s definition was felt to be incorrect 
(Warkany et al., 1961) and in 1961 the WHO suggested that newborn infants 
weighing 2,500 g or less at birth should be termed "infants of low birth weight" 
(WHO, 1961). 
From the sixties, the duration of the gestational period was recognized as impor-
tant to differentiate children of low birth weight (Warkany et al., 1961). A 
milestone in clinical practice was reached by the introduction of intrauterine 
growth curves of body weight (Lubchenco et al., 1963; Kloosterman, 1969), 
length and head circumference (Lubchenco et al., 1966; Usher and McLean, 
1969). It opened the possibility to separate the growth-retarded infants of low 
birth weight from those who had a normal intrauterine growth pattern. 
Based on Lubchenco's percentile curves for body weight, three groups of infants, 
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regardless of the gestational period, were classified (Battaglia and Lubchenco, 
1967). Those with a birth weight below the 10th percentile were called small-
for-gestational-age and those with a birth weight above the 90th percentile 
large-for-gestational-age. Between both percentiles, infants were classified as 
appropriate-for-gestational-age. 
In order to make a correct classification, the exact gestational age must be known. 
Gestational age is calculated from the day of onset of the mother's last menstrual 
period. However, this information cannot always be obtained exactly; postcon-
ceptional bleeding and the widespread use of oral contraceptive drugs can intro-
duce errors in the calculation of the duration of the gestational period. Shortly 
after the introduction of intrauterine growth curves, methods were developed to 
establish the gestational age by investigation of the newborn infant. 
A number of external characteristics were found to be related to the gestational 
age and this resulted in some methods to establish the gestational age (Usher et 
al., 1966; Farr et al., 1966a, 1966b). In France, the neurological development of 
the fetus was investigated and a relationship with gestational age was defined 
(Saint-Anne Dargassies, 1955; Amiel-Tison, 1968; Minkowski et al., 1968). A 
variety of other parameters, including laboratory tests, have been shown to corre-
late with gestational age (Brans and Cassady, 1975). Both neurological and 
external characteristics were used by Dubowitz et al. (1970). Their method is 
widely used in clinical practice. The degree of precision varies with experience in 
performing the investigations, but appears to be within the limit of one or two 
weeks. Parkin et al. (1976) described a more rapid assessment method, based 
on both neurological and external characteristics. This procedure, however, has 
not replaced Dubowitz's method as yet. 
In The Netherlands, the intrauterine growth curves of Kloosterman ( 1969), based 
on Dutch children, are most frequently used. Babies showing a birth weight at or 
under the 2.3 percentile of these curves are defined as small-for-gestational-age. 
1.3. Etiology 
Many factors can cause intrauterine growth retardation. The extent of intraute-
rine growth failure depends on the responsible factors and the onset of the growth 
failure during pregnancy. Gruenwald (1963) differentiates between "chronic 
fetal distress" starting early in gestation and "subacute fetal distress" which takes 
place in the last part of gestation. Chronic fetal distress results in low birth weight 
and length (proportional growth retardation), whereas subacute fetal distress 
results in normal length but low weight at birth (wasting). 
The factors responsible for growth retardation can be divided into maternal, fetal, 
environmental and placental factors. A rather complete survey of these etiologic 
factors has been given by Lubchenco et al. (1968) and Renfield (1975). 
Of the maternal factors chronic vascular disease, resulting in diminution of 
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uterine blood flow, is of major importance (Lubchenco et al., 1968; Ounsted and 
Taylor, 1971). In twin pregnancy, one of both fetuses can be severely growth-
retarded, especially if birth takes place near term. Undernutrition of the mother 
can result in mild intrauterine growth retardation. Fetal causes include congenital 
anomalies, chromosomal aberrations and intrauterine infections. 
Of the environmental factors causing growth retardation, living at high altitude is 
a well-known one; growth retardation, however, is usually mild. 
It was Gruenwald (1963, 1964a), who pointed to the important role of placental 
insufficiency in intrauterine growth retardation. Previously, Kloosterman and 
Huidekoper (1954) established the role of placental infarcts in antenatal death. 
During the last trimester of pregnancy the placental size increases only at a low 
rate and fetal growth in this period depends largely on the functional capacity of 
the placenta. When functional reserves are insufficient growth retardation of the 
fetus will occur. However, placental weight varies greatly and is not a good 
parameter for functional capacity. In chronic vascular disease of the mother, like 
hypertension and toxemia, a striking reduction of weight and size of the placenta 
is found. There is a proportional reduction in weight of the placenta and in its 
protein and DNA contents in cases of intrauterine growth retardation indicating a 
reduction in cell number (Winick, 1967). Macroscopic lesions of the placenta in 
cases of intrauterine growth retardation include infarcts, premature placental 
separation, hemangiomas, thrombosis of fetal vessels, single umbilical artery and 
avascular terminal villi (Shanklin, 1970). A scoring system based on pathological 
examination of the placenta was developed to detect placental insufficiency (Scott 
and Jordan, 1972). 
It should be stressed that in many cases of even severe intrauterine growth 
retardation no clear cause can be demonstrated. 
1.4. Incidence 
About one third of all newborn infants weighing less than 2,500 g appears to be 
small-for-gestational-age (Warkany et al., 1961; Gruenwald, 1964b; Lugo and 
Cassady, 1971). The incidence per population is said to range between 1.5 to 2 
per cent of all births (Renfield, 1975). 
1.5. Clinical picture 
The clinical appearance of the small-for-gestational-age baby depends on the 
duration and intensity of the growth retardation. Chronic intrauterine growth 
retardation (for weeks to months) leads to decreased body length and sometimes 
even to decreased head circumference; the body weight is proportional to length 
in those cases. Growth retardation of shorter duration (for days to weeks) leads to 
a disproportionally low body weight, length being normal for the gestational age 
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(Gruenwald, 1963). These babies are wasted as a result of loss of subcutaneous 
tissue and body fat (Usher, 1970; McLean and Usher, 1970). 
Head circumference growth is preserved and correlates with gestational age 
(McLean and Usher, 1970; Finnström, 1971). They look "long and thin". 
Muscle wasting is most evident over arms, cheeks, buttocks and thighs. The skin is 
cracked and dry; palms and soles show a peeling appearance. Small-for-
gestational-age newborns are very vigorous after birth, unless they are asphyxia-
ted. Meconium staining is common. 
The weight of most organs is reduced to a variable extent. Weight reduction is the 
result of diminished cell size (Gruenwald, 1963; Naeye, 1965; Naeye and Kelly, 
1966; Chase et al., 1971). Most reduced are liver, spleen, thymus and adrenals. 
Heart, pancreas and especially the brain show a relatively normal weight. Severe 
growth retardation, however, can affect brain growth as well (Gruenwald, 1963; 
M c Lean and Usher, 1970). Skeletal development is commonly delayed (Wilson 
et al., 1967; Philip, 1978). 
1.6. Mortality and morbidity 
Neonatal mortality is highly dependent on gestational age and birth weight. At all 
gestational ages mortality in small-for-gestational-age newborns is higher than in 
appropriate-for-gestational-age newborns (Papaevangelou et al., 1972). Lub-
chenco et al. (1972b) analyzed mortality rates in relation to gestational age and 
birth weight and emphasized the importance of using both weight and gestational 
age in reports on mortality rates in neonatal populations. 
The small-for-gestational-age infant is threatened by many hazards. The risk of 
perinatal asphyxia and its sequelae is increased in comparison with premature 
babies and meconium aspiration is more common (Lugo and Cassady, 1971; 
Usher, 1970). Symptomatic or asymptomatic neonatal hypoglycemia is well-
known in the small-for-gestational-age infant (Pagliara et al., 1973). Blood 
hyperviscosity as a result of polycythemia occurs frequently (Humbert et al., 
1969; Lugo and Cassady, 1971). Congenital malformations (Lugo and Cassady, 
1971) and intrauterine infections are found more frequently in small-for-ges-
tational-age newborns. Increased susceptibility to infection in the neonatal period 
is reported to occur (Papaevangelou et al., 1972), probably as a result of defec-
tive cellular (Ferguson, 1978) and humoral (Papadatos et al., 1969) immunity. 
The thermoregulation is limited in small-for-gestational-age children (Sinclair, 
1970) and, as a result, cold stress is quite common. Adrenal response to stress, 
measured as the urinary excretion of corticosteroids, is diminished (Cathro et al., 
1969). 
In some respects, the small-for-gestational-age baby carries less risk than his 
premature counterpart. Hyperbilirubinemia is less common, as well as respiratory 
distress syndrome. Gluck and Kulovich (1973) showed that intrauterine growth 
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retardation results in accelerated maturation of the lecithin/sphingomyelin ratio 
in amniotic fluid. 
1.7. Treatment 
If inadequate fetal growth is expected, careful monitoring of the condition of the 
fetus is indicated to detect fetal distress and asphyxia. Many small-for-
gestational-age newborns require intermediate or intensive care after delivery. 
Because of the risk of hypoglycemia early parenteral glucose administration is 
indicated. Hyperviscosity should be anticipated and treated by a partial exchange 
transfusion. The feeding schedule should be adequate to permit catch-up growth. 
Wasted small-for-gestational-age babies increase their weight relatively more 
than length in the first year of postnatal life, body proportions becoming normal 
(Davies and Beverly, 1979). If parenteral feeding is needed, this should include 
amino acid mixtures and lipids. 
1.8. Long-term prognosis 
To establish clear facts with regard to the long term prognosis of small-for-
gestational-age infants prospective follow-up studies are needed. 
Only a few of such studies are available. Most reports on long-term prognosis 
have the disadvantage of being based on children with low birth weight without 
taking gestational age into account. It can be concluded from the available 
literature that children of low birth weight show more long-term sequelae than 
normal children (Eaves et al., 1970; Wiener, 1970; Fitzhardinge and Steven, 
1972; Lubchenco et al., 1972a; Francis-Williams and Davies, 1974; Davies and 
Tizard, 1975). 
In some studies, the prognosis of small-for-gestational-age children was found to 
be the same as of prematures (Drillien, 1968; Lubchenco et al., 1974). A 
comprehensive and detailed follow-up study until the age of seven years was 
published by Neligan et al. (1976). Three groups of children were investigated: 
prematures, small-for-gestational-age infants and a control group. Assessment 
was made of physical growth, neurological findings, behaviour and temperament, 
psychometric parameters, and a variety of associated family and environmental 
factors. From this study a number of firm conclusions can be drawn. Both 
premature and small-for-gestational-age infants perform significantly less well 
than those in a random control group. The over-all performance of small-for-
gestational-age children is significantly worse than of prematures. Some of the 
associated factors (especially those which are more directly related to the chil-
dren's upbringing) appear to be of great influence on the later performance of 
the small-for-gestational-age infants. 
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Chapter 2. 
HYPOGLYCEMIA IN THE SMALL-FOR-GESTATIONAL-AGE 
NEWBORN INFANT 
2.1. Introduction 
Hypoglycemia is frequently observed in the neonatal period. The clinical syn-
drome of transient symptomatic neonatal hypoglycemia was first reported by 
Cornblath et al. (1959), followed by many other reports (Haworth and Vidyasa-
gar, 1971; Koivisto et al., 1972; Fluge, 1974). 
A variety of conditions in the neonate can be accompanied by hypoglycemia and a 
significant number of the infants do not show any clinical manifestations. Corn-
blath and Schwartz (1976) distinguish between four categories of neonatal hypo-
glycemia. 
Category I is described as early transitional hypoglycemia and refers to the most 
frequent form, which is characterized by early onset, short duration and, in most 
cases, absence of symptoms. There is no clear relationship with sex, gestational 
age or birth-weight, but the frequency of perinatal distress is increased. Response 
to treatment with even low quantities of glucose is good. 
Category II is called secondary hypoglycemia, because the hypoglycemia can be 
attributed to other abnormalities such as central nervous system defects, bacterial 
sepsis, anoxia, cold injury, salicylate poisoning, abrupt cessation of parenteral 
glucose, trisomy 18 and others. 
Category III is the classical, transient hypoglycemia of the intrauterine growth-
retarded infant which will be discussed in more detail in this section. 
Category IV refers to the persistent or recurrent neonatal hypoglycemia, which is 
the least common of all types of hypoglycemia, but which is associated with the 
highest mortality and morbidity. This type of neonatal hypoglycemia persists or 
recurs after the second week of life and requires large amounts of glucose to 
establish normoglycemia. Hypoglycemia is caused by specific endocrine deficien-
cies such as Cortisol deficiency, several forms of hyperinsulinism and some heredi-
tary defects in amino acid and carbohydrate metabolism. A specific defect cannot 
always be detected in patients of this category and these cases are defined as 
idiopathic persistent neonatal hypoglycemia (Mc.Quarrie, 1954). The list of 
defects, responsible for category IV neonatal hypoglycemia, will continue to grow 
as more biochemical investigations are undertaken in those patients. Glucagon 
deficiency, mentioned by Cornblath and Schwartz (1976) as theoretical possibil-
ity, was recently described (Vidnes and Öyasaeter, 1977; Kollée et al., 1978). 
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2.2. Definition and clinical symptoms 
Various criteria were used in the past to define neonatal hypoglycemia in the 
newborn infant. It is now accepted that blood glucose levels of less than 30 mg per 
100 ml in full-term and less than 20 mg per 100 ml in premature newborn infants 
should be considered as abnormal (Cornblath and Reisner, 1965). The diagnosis 
of hypoglycemia in small-for-gestational-age infants depends on the findings of 
sequential levels of blood glucose below 20 mg per 100 ml (Cornblath and 
Schwartz, 1976) or plasma glucose below 25 mg per 100 ml (Behrman, 1977). 
Reduced glucose levels are not necessarily associated with clinical symptoms. In 
fact, many cases are asymptomatic (Campbell et al., 1967; Griffith, 1968; Beard 
et al., 1971; Fluge, 1974). Clinical symptoms are variable and not specific. 
Episodes of apnea, cyanosis, jitteriness, convulsions, apathy, abnormal cry, feed-
ing difficulties, limpness, tremors, tachypnea and coma all occur. Jitteriness, 
cyanosis, apnea, apathy and convulsions are frequently observed (Raivio, 1968; 
Cornblath and Schwartz, 1976). In a hypoglycemic small-for-gestational-age 
newborn infant, intravenous injection of glucose will result in the disappearance 
of the symptoms if hypoglycemia alone was responsible for the symptoms. Onset 
of hypoglycemia is in the first two days after delivery, mostly during the first day of 
life (Raivio, 1968; Griffith, 1968). There is no correlation between the severity of 
the symptoms and the blood glucose level. 
In an interesting study Járai et al. (1977) established that the "ponderal index", 
the ratio of weight to the third power of length, is a reliable predictor of the risk of 
hypoglycemia in small-for-gestational-age newborns. The hypoglycemic neo-
nates show a significantly lower mean ponderal index, being more wasted than 
the normoglycemic neonates. 
2.3. Incidence 
It is difficult to compare the data of different authors, because varying criteria are 
used to define hypoglycemia. The frequency of symptomatic neonatal hypogly-
cemia is reported to be at a rate of 2-3 per 1000 live births (Cornblath and 
Schwartz, 1976). From routine measurements of glucose levels in large series of 
consecutive births a figure of 1.7% symptomatic plus asymptomatic hypoglyce-
mia was calculated (Campbell et al., 1967; Griffith, 1968). In newborn nurseries 
the incidence figure varies from 1 to 5% (Lubchenco and Bard, 1971). Special 
neonatal care units show, of course, a higher frequency. From a special care unit, 
Griffith (1968) reported a frequency of 14.8% among 1000 consecutive admis-
sions. Among children of low birth weight (below 2,500 g), an incidence of 5.7% 
was reported (Pildes et al., 1967). More recently, however, a lower frequency 
(1.5%) of hypoglycemia in this category of infants was found (Gutberlet and 
Cornblath, 1976). The overall incidence of neonatal hypoglycemia in small-for-
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gestational-age newborns is in the range of 18 to 24% (Lubchenco and Bard, 
1971; de Leeuw and de Vries, 1976; Járai et al., 1977). In term small-for-
gestational-age newborns (gestation period over 37 weeks) an incidence of 18% 
was established (Blum et al., 1969). 
In preterm (less than 38 weeks of gestational age) small-for-gestational-age 
newborns, the incidence was found to be higher than in term ones, the figures 
being 40% and 2 1 % , respectively (Lubchenco and Bard, 1971). 
Glucose levels in term small-for-gestational-age newborns in Lubchenco's mate-
rial revealed a bimodal distribution with two peaks: one below 20 mg per 100 ml 
and one at a normal level of about 50 mg per 100 ml. This suggests the presence of 
two distinct groups of infants (Lubchenco and Bard, 1971). 
When the ponderal index is used as an index of body proportion the two forms of 
intrauterine growth retardation, reduction in both weight and length (stunting) as 
a result of chronic undernutrition and reduction in weight for length (wasting) as a 
result of relatively acute undernutrition, show clear differences in the incidence of 
neonatal hypoglycemia. Hypoglycemia is quite common in wasted newborns, but 
not in stunted newborns (Járai et al., 1977). 
Several authors established that the incidence of neonatal hypoglycemia is higher 
in the smaller member of twins (Wybregt et al., 1964; Reisner et al., 1965) and 
that it occurs 2-3 times more often in males (Raivio, 1968; de Leeuw and de 
Vries, 1976; Járai et al., 1977). 
2.4. Prognosis 
The available literature on studies of long-term prognosis of neonatal hypogly-
cemia shows striking discrepancies. The main reason is that in cases of neonatal 
hypoglycemia a variety of other factors may operate at the same time. The risk of 
intrauterine growth retardation itself, premature birth, asphyxia, hypothermia, 
sepsis and other complicating factors can influence the ultimate prognosis. It is 
difficult, therefore, to study separately the risk of neonatal hypoglycemia. Corn-
blath et al. (1959) were the first to point to cerebral damage after neonatal 
hypoglycemia. In 2 out of 8 hypoglycemic low birth weight infants of toxemic 
mothers, delivered uncomplicated, permanent cerebral damage was present; one 
has spasticity and epilepsia, the other was severely mentally retarded. 
Asymptomatic neonatal hypoglycemia has a favourable prognosis (Haworth and 
Mc.Rae, 1965; Griffith and Bryant, 1971; Fluge, 1975; Smolders-de Haas et al., 
1979). The prospect for children with symptomatic neonatal hypoglycemia is, 
however, less good, especially if convulsions were present (Koivisto et al., 1972; 
Pildes et al., 1974). In these author's patients treatment was started early, and 
follow-up was performed over 5 to 7 years. Detailed neurological and psychologi-
cal investigations were done. A significant number of neurological abnormalities 
were observed, but a large proportion of them had disappeared by school age. The 
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frequency of EEG abnormalities was not increased in the hypoglycemic patients. 
A significantly larger number of hypoglycemic children had IQ scores below 86. 
Increasing intensive care facilities result in less risk and a better prognosis in this 
category of infants (Lubchenco et al., 1974) because there is general agreement 
that early treatment with prevention of convulsions will lead to a better outcome. 
Neuropathological changes were found after neonatal hypoglycemia (Anderson 
et al., 1966, 1967). Severe and untreated neonatal hypoglycemia results in 
extensive degeneration of neurones and glial cells throughout the central nervous 
system, fragmentation of nuclear membranes, chromatolysis and many other 
changes. They are most pronounced in the cortex, putamen, and nucleus cauda-
tus. The brain stem is relatively spared. 
The biochemical changes in the brain after neonatal hypoglycemia, induced by 
subcutaneous injection of insulin, were investigated in the rat by Chase et al. 
(1973). They found diffuse changes with reduction of brain weight and DNA, 
protein, glucose and glycogen content. Myelin, measured by cerebroside-
sulfatide content, was decreased; cholesterol and phospholipids, which are loca­
ted in cell membranes, were decreased as well. 
2.5. Treatment 
Prevention of hypoglycemia in the susceptible, small-for-gestational-age, new­
born infant should be emphasized. Early feeding, from a few hours after birth, is 
therefore indicated. To detect significant hypoglycemia, regular blood glucose 
measurements on a routine basis have to be done during the first day of life. The 
feeding schedule should include both oral and intravenous glucose (Beard, 1975; 
Bossi, 1975; Cornblath and Schwartz, 1976). The glucose infusions should be 
given through a peripheral vein at a rate of about 5-10 mg glucose per kg body 
weight per min. A glucose solution of 10-15% is used. In many centres a bolus 
injection of 0.5-1 g glucose per kg body weight in a 25% solution is given before 
the continuous infusion is started, but the use of a rapid injection of hypertonic 
glucose may lead to hyperglycemia (Zarif et al., 1975; Salle and Ruitton-Uglien-
co, 1976; Cowett et al., 1979). The usefulness and necessity of the bolus injection 
are, therefore, doubtful (Lilien et al., 1977). 
Glucose infusions must not abruptly be stopped but gradually decreased. Other­
wise, secondary reactive hypoglycemia may occur. Corticosteroids or АСГН can 
be used, together with glucose infusions, if the hypoglycemia is severe and glucose 
treatment alone does not result in normoglycemia (Creery, 1966; Beard et al., 
1971; Cornblath and Schwartz, 1976). 
Prenatal treatment of the mother during labour to prevent hypoglycemia in the 
newborn has been advocated (Sabata et al., 1973), but is not used on a routine 
basis. Treatment with infusion of fat emulsions (Mestyán et al., 1976) might be 
useful since it enhances glucose production from gluconeogenesis. 
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Chapter 3. 
MODELS AND ANIMAL SPECIES IN THE STUDY OF 
INTRAUTERINE GROWTH RETARDATION 
3.1. Introduction 
A number of models were developed to study intrauterine growth retardation 
(Wigglesworth, 1964; Zeman, 1967; Emmanouilides et al., 1968; Zamenhof et 
al., 1968; Dickerson et al., 1971; Myers et al., 1971; van Marthens et al., 1975). 
They are based on the principle of diminution of the supply of nutrients or reduc-
tion of the uterine blood flow. Both mechanisms (maternal malnutrition and 
vascular disturbances) are thought to be causes of intrauterine growth retarda-
tion in the human fetus. 
Pigs, which are spontaneously intrauterine growth-retarded (Dickerson et al., 
1971; Cooper, 1975) and rats, in which intrauterine growth was inhibited by 
drugs (Klionsky and Wigglesworth, 1970) were used to study intrauterine growth 
retardation as well. 
In this section the described experimental models and the effects on growth of 
individual organs are reviewed. The choice of our experimental model and of the 
animal species used are discussed. 
3.2. Reduction of the uterine blood flow 
The classical model to study intrauterine growth retardation by reduction of 
uterine blood flow was developed by Wigglesworth (1964) in the rat. 
Female rats were mated and on the 17th day of gestation two silk ligatures, about 
0.5 cm apart, were placed around the uterine vessel near the lower end of the 
uterine horn under general ether anesthesia. A third ligature was placed in the 
mesometrium at right angles to the main vessel to prevent dilatation of anastomo-
tic vessels. After this procedure the blood supply to the experimental uterine 
horns is limited to that derived from the ovarian artery. The opposite horn was 
untouched. Animals were sacrificed on the 21th day of pregnancy and the fetuses 
delivered by caesarean section. A variable number of fetuses were dead and had 
been partially resorbed. The stunted animals showed a variable weight reduction, 
and there was a weight gradient between the upper and the lower end of the 
experimental hom; the animals situated near the ligatures were the smallest. 
Weight of normal newborn animals was 3.55 ± 0.35 g. Animals from control 
horns weighed 3.42 ± 0.47 g, whereas stunted animals from the experimental 
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horns weighed 2.81 ± 1.02 g. No consistent morphological or histological changes 
in the placentas from the stunted fetuses were observed. Some animals were 
sacrificed at term on the 22nd day of pregnancy; in these animals more fetuses 
were dead and the weight differences between the newborns from experimental 
and control horns were even greater than in the animals, killed on the 21st day of 
pregnancy. 
Several authors confirmed the validity of the model of Wigglesworth to produce 
intrauterine growth-retarded newborn rats (Tordet-Caridroit et al., 1969; Hohe-
nauer and Oh, 1969; Roux et al., 1970; Oh et al., 1970; Nitzan and Groffman, 
1970; Roux, 1971a, 1971b; Nitzan and Groffman, 1971a, 1971b; Oh and Guy, 
1971; Brans and Ortega, 1977). A birth weight reduction of 15% or more was 
generally used as a criterion for intrauterine growth retardation (Tordet-
Caridroit et al., 1969; Roux et al., 1970; Brans and Ortega, 1977). 
Some authors (Levitsky et al., 1976; Pollak et al., 1979) modified the Wiggles-
worth model by ligating both uterine arteries. It is unknown, however, which 
circulatory alterations are induced in the experimental fetuses in comparison with 
the original model. 
Weight reduction as a result of experimental intrauterine growth retardation in 
the rat continues to exist until adult life, despite good nursing conditions 
(Tordet-Caridroit et al., 1969; Roux, 1971a). Placenta, heart, kidney and espe-
cially the liver show a reduced weight after experimental intrauterine growth 
retardation (Wigglesworth, 1964; Tordet-Caridroit et al., 1969; Roux et al., 
1970; Oh et al., 1970). The brain weight, however, is spared and the ratio of 
brain/body weight in the intrauterine growth-retarded fetuses is greater than in 
control animals (Wigglesworth, 1964; Roux et al., 1970; Oh and Guy, 1971). 
Wigglesworth (1964) found no significant difference in the weight distribution 
between the fetuses from more crowded uterine horns and from less crowded 
horns. Smart et al. ( 1972) reported an inverse correlation between litter size and 
birth weight, but Croskerry et al. (1978) could not demonstrate such a correla-
tion in normal rats. The inverse correlation between litter size and placental 
weight, however, was highly significant (Croskerry et al., 1978). 
Attention has been paid to the cellular composition of different organs in this 
model of experimental intrauterine growth retardation. The total amount of 
DNA reflects the cell number, because DNA content per nucleus is constant. 
RNA on the other hand, which is almost completely located in the cytoplasm, 
reflects cell size. During the last 10 days of prenatal development in the rat there is 
a dramatic increase in the number of cells of the whole body, slowing down after 
birth. Cell size increases between 6 and 4 days before birth, remaining constant 
afterwards until 10 days after birth (Enesco and Leblond, 1962). The effects of 
experimental intrauterine growth retardation on the composition of liver and 
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brain were studied by Roux and her associates. They found that DNA and RNA 
concentrations, expressed per gram wet weight, were comparable in the liver of 
growth-retarded and of control rats (Roux et al., 1970). Total DNA content of 
the liver, however, was lower in intrauterine growth retardation (Roux, 1971a; 
Oh and Guy, 1971), indicating that the decrease in liver size as a result of 
experimental intrauterine growth retardation is caused by reduction of the cell 
number. The incorporation rate of labelled thymidine into DNA was significantly 
lower in liver, heart and lung of intrauterine growth-retarded rats, indicating a 
reduced rate of DNA synthesis in these animals at birth (Roux, 1971b). After 
birth, there was a progressive increase in the DNA content of the liver, of the 
same order of magnitude in intrauterine growth-retarded and in normal rats. 
Total DNA content of the brain was comparable in growth-retarded and control 
animals (Roux, 1971a). Body water expressed as a percentage of birth weight was 
higher in intrauterine growth-retarded rats (Hohenauer and Oh, 1969; Roux et 
al., 1970; Brans and Ortega, 1977). Liver and brain protein content as a percent-
age of wet weight was unchanged (Roux et al., 1970), but body protein (expressed 
as nitrogen) and fat content were lower (Hohenauer and Oh, 1969). 
In the rhesus monkey intrauterine growth retardation was achieved by ligation of 
interplacental blood vessels between the primary and secondary placental discs 
(Myers et al., 1971; Hill et al., 1971). In these monkeys liver growth was most 
severely impaired but brain growth was spared. The liver of growth-retarded 
animals contained less DNA, RNA and total protein. 
The rabbit was used by van Marthens et al. (1975) as an experimental animal. 
Approximately 35% of the spiral arterioles were ligated on the 25th day of 
gestation (normal duration of gestation in this species is 31.5 days). A significant 
birth weight reduction of 15% was noted in the experimental fetuses, delivered 
on the 30th day of gestation. Placenta and brain weight were significantly re-
duced, but liver weight was not measured. Examination of the chemical com-
position of the brain revealed a significantly reduced DNA and protein content. 
Since the rabbit shows the brain growth spurt in the perinatal period, the findings 
of a reduced brain weight in intrauterine growth-retarded rabbits indicate an 
increased vulnerability of the brain during this period (Dobbing, 1968). 
Single umbilical artery ligation in the lamb fetus was performed (Emmanouilides 
et al., 1968), but this procedure resulted in a high mortality rate before the end of 
the normal gestation period. Only 2 out of 20 fetuses reached term age, and they 
were severely growth-retarded. In the same species intrauterine growth retarda-
tion was produced by embolizing the uterine vascular bed of the pregnant sheep 
with non-radioactive microspheres through a catheter, placed in the uterine 
artery. Liver growth was impaired, but brain growth was spared (Creasy et al., 
1972). 
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Ligation of one of both uterine vessels, recently performed in the guinea pig 
(Lafeber et al., 1979), resulted in a significant birth weight reduction. Brain 
weight was relatively spared, whereas liver weight was much reduced. Liver 
glycogen content was, in contrast to that in the intrauterine growth-retarded rat, 
higher than in control animals. 
3.3. Maternal dietary restriction 
Restriction of the maternal intake of nutrients can be accomplished by reducing 
calorie or protein intake during gestation. Caloric restriction during gestation 
results in a significant decrease of birth weight, cerebral weight and cerebral DNA 
and protein content (Zamenhof et al., 1971a; Adlard et al., 1973; Smart et al., 
1974). The newborn rat brain is less mature than that of the human newborn and 
peak velocity of brain weight gain occurs at about 5 days after birth (Dobbing and 
Sands, 1970, 1971). Dobbing's group, therefore, proposed an alternative animal 
model to study the effect of intrauterine malnutrition on the brain (Adlard et al., 
1973). In this model, maternal food restriction was continued until 5 days after 
birth and the 5 days old newborn rat was used to study the effect on the brain. 
Restriction of the amount of casein in the maternal diet during gestation results in 
permanent stunting in rats (Zeman, 1967; Zamenhof et al., 1968; Zamenhof et 
al., 1971b; Shrader and Zeman, 1973; Zamenhof et al., 1973). Zamenhof et al. 
(1971b) showed that protein restriction of even short duration (5-10 days) at 
various periods of pregnancy resulted in stunted growth and reduced DNA and 
protein content of the brain. 
3.4. The "runt" pig model 
A considerable number of naturally born piglets are very small. They are known 
as "runts". Growth of the porcine fetus depends on its position in the uterine 
horn, those distal from the ovarian end being smaller. After growth to maturity 
the "runt" pig is still smaller than its larger littermate and its organs are smaller 
both after birth and in adult life (Widdowson, 1971). Skeletal development is 
retarded, being dependent not only on the age but also on the size of the fetus 
(Adams, 1971). The brain contains less total DNA, but DNA and protein content 
per gram brain weight is similar to large littermates. This means that the "runt" 
brain contains a smaller number of normal sized cells (Dickerson et al., 1971). 
The runt pig was advocated as a model to study human intrauterine growth 
retardation (Dickerson et al., 1971; Cooper, 1975). 
3.5. Inhibition of growth by drugs 
Klionsky and Wigglesworth (1970) induced fetal growth retardation in rats by 
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inhibition of DNA synthesis with hydroxyurea or by inhibition of protein synthe-
sis with cycloheximide. They studied the chemical composition of liver and brain 
after injection of hydroxyurea into the dam on day 15 after conception. A 
significant reduction in total DNA content of liver and brain was observed. RNA 
content was not different from controls and mean cell weight was not altered. 
Their results indicate a reduction in cell number without any effect on cell size 
after inhibition of DNA synthesis. After cycloheximide injection into the dam on 
day 15 the resulting growth-retarded newborn rats showed a significant reduction 
in total DNA in brain, but not in liver. Mean cell weight and total DNA content 
were reduced in liver, but not in brain. So, inhibition of protein synthesis resulted 
in a reduction in hepatic cell size without affecting cell number. 
3.6. Choice of the experimental model and animal species 
The choice of the experimental model and of the animal species in the study of 
intrauterine growth retardation depends on the aspects of intrauterine growth 
retardation, which are to be studied. In our investigations we preferred the model 
of intrauterine growth retardation induced by reduction of the uteroplacental 
blood flow because it resembles intrauterine growth retardation due to chronic 
vascular disease in the human fetus. 
In both rat and man neonatal hypoglycemia has been described, as well as 
progressive development of gluconeogenic enzyme activities in the perinatal 
period. So, from this point of view, it seems to be justified to choose the rat as 
experimental animal to study neonatal hypoglycemia in relation to gluconeogene-
sis. However, one has to be aware of the differences in intracellular localization of 
the gluconeogenic enzymes between rat and man species. Phosphoenolpyruvate 
carboxykinase, for example, is located mainly in the cytosol in rat liver. Oxaloace-
tate formed in the mitochondria has to be transported to the cytosol via a shuttle 
system. It is converted to malate or aspartate within the mitochondrial matrix, 
transported into the cytosol and thereafter reconverted to oxaloacetate. In man 
and guinea pig intramitochondrially produced oxaloacetate can be converted to 
phosphoenolpyruvate directly by phosphoenolpyruvate carboxykinase, which is 
located mainly intramitochondrially (Hanson, 1974). 
Subcutaneous fat deposits are low in the normal newborn rat, pig (Widdowson, 
1950, Hahn and Novak, 1975) and rhesus monkey (Hill et al., 1971). Guinea 
pigs, even the growth-retarded (Lafeber et al., 1979), and man have considerable 
fat deposits at birth (Widdowson, 1950; Girard, 1975). 
For the study of the influence of lipid metabolism on glucose homeostasis in 
normal human neonates, the guinea pig might be more adequate as an experimen-
tal animal (Ferré et al., 1978). For the study of intrauterine growth-retarded 
human neonates the rat might be a suitable experimental animal in this respect 
since both have small fat stores. For investigations of the effects of intrauterine 
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growth retardation on brain development one has to take into account the timing 
of the brain growth spurt of the animal. If the aim of the investigations is directed 
towards the effects of intrauterine growth retardation on brain development in 
the human fetus and newborn, it might be appropriate to use the pig or the rabbit 
as experimental animal. Both species are, like man, "perinatal brain developers" 
(Dickerson et al., 1971; Harel et al., 1972). The rat, being a "postnatal brain 
developer", is not comparable with the human neonate with regard to brain 
development and might, therefore, not be adequate in this respect. The same is 
true for the guinea pig and rhesus monkey, who are "prenatal brain developers" 
(Dobbing and Sands, 1970). 
For our investigations we choose the rat as an experimental animal because the 
development of gluconeogenic enzyme activities in the perinatal period is similar 
to man and the fat deposits are low as it is in small-for-gestational-age newborn 
infants. Most of the knowledge on experimental intrauterine growth retardation 
comes from this animal. 
Although the chosen experimental model has some disadvantages, its study can 
help towards understanding hypoglycemia in small-for-gestational-age newborn 
infants. Investigations with the recently developed model in the guinea pig can 
supplement our knowledge. 
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Chapter 4. 
ENERGY METABOLISM IN THE PERINATAL PERIOD 
IN NORMAL RAT AND MAN 
4.1. Fetal energy metabolism 
4.1.1. Introduction 
Nutrients are required during fetal life to provide fuels for energy metabolism and 
to permit growth and differentiation of the organs. 
Most nutrients reach the fetus by the umbilical circulation, originating from the 
placenta. Placental transport facilities vary with nutrients and the animal species. 
Apart from maternal sources, some nutrients might originate from endogenous 
production in the fetus itself. The origin and utilization of the most important 
metabolic substrates - carbohydrates, amino acids, fatty acids and ketone bodies -
will be discussed in the following section. Recent studies on fuel metabolism in the 
fetus of various mammals were reviewed by Battaglia and Meschia (1978) and 
Girard et al. (1979). We will, therefore, limit our review to rat and man. 
4.1.2. Carbohydrates 
Glucose is the most important energy supplying substrate in fetal metabolism. Fig. 
4.1 shows a scheme of sources and fate of glucose in the fetal circulation. 
From day 17 to day 19 blood glucose levels in the fetal rat decrease from 75 to 
36 mg% and subsequently rise towards 90 mg% at birth (Watts et al., 1976; 
Sodoyez-Goffaux et al., 1979). Glucose was generally thought to be the only 
source of energy in fetal life. There is some evidence, however, that glucose alone 
might be inadequate to meet total fetal oxidative metabolism. This evidence 
comes from experiments in four mammalian species in which umbilical glucose/ 
O2 quotients were less than 1 (Battaglia and Meschia, 1978). No data on this 
point are available from the rat. Glucose uptake at term in the human fetus varies 
with the maternal glucose supply but the finding of a mean glucose/02 quotient 
of 0.81 in 11 fetuses might indicate that glucose uptake is inadequate to meet all 
requirements (Morris et al., 1975). 
Placental transport of glucose occurs by facilitated diffusion in the rat (Szabo and 
Grimaldi, 1970) and in man (König et al., 1978). Glucose concentration is con-
sistently lower in fetal than in maternal blood in both rat (Girard et al., 1973b) 
and man (Dancis and Schneider, 1975). Glucose transfer in the rat increases 
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Fig. 4.1. Sources and fate of glucose in the fetal circulation 
markedley between days 14 and 21 of gestation (Rosso, 1975), probably as a 
result of increased perfusion at the maternal side of the placenta. Blood glucose 
levels at day 21 are two times higher than those at day 14 (Dawkins, 1963). 
Endogenous glucose production results from gluconeogenesis and glycogen 
breakdown. Gluconeogenesis is the metabolic process by which glucose is produ­
ced from substrates such as pyruvate, lactate and amino acids. In fetal rat liver, 
gluconeogenesis is virtually absent. Labelled pyruvate (Ballard and Oliver, 
1963) and amino acids (Yeung and Oliver, 1967a) are not incorporated into 
glycogen in fetal rat liver slices. The absence of gluconeogenesis in the fetal rat 
was established in vivo with labelled pyruvate, lactate and aspartate (Philippidis 
and Ballard, 1969; Bossi and Greenberg, 1972). In slices of human fetal liver, 
some gluconeogenesis was demonstrated (Villee, 1953). A low rate of alanine 
incorporation into glucose was detected in human fetal liver expiants (Schwartz 
and Rail, 1975a). Development of the activities of gluconeogenic key enzymes 
during fetal and postnatal life will be discussed more extensively later in this 
section, but it must be pointed out that the rate-limiting key enzyme, phospo-
enolpyruvate carboxykinase, is virtually absent in fetal rat liver (Ballard and 
Hanson, 1967b; Philippidis et al., 1972) and has only low activities in human fetal 
liver (Räi hä and Lindros, 1969). So, endogenous production of glucose by gluco-
neogenesis does not seem to be operative during normal fetal life. Induction of 
gluconeogenic key enzymes and activation of gluconeogenesis can, however, be 
performed in fetal rats by several experimental procedures. Intraperitoneal injec-
tion of glucagon, adrenaline or noradrenaline in utero results in induction of the 
hepatic activity of phosphoenolpyruvate carboxykinase in the rat (Yeung and 
Oliver, 1968a; Ballard and Philippidis, 1971c; Girard et al., 1973a), probably 
through the action of cyclic AMP (Yeung and Oliver, 1968b). 
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Maternal fasting during the last few days of gestation results in a significant 
activity of phosphoenolpyruvate carboxykinase (Girard et al., 1977) and prema-
ture appearance of gluconeogenesis (Bossi and Greenberg, 1972; Girard et al., 
1977). During maternal hypoglycemia, the fetal rat is able to keep glucose levels 
within normal limits (Goodner et al., 1969). 
Glycogen breakdown appears to be nearly absent in fetal rats (Goodner and 
Thompson, 1967; Devos and Hers, 1974). The ability of the rat liver to mobilize 
glycogen develops near term (Hunter, 1969). 
The high insulin-glucagon ratio in fetal plasma is appropriate to the situation in 
which no fetal endogenous glucose production takes place (Girard et al., 1974). 
Activities of hepatic glycogenolytic enzymes increase near term in the fetal rat, 
but full maturation of these enzyme systems is lacking until shortly after birth 
(Ballard and Oliver, 1963; Schaub et al., 1972; Biondi and Viola-Magni, 1977; 
Vaillant et al., 1979). 
Exogenous glucagon can provoke premature glycogen breakdown in the rat (Gi-
rard and Bal, 1970; Greengard and Dewey, 1970; Schwartz and Rail, 1973), 
probably through the action of cyclic AMP. Glucagon (Greengard and Dewey, 
1967; Girard et al., 1973a) and cyclic AMP (Greengard, 1969) can provoke 
premature increase of the activity of glucose-6-phosphatase. 
Phosphorylase, another important glycogenolytic enzyme, can be induced prema-
turely by glucagon (Girard et al., 1973a; Shelley et al., 1975) and cyclic AMP 
(Shirline et al., 1972) as well. Glucose production was found in isolated livers of 
human midterm fetuses (Adam et al., 1978), when the incubation medium did not 
contain glucose. If, however, physiological concentrations of glucose were added 
to the medium glucose production was suppressed. It was concluded that, during 
extreme hypoglycemia, the human fetal liver is capable of glucose production, 
probably as a result of glycogen breakdown. Previously, Slemberà and Hodr 
(1966) suggested that the human fetus may mobilize glucose during hypoxia. 
Glycogenolytic enzymes are present in the human fetal liver, but, like in the rat, in 
limited concentrations (Gennser et al., 1971). Cyclic AMP or glucagon were 
shown to deplete glycogen stores in human fetal liver expiants (Schwartz et al., 
1975b). 
It can be concluded from the available literature that under normal circumstances 
no endogenous glucose production from gluconeogenesis or glycogen breakdown 
takes place in the fetus. In certain situations as maternal hypoglycemia or intra-
uterine hypoxia some endogenous glucose production could take place. 
Glycogen synthesis from glucose occurs to a large extent during the last 4 days of 
gestation in the fetal rat liver (Shelley, 1961; Jacquot and Kretchmer, 1964; 
Dawkins, 1963; Greengard and Dewey, 1970; Devos and Hers, 1974; Pines et 
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al., 1975; Bashan et al., 1979). In man glycogen synthesis starts from 3 months of 
intrauterine life (Schwartz et al., 1975b). 
The rate of glycogenesis increases towards term; at term liver glycogen stores are 
estimated to be 90 mg per g liver in both man and rat (Girard, 1975a). 
The fetal liver is well equipped for the synthesis of glycogen from glucose 
(Dawkins, 1966). Total glycogen synthetase activity incrpases from day 16 in fetal 
rat liver (Devos and Hers, 1974; Pines et al., 1975; Bashan et al., 1979) and from 
the second month in the human fetus (Schwartz et al., 1975b). In human fetal 
liver, the increase of the active form of glycogen synthetase parallels the increase 
of glycogen stores (Schwartz and Rail, 1975c). Glucocorticoids are involved in 
the induction of glycogen synthetase, while insulin activates the enzyme (Eisen et 
al., 1973). 
Hydrocortisone injection in fetal rat promotes premature glycogen formation 
(Greengard and Dewey, 1970). Fetal hepatic glycogen accumulation is inhibited 
by glucagon and cyclic AMP in rat (Greengard and Dewey, 1970; Schwartz and 
Rail, 1973) and man (Schwartz et al., 1975b). In conclusion, glycogen formation 
is important in the last period of gestation and seems to be under hormonal 
control. 
Utilization of glucose can occur in several ways. In fetal rat liver the glycolytic 
pathway is intact (Burch et al., 1963; Vernon and Walker, 1968a) and glucose 
is oxidized to CO2 and water in the citric acid cycle. Lipogenesis from glucose 
was shown to occur in fetal rat liver (Ballard and Hanson, 1967a). NADPH, used 
in the synthesis of fatty acids, is presumably provided by the hexose monophos-
phate shunt. Oxidation of glucose by this pathway was calculated as 6 times less 
than utilization for lipogenesis in human fetal liver (Villee and Loring, 1961). 
Lactate production takes place under aerobic conditions in vitro in rat and human 
placentas, probably derived from maternal glucose (Battaglia and Meschia, 1978). 
It is not known, however, whether it is used as fuel for energy metabolism in the 
fetal period. 
4.1.3. Amino acids 
Amino acids are derived from the maternal circulation and are transported across 
the placenta by specific active transport mechanisms (Dancis and Schneider, 
1975). The levels of most amino acids in fetal blood are higher than those in 
maternal blood (Battaglia and Meschia, 1978). Glutamate and aspartate do not 
cross the placenta in the rat fetus (Dierks-Ventling et al., 1971). The serum 
pattern shows a strikingly high alanine concentration, corresponding with the 
absence of fetal gluconeogenesis (Hill and Young, 1973). 
During fetal life glucose serves as the primary energy source and amino acids are 
used for protein synthesis. There is some indication, however, that amino acids 
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contribute to energy requirements in man during fetal life since the human fetus 
has a higher plasma urea concentration than his mother and a high production 
rate of urea (Gresham et al., 1971). 
4.1.4. Fatty acids 
Fatty acids are transferred across the placenta to a limited extent in the rat 
(Hummel et al., 1975; Hull, 1975) and human (Dancis et al., 1973) fetus. 
Levels of free fatty acids in the maternal circulation are higher than those in the 
fetal circulation in rat (Girard, 1975a) and man (Sabata et al., 1968; Wolf et al., 
1974). Most of the fatty acids in the fetal circulation are thought to be derived 
from the maternal circulation, but this source probably provides only partially for 
the fatty acid requirements of the fetus. Active hepatic fatty acid synthesis from 
substrates as glucose, acetate and citrate takes place during the late fetal period in 
the rat (Roux et al., 1967; Taylor et al., 1967; Ballard and Hanson, 1967a) and in 
man (King et al., 1971). 
Recently, it was argued that the fatty acid demand of the term rat fetus is fulfilled 
equally by placental transfer and fetal fatty acid synthesis (Zimmerman et al., 
1979). It is unknown to what extent lipolysis from adipose tissue occurs in fetal 
rats (Hull, 1979). The capacity of the liver to oxidize fatty acids is small in the rat 
fetus (Augenfeld and Fritz, 1970; Lee and Fritz, 1971; Warshaw, 1972; Bailey 
and Lockwood, 1973). So, fatty acids are not important as energy delivering 
nutrients during fetal life but serve as substrates for lipid synthesis. 
4.1.5. Ketone bodies 
Ketogenesis is virtually absent in the rat fetus (Augenfeld and Fritz, 1970; Baily 
and Lockwood, 1973) in spite of an intact ketogenic enzyme system (Lee and 
Fritz, 1971). In the liver of human fetuses aged 8-17 weeks, some production of 
ketone bodies was demonstrated in vitro (Hahn et al., 1964). 
Placental transport of ketone bodies is rapid and a close correlation exists be-
tween maternal and fetal blood levels of these compounds in rat (Girard et al., 
1973b; Girard, 1975a) and in man (Sabata et al., 1968). 
4.2. Neonatal energy metabolism 
4.2.1. Introduction 
At delivery, the constant supply of nutrients from the maternal circulation is 
abruptly terminated and the newborn has to become self supporting. 
Until weaning, blood glucose levels have to be maintained to a large extent by 
endogenous glucose production. Other substrates for energy metabolism have 
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also to be used to meet the needs for temperature regulation and respiratory and 
muscular activity. 
4.2.2. Glucose 
Glucose is the most important energy-providing substrate not only in the fetus, 
but also in the newborn rat (De Meyer et al., 1971; Girard, 1975a). 
In the fasted newborn rat, blood glucose levels show a characteristic pattern 
during the first 16 h after birth (Fig. 4.2). Within the first 2-3 h the blood glucose 
level falls rapidly (Dawkins, 1963; Yeung and Oliver, 1968a; Cake et al., 1971; 
Snell and Walker, 1973a; Girard et al., 1973b). In the human newborn, blood 
glucose levels fall within 4-6 h after delivery (Cornblath and Schwartz, 1976). 
The initial fall of blood glucose levels is caused by two factors, one of which is the 
abrupt termination of maternal glucose supply. The other is that both pathways to 
provide endogenous glucose, glycogenolysis and gluconeogenesis, are not yet 
fully operative. If metabolic demands are diminished, as in hypothermia (250C), 
the blood glucose levels do not fall (Girard and Zeghal, 1975c). The transient 
hypoglycemia during the first period after birth disappears. Normal blood glucose 
levels are reached at about 6 h in the rat, even if food is withheld (Dawkins, 1963 ; 
Girard et al., 1973b; DiMarco et al., 1976). Blood glucose levels decrease again 
from about 6 h after birth in fasting conditions (Girard et al., 1973b). The 
newborn rat normally starts to suckle from about 2-3 h of age and the glucose 
levels remain stable after 6 h of age. (Gain and Watts, 1976). 
bloedglucose (mmol /1) 
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Fig. 4.2. Blood glucose concentrations from 0-16 h after birth in the fasted rat (adapted from 
Girard et al., 1973b) 
What causes the blood glucose levels to rise from a few hours after birth in the 
fasted rat? To answer this question we have to discuss both glycogenolysis and 
gluconeogenesis. 
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Glycogenolysis is the first glucose providing pathway which appears after birth 
and the main source of glucose until gluconeogenesis, fatty acid oxidation and 
calorie intake are established. High concentrations of hepatic glycogen are stor-
ed at term. The hepatic glycogen stores are 80 - 100 mg per gram liver wet weight 
in man and rat (Shelley, 1961; Girard, 1975a). Immediately after birth the 
appropriate enzyme activities show relevant changes. Phosphorylase activity rises 
in newborn rats (Cake and Oliver, 1969; Girard et al., 1973a; Bashan et al., 1979) 
mainly due to activation of its inactive form. Glucose-6-phosphatase activity also 
increases (Chanez et al., 1971). The activity of glycogen synthetase, on the other 
hand, falls already before birth (Devos and Hers, 1974; Pines et al., 1975 ; Bashan 
et al., 1979). 
Depletion of glycogen stores occurs soon after birth in fasted rats (Shelley, 1961 ; 
Dawkins, 1963; Ballard and Oliver, 1963; Ballard, 1971b; Bashan et al., 1979; 
De Meyer et al., 1979). After 8 h 50% (Ballard, 1971b) and after 24 h only 10% 
(Shelley, 1961) is left in the rat liver. Glycogen depletion is partially prevented by 
glucose administration (Dawkins, 1963; Girard et al., 1973a). 
The lag period of about 2 h before glycogenolysis becomes active after birth 
(Dawkins, 1963; Cake et al., 1971; Girard et al., 1972; Snell and Walker, 1973a) 
probably causes the dip in the glucose concentration at about 2 h after birth. 
The gluconeogenic pathway is depicted in Fig. 4.3. Most gluconeogenic substrates 
enter the gluconeogenic pathway through pyruvate and oxaloacetate. Glycerol 
enters at the dihydroxyacetone phospate step. Pyruvate is first carboxylated to 
oxaloacetate within the mitochondrion by pyruvate carboxylase. 
Oxaloacetate does not readily cross the mitochondrial inner membrane (Haslam 
and Krebs, 1968). The next gluconeogenic key enzyme, phosphoenolpyruvate 
carboxykinase, is located mainly in the cytosol in the rat (Hanson and Garber, 
1972). In human liver, however, this enzyme is located both in the mitochondrion 
and in the cytosol (Wieland et al., 1968; Diesterhaft et al., 1971). Because of the 
cytosolic localization of phosphoenolpyruvate carboxykinase in the rat liver, 
oxaloacetate has to be transported from the mitochondrion into the cytosol. 
Shuttle systems, involving reduction to malate or conversion to aspartate, operate 
to transfer oxaloacetate into the cytosol (Lardy et al., 1965; Krebs et al., 1967; 
Ferré and Williamson, 1978c). In human liver, oxaloacetate can also be converted 
to phosphoenolpyruvate by intramitochondrial phosphoenolpyruvate carboxyki-
nase. Phosphoenolpyruvate is converted to fructose- 1,6-disphosphate in the 
cytosol by a reversal of the glycolytic sequence. Fructose-1,6-diphosphate is 
dephosphorylated to fructose-6-phosphate by fructose-1,6-diphosphatase. 
Fructose-6-phosphate is converted to glucose-6-phosphate by hexosephosphate 
isomerase. Glucose is formed by glucose-6-phosphatase. In the overall gluconeo-
genic sequence, 6 moles of ATP and 2 moles of NADH are required to produce 1 
mol of glucose from pyruvate. Pyruvate carboxylase requires acetyl-CoA for ac-
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tivation. Fructose-1,6-diphosphatase is strongly inhibited by AMP. The rate of 
gluconeogenesis is influenced by the redox state of the mitochondrion and the 
cytosol. A high ratio of NADH / NAD + in the mitochondria and a low ratio in the 
cytosol favor the transport of reducing equivalents to the cytosol. Free fatty acid 
oxidation stimulates gluconeogenesis by increasing the intramitochondrial con-
centrations of acetyl-CoA and NADH (Ferré et al., 1978b). Several hormones 
are of regulatory importance. Glucagon and epinephrine accelerate gluconeo-
genesis whereas insulin depresses the rate of gluconeogenesis. 
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The normal developmental pattern of gluconeogenesis in the neonatal period in 
rat and man will be discussed next. Figure 4.4 shows the developmental patterns 
of the activities of the four gluconeogenic key enzymes and the increase of 
gluconeogenesis from labelled lactate in rat liver after birth. 
Pyruvate carboxylase activity in rat liver is located mainly in the mitochondria; 
only 10% is located in the cytosol (Böttger et al., 1969; Ballard and Hanson, 
1967b; Saggerson and Evans, 1975; Chang, 1977). Its activity increases from the 
18th day of gestation to peak values above the adult level at one week of age in 
rat liver (Ballard and Hanson, 1967b; Yeung et al., 1967b; Räihä and Lindros, 
1969). 
Premature or postmature birth has virtually no effect on the developmental 
pattern of pyruvate carboxylase activity (Chang, 1977). Birth itself does not 
change the velocity of increase in enzyme activity (Yeung et al., 1967b). Table 4.1 
relative change inactivity 
pyruvate carboxylase 
"T 1 ι ι r — 
Τ 4 8 12 16 20 
days after b i r th 
Fig. 4.4. Developmental pattern of the activities of gluconeogenic key enzymes and of gluconeo­
genesis m rat liver (from Tilghman et al., 1976) 
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Table 4.1 Pyruvate carboxylase activity m the neonatal period in rat and human liver (in μ mol/ 
min per g liver) 
Rat liver Ballard and Hanson, 1967b* Chang, 1977 
(mitochondrial 
activity) 
at term 6 
4 h 
8 h 
2 days 11.5 
7 days 14 
14 days 10 
Human liver 
(total activity) Marsac et al , 1976 
1 day 4.30 ± 0 40 
10 days 8* 
15 days 6 00 ± 1.69 
* Estimated from a figure 
shows values of pyruvate carboxylase activities from the literature in the early 
neonatal period in rat and human liver. 
Only the cytosolic form of phosphoenolpyruvate carboxykinase is involved in 
gluconeogenesis and responsive to hormonal stimuli (Shrago et al., 1963 ; Nordlie 
et al., 1965). Mitochondrial phosphoenolpyruvate carboxykinase activity does 
not increase after birth in rat liver (Ballard and Hanson, 1967b). Phosphoenolpy­
ruvate carboxykinase activity in the soluble fraction of the rat liver increases 
dramatically in the first few days after birth (Ballard and Hanson, 1967b; Yeung 
et al., 1967b; Philippidis et al., 1972). Enzyme activity is virtually absent in fetal 
rat liver, but appears within a few hours after birth, probably triggered by this 
event (Girard et al., 1973b; Pearce et al., 1974; DiMarcoetal., 1976). Premature 
delivery in the rat results also in development of this enzyme (Yeung and Oliver, 
1967c). The time-lag is more pronounced when the rats are born more prematu­
rely (DiMarco et al., 1976). The activity of phosphoenolpyruvate carboxykinase 
in the liver of human newborns increases sharply from a few days after delivery 
and reaches its peak value at about 10 days (Marsac et al., 1976). Table 4.2 shows 
values from the literature on phosphoenolpyruvate carboxykinase activity in the 
early neonatal period in rat and man. 
1 86 ± 0 08 
2.34 ± 0 16 
2.62 ± 0.15 
35 
Table 4.2 Phosphoenolpymvate carboxykinase activity in the neonatal period in rat and human 
liver* 
Rat liver 
Age (h) 
at term 
1 
2 
3 
4 
5 
6 
8 
16 
Human 
liver 
Age (days) 
1 
3 
7 
10 
Ballard, 1971b 
(fimol/h per 
liver) 
I 
2.0 ± 0.8 
2.0 ± 0.9 
3.2 ± 1.2 
7.3 ± 1.5 
10.5 ± 2.1 
15.6 ± 4.1 
17.3 ± 4.5 
26.6 ± 4.9 
Girard et al., 
1973b 
(nmol/h per mg 
protein) 
24 ± 3 
48 ± 4 
240 ± 28 
1140 ± 90 
1440 ± 120 
1800 ± 120 
Marsacet al., 1976 
(//mol/min per g 
7.5 
8.5 
12.0 
18.0 
liver)" 
Pearce et al., 
1974 
(μ mol/h per g 
liver)** 
0.6 
0.8 
2.0 ± 0.2 
6.3 ± 1.0 
8.0 ± 1.7 
10 ± 1.7 
DiMarco et al., 
1976 
(μ mol/h per g 
liver)** 
3 
4 
10 ± 3 
20 ± 6 
28 ± 6 
27 ± 3 
* AH values are activities of total liver, except those presented from Girard et al. for cytosol 
** Estimated from a figure 
Fructose-1,6-diphosphatase is located in the cytosol. Its activity in rat liver 
increases from a few days before birth (Ballard and Oliver, 1962; Yeung et al., 
1967b; Vernon and Walker, 1968a; Chanez et al., 1971; Schaub et al., 1972). 
The activity of this enzyme in neonatal human liver increases also after birth 
(Räihä and Lindros, 1969; Marsac et al., 1976). 
Premature delivery in the rat does not change the developmental pattern of 
fructose-1,6-diphosphatase activity (Yeung and Oliver, 1967c). Table 4.3 shows 
hepatic activities of this enzyme, taken from the literature. 
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Table 4.3 Activities of fructose-1,6-diphosphaiase in the early neonatal period in rat and human 
liver 
Rat 
liver 
Age 
at term 
0-3 h 
Iday 
3 days 
5 days 
7 days 
10 days 
Human 
liver 
Age (days) 
at term 
7 
15 
Ballard and Oliver, 
1962 
(ftmoVh per g liver)* 
50 
100 ± 10 
240 ± 10 
Marsac et al., 1976 
(μ mol/min per g liver) 
1.20 ± 0.20 
2.8* 
3.00 ± 1.13 
Raihà and Lindros, 
1969 
(pmoVmin per g liver) 
2.5 
4.0 ± 1.0 
Chanez et 
al., 1971 
(mg Pi/20 min per g liver) 
0.69 ± 0.33 
1.20 ± 0.85 
3.40 ± 1.21 
4.21 ± 1.92 
8.40 ± 1.02 
7.34 ± 1.54 
1
 Estimated from a figure 
Glucose-6-phosphatase activity is located in the endoplasmic reticulum. During 
the last 5 days of gestation the activity increases in rat liver. After birth a further 
increase is found to levels above those in adult liver (Dawkins, 1963; Yeung 
et al., 1967b; Vernon and Walker, 1968a; Chanez et al., 1971; Schaub et al., 
1972; Girard et al., 1973b). Premature delivery results only to a small extent 
in a rise of the enzyme activity (Yeung and Oliver, 1967c). Table 4.4 shows 
values from the literature for the activity of glucose-6-phosphatase in the early 
neonatal period in the rat liver. Considerable glucose-6-phosphatase activity has 
been found in liver of human fetuses aged 22-38 weeks. (Auricchio and Rigillo, 
1960). No other values for this enzyme in fetal or neonatal human liver are 
known. 
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Table 4.4 Activities of glucose-6-phosphatase in the neonatal period in the rat liver 
Age 
at term 
0-3 h 
4 h 
6 h 
1 day 
Dawkins, 1963 
(μ mol/h per mg 
16.7 ± 2.6 
22.8 ± 3.3 
28.9 ± 3.8 
N) 
Chanez et al., 
(mg Pi/10 mir 
liver) 
0.79 ± 0.02 
1.11 ± 0.30 
4.08 ± 0.85 
1971 
'Per g 
Girard et al., 1973b 
(pmol/h per mg protein) 
0.75 ± 0.04 
1.43 ± 0.04 
1.61 ± 0.04 
Gluconeogenesis, normally being absent before birth, develops soon after deli­
very (Ballard and Oliver, 1963; Ballard, 1967b). The development parallels the 
increase in activity of the gluconeogenic key enzymes. The relationship between 
the development of phosphoenolpyruvate carboxykinase and gluconeogenesis is 
especially striking (Fig. 4.4; Yeung and Oliver, 1967c; Ballard and Hanson, 
1967b; Ballard, 1971b). Cytosolic phosphoenolpyruvate carboxykinase is 
thought to be an important controlling factor in overall gluconeogenesis in the rat 
(Hanson et al., 1975). 
The development of both cytosolic phosphoenolpyruvate carboxykinase activity 
and gluconeogenesis is triggered by the birth process (Yeung and Oliver, 1967c). 
There exists, however, a time-lag of about 2 h in the appearance of both. Because 
blood glucose levels decrease during the first hours after birth, a low blood 
glucose level might be the trigger (Yeung and Oliver, 1968b). Development of 
gluconeogenesis is inhibited by glucose administration in the newborn rat (Yeung 
and Oliver, 1968a; Girard et al., 1973a). 
Data on gluconeogenesis in the newborn rat were obtained in several studies. The 
in vivo incorporation rate of labelled lactate into hepatic carbohydrate increases 
rapidly after birth in the rat (Philippidis and Ballard, 1969; Ballard, 1971a; 
Vernon and Walker, 1972; Pearce et al., 1974; Girard et al., 1975b). Lactate 
concentrations at birth are high, but fall rapidly in the first hours of life (Girard et 
al., 1973b; De Meyer et al., 1979). It was suggested recently that lactate is utilized 
by oxidation during the first hours after birth in the rat, gluconeogenesis from this 
substrate being insignificant (Medina et al., 1980). The incorporation rate of 
pyruvate into hepatic carbohydrate in rat liver slices increases sharply after birth 
(Vernon et al., 1968b). The incorporation rate of amino acids into hepatic car­
bohydrate in vivo and in vitro increases from a few hours after birth (Yeung and 
Oliver, 1967a; Vernon et al., 1968b; Girard et al., 1975b). Glycerol might be an 
important gluconeogenic substrate in the newborn rat as well (Vernon et al., 
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1968b; Vernon and Walker, 1970; Ward and Walker, 1972). In the human 
newborn, gluconeogenesis from labelled alanine is active by 6 h of age (Frazer 
et al., 1979). 
The hormonal regulation of gluconeogenic activity after birth has not completely 
been elucidated. Glucagon plays an important role. Treatment of cultured fetal 
rat hepatocytes with glucagon results in an increase of cytosolic phosphoenolpy-
ruvate carboxykinase activity (Bulanyi et al., 1979). Injection of glucagon in utero 
results in development of phosphoenolpyruvate carboxykinase activity in rats 
(Yeung and Oliver, 1968a; Girard et al., 1973a; Hanson et al., 1973). 
Injection of dibutyryl cyclic AMP has the same effect (Yeung and Oliver, 1968b; 
Hanson et al., 1973). The increase of phosphoenolpyruvate carboxykinase acti-
vity is due to protein synthesis (Philippidis et al., 1972; Hanson et al., 1973). 
Glucagon and dibutyryl cyclic AMP stimulate the incorporation of alanine into 
glucose in human fetal liver expiants (Schwartz and Rail, 1975a). 
Glucagon administration to newborn rats at delivery results in an increase of the 
incorporation rate of lactate into glucose (Snell and Walker, 1973b). Plasma 
glucagon and hepatic cyclic AMP concentrations rise sharply in the first hours 
after birth in the rat (Girard et al., 1972; Blázquez et al., 1974; Dimarco and 
Oliver, 1978a; DiMarco et al., 1978b). In human newborns, plasma glucagon 
levels were also found to rise (Blázquez et al., 1974). 
Plasma insulin levels, in contrast to glucagon levels, fall in the early neonatal 
period in the rat (Girard et al., 1973b; Blázquez et al., 1974). 
Insulin injection in utero represses the synthesis of phosphoenolpyruvate car-
boxykinase in the rat (Yeung and Oliver, 1968b). Administration of this hormone 
at delivery prevents the normal development of phosphoenolpyruvate carboxy-
kinase activity (Girard et al., 1973a). Insulin decreases the incorporation rate of 
alanine into glucose in human fetal liver expiants (Schwartz and Rail 1975a). The 
glucagon/insulin ratio increases in the first hours after birth (Girard et al., 1973b; 
DiMarco et al., 1978b). 
It is generally accepted that glucagon initiates the appearance of gluconeogenesis 
after birth through the action of cyclic AMP (Girard et al., 1973a, 1974; Snell and 
Walker, 1978; DiMarco et al., 1978b). 
The responsiveness of hepatic adenylate cyclase to glucagon was shown to in-
crease after birth in the rat (Vinicor et al., 1976). Glucocorticoids do not play a 
role in the initiation of gluconeogenesis in the rat (Yeung et al., 1967b; DiMarco 
et al., 1978b). 
4.2.3. Amino acids 
Amino acids and other gluconeogenic substrates such as lactate are present in 
high concentrations in plasma at birth in the rat (Haymond et al., 1972; Girard et 
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al., 1973b, 1975b, 1976) and in the human neonate (Mestyán et al., 1969a, 
1969b; Lindblad and Baldesten, 1969; Lindblad, 1970). In fasted rats, Girard et 
al. (1975b) found a significant decline of the levels of most amino acids in plasma 
from birth until 16 h. The initial decline is very rapid as a result of the cessation of 
maternal supply. Mobilization of amino acids is regarded as a key process in the 
metabolic adjustment to extrauterine life (Mestyán, 1978). 
The amino acids which are important glucose precursors (alanine, serine, threon-
ine, glutamine and proline) show high levels at birth and the most marked decline 
after birth, probably as a result of increased hepatic uptake (Girard et al., 1975b). 
In the immediate period after birth in the rat, however, the rate of conversion of 
amino acids to glucose is low (Yeung and Oliver, 1967a; Vernon and Walker, 
1968b). Alanine is one of the most important substrates for gluconeogenesis 
(Felig, 1973). Snell (1975), however, found in perfused livers of 10 day-old 
neonatal rats a restricted conversion of loading amounts of alanine to glucose as a 
result of low activity of alanine aminotransferase and concluded that gluconeoge-
nesis from alanine is of minor significance in the suckling rat. 
Incorporation of labelled alanine into proteins in the liver of newborn rats 
decreases sharply within 2 h after birth, followed by an increase until 6 h (Ferré 
and Girard, 1976). The conversion rate of serine to glucose increases during the 
first days after birth in the rat (Snell and Walker, 1973c). An increase of conver-
sion of alanine and serine to blood glucose was observed from 2 till 6 h after birth 
in the rat (Girard et al., 1975b). From 6 till 16 h after birth, conversion of these 
amino acids to glucose decreased in fasted rats. The administration of alanine or 
serine to 16 h fasted newborn rats resulted in a small but significant rise of blood 
glucose levels. Injection of a mixture of gluconeogenic substrates into fasted new-
born rats 15 h after birth was shown to result in a two-fold increase in blood glu-
cose (Ferré et al., 1978b). These data indicate that the diminished availability of 
gluconeogenic substrates could be the cause of the observed decrease of conver-
sion of amino acids to glucose. Haymond et al. (1972) concluded that a defi-
ciency of endogenous gluconeogenic substrates could limit glucose homeostasis in 
the neonatal period in the rat since intraperitoneal injection of alanine in fasted 
newborn animals evoked a rapid increase of blood glucose levels. 
Oral (Williams et al., 1975) or intravenous (Delamater et al., 1974; Mestyán et 
al., 1974; Sperlingetal., 1974; Sann et al., 1978) administration of alanine on the 
first day of life in the normal newborn baby results in a significant rise of blood 
glucose levels and glucagon concentration. Because alanine stimulates the release 
of glucagon which is known to stimulate glycogenolysis and gluconeogenesis, the 
effect of alanine on glucose metabolism could result from glycogenolysis. 
Reisner et al. (1973) found that the effect of glucagon injection on blood glucose 
levels in neonates was less on the first day of life than on the third day and 
speculated that the hepatic uptake of amino acids after glucagon stimulation is 
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impaired in the neonate on the first day of extrauterine life. A not yet fully 
developed hepatic sensitivity to glucagon in the early neonatal period (Vinicor et 
al., 1976) could explain this observation. When alanine is administered to 3 
day-old newborns, the glycémie response is more pronounced than in 1 day-old 
newborns in spite of the fact that the rise of glucagon levels after alanine admini-
stration is the same in 1 and 3 day old babies (Sperling et al., 1974). These authors 
concluded that a diminished availability of substrates or inability to mobilize them 
might play a role in neonatal hypoglycemia. Alanine administration to preterm, 
appropriate-for-gestational-age newborns does not result in a rise of blood glu-
cose levels, in spite of stimulated glucagon secretion (Sann et al., 1978). This 
suggests a lower sensitivity to glucagon in preterm babies. 
Cresteil and Leroux (1977) studied catabolism of amino acids in vivo in early 
newborn rats by measuring respiratory 14C02 after intraperitoneal injection of 
labelled precursors. During the first two hours after birth and before gluconeoge-
nesis becomes active the 14C02 production from glutamate and alanine is consi-
derable when compared to glucose oxidation. This suggests that these amino acids 
might be oxidized directly by neonates. 
In conclusion, there are many indications that amino acid metabolism plays an 
important role in neonatal metabolic adaptation. The availability of amino acids 
as substrates for glucose formation might be limited in the fasted state, when 
weaning is postponed. 
4.2.4. Fatty acids 
Plasma concentrations of free fatty acids rapidly increase after birth in suckling 
rats, but in fasted rats the increase is more gradually (Girard et al., 1973b; Snell 
and Walker, 1973a; Ferré et al., 1978d) since the newborn rat has virtually no 
white adipose tissue. Suckling in the rat begins at about 2 h after birth. Rat milk 
contains a high content of fat and small amounts of carbohydrate. Cold exposure. 
of the newborn rat causes a steep rise in fatty acid concentration in the first hours 
after birth as a result of lipolysis in brown adipose tissue (Ferré et al., 1978d). The 
activities of enzymes of fatty acid oxidation increase markedly at birth in the rat 
liver (Foster and Bailey, 1976a). Hepatic oxidation of fatty acids increases also 
(Bailey and Lockwood, 1973; Foster and Bailey, 1976b; Yeh and Zee, 1979) and 
serves as the main supply of energy throughout the suckling period, when fat 
intake is high. Fatty acid oxidation is necessary for gluconeogenesis by providing 
energy, reducing equivalents and acetyl-CoA necessary for pyruvate carboxylase 
activation (Mestyán et al., 1976; Ferré et al., 1978a, 1978b, 1979; Sabel et al., 
1979). Inhibition of fatty acid oxidation results in a decrease of gluconeogenesis 
(Pégorier et al., 1977). Feeding of triglycerides stimulates gluconeogenesis in 
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fasted newborn rats (Ferré et al., 1978b). In the human newborn, lipolysis 
increases immediately after birth and results in increased levels of free fatty acids 
(Novak et al., 1964; Persson and Tunell, 1971; Novak and Monkus, 1972. The 
normal human newborn has, in contrast to the rat, white as well as brown adipose 
tissue. 
In conclusion, fatty acids become important fuels after birth. Due to the absence 
of subcutaneous white fat in the newborn rat, the rate of lipolysis in the immediate 
neonatal period differs between rat and man. 
An important interaction between lipid and carbohydrate metabolism may con-
tribute to the metabolic adaptation after birth, especially in the neonatal period. 
4.2.5. Ketone bodies and carnitine 
The rise of free fatty acid concentrations in the blood of the suckling rat after birth 
is followed by an increase in the concentration of ketone bodies (Snell and 
Walker, 1973a; Wapnir et al., 1973; Yeh and Zee, 1976; Yeh et al., 1977a; Ferré 
et al., 1978d) as a result of hepatic ketogenesis. Fig. 4.5 gives a schematic 
representation of fatty acid oxidation and ketogenesis. Onset of hepatic ketoge-
nesis after birth is rather slow in the rat, even when high levels of free fatty acids 
are present in the blood (Fig. 4.6 and 4.7). The rise of ketone body concentrations 
in the suckling rat occurs when hepatic glycogen is rather depleted (Ferré et al., 
1978d). The reciprocal relationship between glycogen stores and ketogenesis is 
found in the adult rat as well (Robles-Valdes et al., 1976). So, glycogen depletion 
seems to be a strong stimulus for hepatic ketogenesis. 
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It is still questionable whether the carnitine concentration of the liver plays a role 
in the regulation of ketogenesis and fatty acid oxidation. Carnitine facilitates 
transport of fatty acids across the mitochondrial membrane (Pande, 1975). 
Hepatic carnitine concentration increases after birth (Robles-Valdes et al., 1976; 
Borum, 1978; Yeh and Zee, 1979), and is supplied by the mother's milk 
(McGarry and Foster, 1977). 
In the normal human newborn, the high concentrations of ketone bodies at birth, 
originating from the maternal circulation, decrease rapidly after birth (Persson 
andTunell, 1971;Haymondetal., 1974). Ketogenesis increases from a few hours 
after delivery (Haymond et al., 1974). The concentration of free plasma carnitine 
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changes only slightly in the perinatal period in man (Schmidt-Sommerfeld et al., 
1978), but that of acetyl-carnitine increases after birth in man (Novak et al., 
1979) and rat (Seccombe et al., 1978). 
The rise of acetyl-carnitine concentration most probably reflects acetyl-CoA 
production from fatty acid oxidation; there is a positive correlation between 
acetyl-carnitine and ketone body concentration in man (Novak et al., 1979). 
The activities of the enzymes of the carnitine acyltransferase system increase after 
birth in rat liver (Augenfeld and Fritz, 1970; Lockwood and Bailey, 1970; Foster 
and Bailey, 1976a). On the other hand, additional supply of carnitine does not result 
in increased ketogenesis in the newborn rat and the time course of the rise in hepatic 
carnitine and blood ketone bodies after birth is different (Ferré et al., 1978d). 
Feeding newborn rats with triglycerides without carnitine results in an increase 
of blood concentration of ketone bodies (Ferré et al., 1978b; Yeh et al., 1978). 
The increase in the blood concentration of ketone bodies after birth is the 
result of an increased production, rather than a failure to utilize them (Ferré et al., 
1978d), because the enzyme activities for ketone body utilization increase after 
birth (Bailey and Lockwood, 1973). An inverse relationship was demonstrated 
between the concentrations of ketone bodies and insulin and administration of 
insulin suppressed plasma ketone bodies (Yeh and Zee, 1976). So, enhanced 
ketosis after birth may be related to the low insulin levels during this period. It can 
be concluded that the ketogenic potential is established in the neonatal period, 
but that ketone bodies do not play a significant role as fuel in the first period after 
birth in rats. Inhibition of gluconeogenesis with 3-mercaptopicolinate in suckling 
16 h-old newborn rats results in a fall in blood glucose concentration in spite of the 
high plasma concentrations of free fatty acids and ketone bodies (Ferré et al., 
1977). A potential glucose sparing effect of ketone body utilization obviously is 
not sufficient to maintain a normal blood glucose concentration. However, ke-
tone bodies can be utilized as alternative substrates in stead of glucose by the 
neonatal rat brain (Williamson, 1975; Dahlquist and Persson, 1976) and are 
preferred over glucose as substrates for lipid synthesis in rat brain tissue (Yeh et 
al., 1977b; Stumpf and Kraus, 1979). In developing fetal and neonatal human 
brain, utilization of ketone bodies occurs (Page and Williamson, 1971; Patel et 
al., 1975) but accounts for only ten per cent of the total energy balance of the 
brain (Kraus et al., 1974). 
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Chapter 5. 
ENERGY METABOLISM IN THE PERINATAL PERIOD IN 
INTRAUTERINE GROWTH RETARDATION 
5.1. Fetal energy metabolism 
Reduced uteroplacental blood flow results in intrauterine growth retardation 
(IUGR) since the fetus is entirely dependent upon the maternal circulation for 
nutrition and the supply of metabolic substrates will be reduced under these 
conditions. 
Placental transport of glucose and amino acids in intrauterine growth retardation 
was recently studied in the rat (Nitzan et al., 1979). Transfer of labelled 2-
deoxyglucose and a- aminoisobutyric acid, which undergo little or no further 
intracellular alteration, is reduced in term IUGR fetuses. The fetal liver adapts to 
the reduced glucose supply by enhanced extraction of glucose from the circula-
tion. Blood glucose concentrations are lower in IUGR rat fetuses than in control 
fetuses (Chanez et al., 1969; Roux et al., 1970; Nitzan and Groffman, 1970; 
Hohenauer, 1971). Glycogen deposition is also lower in the liver of IUGR rat 
fetuses (Nitzan and Groffman, 1970; Oh et al., 1970; Roux et al., 1970; Hohe-
nauer, 1971; Manniello et al., 1977a), especially during the last two days of 
gestation (Oh et al., 1970; Hohenauer, 1971). The liver of the fetal IUGR rat 
seems, however, to be enzymatically well equipped for glycogen synthesis be-
cause a markedly increased level of glycogen synthesis from labelled glucose was 
found in vivo (Oh et al., 1968) and in vitro (Nitzan and Groffman, 1971a) 
compared to littermates from the contralateral uterine horns. A significant corre-
lation between mean plasma glucose levels and total liver glycogen content at 
birth was established in IUGR rats (Manniello et al., 1977a). Glucose infusion 
into the mother prior to delivery results in a higher blood glucose level and a 
higher hepatic glycogen content at birth in these rats (Oh et al., 1970; Hohenauer, 
1971). The available data indicate that the reduced liver glycogen content in 
IUGR of the rat is the result of inadequate glucose transfer from the maternal 
circulation. No data are available about the role of fat in energy metabolism 
during the fetal period in IUGR. The human small-for-gestational-age fetus has, 
like the normal rat fetus, only very limited amounts of white adipose tissue. 
Some hormonal changes occur in IUGR rat fetuses near term. Plasma insulin 
levels are lower and plasma glucagon levels are higher together with decreased 
blood glucose concentrations compared to control fetuses (Girard et al., 1974, 
1976a). Corticosterone levels in fetal IUGR rats were similar to those in controls 
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(Chanez-Bel and Tordet-Caridroit, 1975). 
In summary, the available data point to the existence of a primary lack of 
metabolic fuels in the IUGR fetus which results in a limited storage of energy 
reserves. 
5.2. Neonatal energy metabolism 
5.2.1. Glucose 
Blood glucose concentrations are lower in the early neonatal period compared to 
controls in the IUGR rat (Chanez et al., 1971, 1972; Manniello et al., 1977a; 
Pollak et al., 1979; Siegel et al., 1979) and the IUGR newborn infant (Cornblath 
and Schwartz, 1976). Early neonatal hypoglycemia between 2 and 4 h of age can 
be prevented by antenatal injection of corticosteroids into the mother of IUGR 
rat fetuses (Manniello et al., 1977a). 
The glucose utilization rate, calculated from the clearance rate of intravenously 
injected glucose is increased in hypoglycemic small-for-gestational-age newborn 
infants (Le Dune, 1972; Soltész et al., 1972; Pildes et al., 1973; Horváth et al., 
1975). 
Glycogen stores, being reduced at birth after intrauterine growth retardation, are 
rapidly mobilized after delivery. The greatest part of liver glycogen stores is 
mobilized within 6 h after birth in both IUGR and normal newborn rats and at the 
age of 24 h hepatic glucogen content reaches its lowest value (Chanez et al., 
1971). The significant reduction of hepatic glycogen content at the age of 2-4 h in 
the IUGR rat is not observed after prenatal corticosteroid treatment of the 
mother (Manniello et al., 1977a). 
Hepatic gluconeogenesis was not studied extensively in the early neonatal period in 
IUGR. Glucose production from alanine was studied in the IUGR rat and man. In 
liver slices of these rats, the conversion of alanine to glucose is significantly lower 
than in those of control animals (Nitzan and Groffman, 1971b). Reports on the 
glycémie response after alanine administration to newborn babies show contra-
dictory results. Oral administration of alanine in a dose of 500 mg per kg body 
weight resulted in a glycémie response in normal newborns, whereas in small-
for-gestational-age infants no response occurred (Williams et al., 1975). In this 
study, however, fasting blood glucose levels in the small-for-gestational-age 
group were higher than in the group of normal infants. In normal infants, intra-
venous injection of alanine in a dose of 500 mg per kg body weight results in a 
significant glycémie response only when the fasting blood glucose level is in the 
hypoglycemic range (Kollée et al., unpublished). Intravenous injection of alanine 
in a dose of 125 mg per kg body weight to newborn babies resulted in a glycémie 
response which was lower in small-for-gestational-age infants than in normal 
newborns despite the lower fasting blood glucose levels in the former group 
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(Mestyán et al., 1974). This diminished glycémie response was even more pro-
nounced in hypoglycemic small-for-gestational-age infants (Sóvik and Finne, 
1977). Incorporation of labelled alanine into glucose in small-for-gestational-age 
newborn babies between 4-8 h of postnatal age was not significantly different 
from that in normal infants (Frazer et al., 1979). Disappearance of intravenously 
injected alanine from the blood is slower in IUGR newborns on the first day of life 
(Mestyán et al., 1974). In the interpretation of these data, stimulation of glycogen 
breakdown by alanine via glucagon and utilization of glucose have to be taken 
into account. Exogenous glucagon administration to hypoglycemic IUGR new-
born babies during the first day of life results in an increase in the blood glucose 
level which is not different from that in normal babies and nonhypoglycemic 
IUGR controls indicating that the glycogenolytic pathway is intact (Falorni et al., 
1975). The decrease of amino acid concentrations after glucagon administration 
on the first day of life was less in small-for-gestational-age newborns than in 
normal full-term infants (Reisner et al., 1973). It must be concluded from the 
available data that IUGR might result in inadequate glucose production in the 
neonatal period. 
With respect to the development of hepatic gluconeogenic key enzymes in IUGR 
no data are available on the human infant and limited data on the rat. Develop-
ment of glucose-6-phosphatase activity after birth was similar in IUGR and 
control rats (Chanez et al., 1971; Siegel et al., 1979). A slight delay in the 
development of fructose-1,6-diphosphatase was established in IUGR rats, but 
the activity reached its peak value at 5 days of age as in control animals (Chanez et 
al., 1971; Siegel et al., 1979). Pollak et al. (1979) reported recently that the 
activity of phosphoenolpyruvate carboxykinase at 4 h after birth was significantly 
lower in IUGR rats than in control animals. 
5.2.2. Amino acids 
Significantly higher total serum amino acid concentrations were found at birth in 
IUGR rats compared to control animals (Roux and Jahchan, 1974; Manniello et 
al., 1977b). 
Gluconeogenic amino acids (alanine, glycine, proline, valine) were particularly 
elevated, decreasing rapidly from 2 - 4 h after birth (Manniello et al., 1977b). 
Prenatal treatment of IUGR animals with corticosteroids caused a reduced 
tendency to develop hypoglycemia (Manniello et al., 1977a). In this group of 
animals gluconeogenic amino acid concentrations at birth were higher than in 
untreated animals, alanine especially showed much higher concentrations (Man-
niello et al., 1977b). These authors concluded that prenatal treatment with corti-
costeroids is associated with both greater availability and increased utilization of 
gluconeogenic amino acids. 
Some data are available on amino acid concentrations in IUGR newborn infants. 
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In the postnatal period (3-12 h after birth) in these infants a hyperaminoacidemia 
was found which was even more pronounced in hypoglycemic small-for-
gestational-age newborns (Mestyán et al., 1975). Haymond et al. (1974) found 
elevated cord blood levels of alanine, aspartate, serine, glycine and threonine in 
small-for-gestational-age newborns. At 2 h after birth concentration of amino 
acids entering the gluconeogenic pathway at the pyruvate step were still elevated, 
whereas the concentration of aspartate, entering at the oxaloacetate step, was 
normalized. At 24 h of life, alanine levels were still elevated. 
Reisner et al. (1973), however, found a lower total amino acid concentration in 
small-for-gestational-age newborns compared to normal full-term infants at a 
mean age of 7.5 h. An inverse correlation between blood glucose and alanine 
concentrations was established (Haymond et al., 1974; Mestyán et al., 1975). 
The rise of blood glucose concentrations in small-for-gestational-age infants after 
administration of fat emulsion is accompanied by a fall in gluconeogenic amino 
acid concentrations (Mestyán et al., 1976), probably as a result of increased 
gluconeogenesis. 
In summary, the IUGR individual seems to accumulate important gluconeogenic 
substrates in the first period immediately after birth. 
5.2.3. Free fatty acids 
Free fatty acid concentrations were lower in fed IUGR newborn rats than in 
control animals during the first day of life (Roux et al., 1970; Chanez and 
Tordet-Caridroit, 1972); the rise of free fatty acid concentrations occurred later, 
at the age of 12 h. 
Neonatal hypoglycemia in the fasting rat could partially be reversed by oral 
feeding with triglycerides or gluconeogenic substrates, but in combination a 
complete reversal could be obtained (Ferré et al., 1978). 
The small-for-gestational-age human baby has, like the normal newborn rat, only 
small fat stores. In these infants free fatty acid concentrations were reported to be 
significantly higher compared to preterm babies (Gentz et al., 1969; Christensen, 
1977). In another study (Harris, 1974), free fatty acid concentrations in term 
small-for-gestational-age newborns were found to be significantly lower from 3 
till 72 h after birth than in term appropriate-for-gestational-age newborns. 
The data of Gentz et al. ( 1969) refer to values at variable times during the first day 
of life and those of Christensen (1977) to cord blood values. Reports on free fatty 
acids concentrations in small-for-gestational-age newborn infants are thus confu-
sing. In a comparison of hypoglycemic with nonhypoglycemic small-for-
gestational-age newborns, de Leeuw and de Vries (1976) found a smaller in-
crease in free fatty acid levels from birth till 6 h of age in the former, probably due 
to a diminished lipolysis. When low-birth-weight infants are fed with fat emul-
sions the rate of fatty acid oxidation and gluconeogenesis increases (Mestyán et 
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al., 1976). It was suggested that a lack of availability or oxidation of fatty acids in 
IUGR results in insufficient energy production for optimal gluconeogenesis 
which could cause neonatal hypoglycemia in these infants (Ferré et al., 1978). 
In summary, the available data point to a reduced contribution of fat metabolism 
to the metabolic demands in the neonatal period after IUGR. 
5.2.4. Ketone bodies 
Ketone body metabolism was not extensively studied in IUGR. Plasma concen-
trations of ketone bodies in IUGR rats were not statistically different from those 
in normal littermates from the day of birth till 60 days of age under a normal 
feeding regimen (Dahlquist and Persson, 1976). In 20-dayold IUGR rats, starved 
for 72 h, blood levels of ketone bodies were, however, significantly lower than in 
normal animals (Dahlquist, 1976). In IUGR rats under similar conditions cere-
bral uptake of ketone bodies was significantly lower whereas that of ketone 
bodies plus glucose was similar to controls (Dahlquist, 1976). It was concluded 
from these studies that IUGR rats are more dependent on glucose as a substrate 
for the brain during starvation. In rats, malnourished after birth, reduced incorpo-
ration of labelled glucose (Chase et al., 1976; Swiatek et al., 1979) and hydroxy-
butyrate (Swiatek et al., 1979) into brain lipids was demonstrated during the first 
two weeks of life. Activities of enzymes of ketone body utilization in liver and 
brain of these rats were normal (Swiatek et al., 1979). 
In small-for-gestational-age newborn infants, the ketone body concentrations in 
cord blood are high and similar to those in normal infants, which might reflect 
placental transfer (Haymond et al., 1974). Ketone body concentrations fall within 
2 h after birth in both small-for-gestational-age and normal newborns (Haymond 
et al., 1974). Thereafter, ketone body concentrations rise again in normal but 
remain low in small-for-gestational-age newborns (Haymond et al., 1974; Stan-
ley et al., 1979). The low values in these infants might reflect defective ketogene-
sis or increased utilization of ketone bodies (Haymond et al., 1974). Administra-
tion of triglycerides to small-for-gestational-age (Sabel et al., 1979) or preterm 
(Sann et al., 1980) newborns results in an increase in the β -hydroxybutyrate 
concentration as a result of increased fat oxidation. 
In summary these data point to the possibility of defective production and/or 
cerebral utilization of ketone bodies in IUGR. 
5.2.5. Insulin and glucagon 
Insulin and glucagon are important hormones in the regulation of carbohydrate 
metabolism in the neonatal period (Girard et al., 1975). Snell suggested that the 
fall in plasma insulin triggers glycogenolysis and that the rise in plasma glucagon 
after birth initiates gluconeogenesis (Snell and Walker, 1978). In both the IUGR 
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and normal rat, glucagon levels increase and insulin levels decrease after birth 
(Girard et a l , 1976). The increase of blood glucose concentrations after admini­
stration of glucagon to hypoglycemic IUGR newborn babies during the first day 
of life is similar to that in nonhypoglycemic small-for-gestational-age and normal 
newborns (Falorni et a l , 1975). No differences in plasma insulin and glucagon 
levels were found in the early neonatal period between small-for-gestational-age 
and normal newborn babies (Stanley et al., 1979). These data indicate that 
neonatal hypoglycemia in IUGR is not related to inappropriate secretion of these 
hormones. The low somatomedin activity in cord serum of small-for-
gestational-age newborns might reflect impaired intrauterine nutrition (Foley et 
a l , 1980). 
5.3. Conclusions 
From the available data the following conclusions can be drawn about the possible 
relations between IUGR and neonatal hypoglycemia. In intrauterine growth 
retardation. 
- less glycogen is stored in the fetal liver due to reduced glucose supply. 
- plasma glucose levels are decreased during the early neonatal penod. 
- development of gluconeogenic capacity after birth might be delayed since 
gluconeogenic substrates accumulate and some gluconeogenic key enzyme 
activities show lower values 
- a disturbed lipid metabolism can influence gluconeogenesis. 
- defective production or cerebral utilization of ketone bodies might influence 
glucose homeostasis. 
- hormonal regulation of carbohydrate metabolism by insulin and glucagon 
appears to be intact. 
- increased glucose utilization, for example by the brain, might contribute to 
the development of neonatal hypoglycemia. 
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Chapter 6. 
MATERIALS AND METHODS 
6.1. Experimental animal model 
6.1.1. Animals 
Female albino rats of the Wistar strain, weighing 150-200 g, were housed in the 
Central Animal Laboratory of this University. They were fed ad libitum. The 
animals were mated between 9 and 12 a.m. and conception was confirmed by the 
vaginal smear method. 
6.1.2. Ligation and sham-operation procedure 
The ligation technique was performed essentially as proposed by Wigglesworth 
(1964). Ligation of one of both uterine arteries was performed on the 17th day of 
gestation at 4 p.m. The abdomen was shaved, cleaned with iodine, and opened by 
a lower midline incision under light ether anesthesia. The whole uterus was 
exposed and a silk ligature was firmly placed around the main vessel near the 
Fig. 6.2. The ligation procedure in the Wigglesworth model 
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lower end of the uterine horn. This is shown in Figs. 6.1 and 6.2. After ligation the 
uterus was replaced in the abdominal cavity and the abdomen was closed in layers. 
Sham-operation was performed in the same way, without ligation. 
6.1.3. Delivery of the fetuses 
On the 21th day of gestation, at 9 a.m., the fetuses were delivered by caesarean 
section. The dams were sacrified by a blow on the head and cervical dislocation. 
Anesthesia was not used. Ether anesthesia presumably results in inhibition of 
gluconeogenesis (Philippidis and Ballard, 1970). The uterine wall was opened 
and the fetuses were removed by detaching the placentas. Fetal membranes were 
removed and the umbilical cord ligated. The fetuses were dried with gauze to 
prevent early hypothermia, weighed on a Mettler microbalance and placed in an 
incubator (Dräger, Lübeck). Relative humidity was approximately 65 per cent 
and environmental temperature 370C (thermal neutrality). Environmental tem-
perature influences carbohydrate metabolism in the first hours after birth in the 
rat. Cold exposure (250C) results in unresponsiveness of the beta cells to glucose 
and no transitory hypoglycemia is observed in this period (Girard and Zeghal, 
1975; Kervran et al., 1976). The newborn animals were not fed during their stay 
in the incubator. Fig. 6.3 shows two newborn litters in the incubator. 
Fig. 6.3. Two litters of newborn rats in the incubator 
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6.1.4. Blood sampling technique 
The thoracal wall was opened and blood was sampled by cardiac puncture using a 
sharp heparinized capillary. It was collected in test tubes which contained a 
minimal amount of solid sodium fluoride to prevent glycolysis. The plasma 
was separated by centrifugation and stored at -70oC. In the glucose turnover 
studies, the animals were decapitated and blood samples were collected from 
the carotic vessels in Eppendorf micro test tubes, containing 100 μί 1.0 M 
perchloric acid. The test tubes had exactly been weighed before on a Metti er НЗЗ 
microbalance. After mixing on a Vortex whirlmix the tubes were placed in a 
refrigerator at 40C until weighing again for calculation of the blood volumes 
collected. The tubes were centrifuged in an Eppendorf centrifuge 3200, for 2.5 
min at 9,000 χ g. 100 μ\ of the clear supernatant were mixed with 50 μί 0.7 M 
КзРОд and placed on ice for 15 min. Thereafter, the tubes were centrifuged again 
for 2.5 min at 9,000 χ g and 120μ1 of the supernatant were freeze-dried overnight 
to remove the 3Η2θ formed by glucose phosphate isomerase during glycolysis 
(Katz and Dunn, 1967). The freeze-dried powder was dissolved in 120μί water. 
6.1.5. Liver tissue preparation 
After exsanguination of the animal by cardiac puncture, its liver was excised as 
completely as possible and immediately frozen in liquid nitrogen. Afterwards 
livers were stored at -70oC until assays of enzyme activities were performed. 
6.2. Biochemical methods 
6.2.1. Chemicals 
The specific reagents used in this study are listed together with the suppliers. 
Citrate synthase (EC 4.1.3.7) phosphotransacetylase (EC 2.3.1.8), malate de­
hydrogenase (EC 1.1.1.37), lactate dehydrogenase (EC 1.1.1.27), pyruvate ki­
nase (EC 2.7.1.40), glucosephosphate isomerase (EC 5.3.1.9), glucose-6-
phosphate dehydrogenase (EC 1.1.1.49), amyloglucosidase (EC3.2.1.3.), hexo-
kinase (EC 2.7.1.1), carnitine acetyltransferase (EC 2.3.1.7), coenzyme A, cy­
tochrome c, acetyl-CoA, adenosine monophosphate, adenosine diphosphate, 
adenosine triphosphate, inosine triphosphate, reduced nicotinamide-adenine di-
nucleotide, oxidized nicotinamide-adenine dinucleotide phosphate, glutathione, 
pyruvate, oxaloacetate, acetyl-phosphate, fructose-l,6-diphosphate and 
glucose-6-phosphate: Boehringer, Mannheim, West-Germany. 
Instagel: Packard Instrument Co., Chicago, USA. 
L-carnitine: Sigma Chemical Co., St. Louis, USA. 
Aquasol and Omnifluor: New England Nuclear, Dreieichenhain, West-
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Germany. 
Sodium salt of [1-14C] bicarbonate, [1-14C] acetyl-CoA, [2-3H] glucose, [U-1 4C] 
palmitic acid and 6 3NiCk: Radiochemical Centre, Amersham, England. 
Active charcoal: Merck, Darmstadt, West-Germany. 
Silicid acid: Mallinckrodt Chemical Works, St. Louis, USA. 
All other chemicals were of the purest grade commercially available. 
6.2.2. Homogenization procedure 
A 5% (w/v) homogenate was prepared in ice-cold 2 mM EDTA, 5 mM Tris-HCl 
buffer (pH 7.4). Homogenization was performed by hand with a teflon-glass 
Potter-Elvehjem type homogenizer. The resulting homogenate was centrifuged 
for 10 min at 600 χ g to remove nuclei and cell debris. Supernatant was used for 
assay of enzyme activities and determination of protein concentrations. 
6.2.3. Protein concentration of the homogenate 
Protein concentration of the homogenates was determined according to Lowry et 
al. (1951), using bovine serum albumin as a standard. 
6.2.4. Plasma glucose 
Plasma true glucose was measured by the glucose-oxidase method in a Beekman 
glucose analyzer. 
In the glucose turnover studies, glucose concentration was assayed according to 
Bergmeyer et al. (1962) with slight modifications in the blood sample treatment 
as described in 6.1.4. A 50^1 sample of the prepared solution (see 6.1.4.) was 
mixed with 1 ml buffer solution, containing 0.3 M triethanolamine, 4 mM MgSOi, 
ImM ATP, 0.9 mM N A D P + and 3.5 U glucose-6-phosphate dehydrogenase, 
pH 7.5, in a glass cuvette. The absorbance at 340 nm was read whereafter 5 μΐ 
(1.4 U) hexokinase were added. After termination of the reaction (10-15 min) 
the absorbance was read again. From the difference between both absorbance 
values, the glucose content of the blood was calculated. 
6.2.5. Hepatic gluconeogenic enzymes 
6.2.5.1. Pyruvate carboxylase 
Principle 
Pyruvate carboxylase activity was measured according to Utter and Keech 
(1963), complete with a regenerating system for acetyl-CoA as proposed by 
Henning and Seubert (1964). Oxaloacetate formation is dependent on the pre-
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sence of acetyl-CoA. The reactions involved can be summarized as follows: 
_ pyruvate carboxylase , , „ , 
(1) Pyruvate + ATP + Н14СОз ——гт^—г 14C oxaloacetate + ADP + Pi 
v
 ' ' acetyl-CoA 
Mg + + 
Ca + + 
(2) Acetyl-CoA + [14C) oxaloacetate S > n " e • [14C) citrate + CoA - SH 
regenerating system for acetyl-CoA: 
~ . „ . . phosphotransacetylase , „ „ 
Acetylphosphate + CoA - SH — «- acetyl-CoA + Pi 
Assay 
Determination of pyruvate carboxylase activity was performed immediately after 
preparation of the homogenate because of the instability of the enzyme (Henning 
and Seubert, 1964). A 200^1 sample of the 5% (w/v) homogenate was incubated 
at 370C in a shaking water-bath in glass vials provided with rubber sealed 
stoppers. The vials contained two small plastic tubes, one (an Eppendorf micro 
test tube) fitting inside the other. 
The incubation mixture contained 100 mM Tris-HCl, 10 mM MgCh, 2.5 mM 
ATP, 0.7 mM CoA, 4 mM acetylphosphate, 5 mM pyruvate, 1.1 U citrate-
synthase, 5 U phosphotransacetylase in a final volume of 1 ml. After preincuba­
tion for 3 min at 370C, the reaction was started by addition of 100 μΐ 0.2 mM 
КНСОз, containing 1.25 j/Ci/ml NaH , 4 CCh (specific activity 0.1 mCi/mmol). 
The incubations were terminated after 15 min by addition of 200 μ 1 6 M per­
chloric acid. Thereafter, 0.5 ml 4 M КОН was injected immediately through the 
rubber sealed stoppers into the Eppendorf micro test tubes in order to trap the 
excess of 1 4 C02. The vials were left for an additional 2 h period in the shaking 
water-bath and left overnight at room temperature to ensure complete trapping 
of the excess of 1 4 C02. Thereafter, the Eppendorf micro test tubes with KOH 
were discarded and 10 ml Instagel were added to the incubation mixture. Radio­
activity was measured in a Nuclear Chicago liquid scintillation counter (type 
Mark II) and corrected for quenching with the aid of a quench correction curve. 
Assays were performed in duplicate. 
Blanks were incubated in the absence of pyruvate. Activities were expressed as 
nmol НСОз fixated/min per mg protein. 
6.2.5.2. P h o s p h o e n o l p y r u v a t e carboxykinase 
Principle 
Phosphoenolpyruvate carboxykinase activity was measured according to Flores 
and Alleyne (1971). The following reactions are involved: 
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(1) Oxaloacetate + ITP P °S p ° е П 0 рути а e . phosphoenolpyruvate + IDP + Pi 
carboxykinase r r 
Mg+ + 
GSH 
^ , malate dehydrogenase . . . . „ j . 
(2) Oxaloacetate + NADH + H + • malate + NAD + 
pyruvate kinase (3) Phosphoenolpyruvate + ADP
 + + • pyruvate + ATP 
lactate dehydrogenase (4) Pyruvate + NADH + H+ «- lactate + NAD + 
The homogenate is incubated with oxaloacetate and ITP (reaction (1) ). 
After termination of the incubation excess oxaloacetate and some endogeneously 
formed pyruvate are first converted with malate dehydrogenase and lactate 
dehydrogenase according to reactions (2) and (4). The formed phosphoenol­
pyruvate is finally converted to lactate according to reactions (3) and (4) and 
measured by the NADH disappearance. 
Assay 
100μ\ homogenate ( 5 % w/v) were incubated in plastic tubes at 370C in a shaking 
water-bath. The incubation mixture contained 100 mM Tris-HCl (pH 7.5), 13 
mM NaF, 15 mM MgSCh, 6 mM ITP, 2 mM GSH, 5 mM oxaloacetate in a final 
volume of 1 ml. The presence of fluoride prevented the conversion of phospho­
enolpyruvate to 2-phosphoglycerate. The incubation was started by addition of the 
homogenate and terminated after 3 min by addition of 1 ml ice-cold 0.8 M per­
chloric acid. After mixing, the incubation mixture was placed in ice, neutralized 
with 5 M КгСОз and centrifugated at 4°C for 10 min at 600 χ g. 0.5 ml neutralized 
supernatant was transferred to a micro-cuvette in a final volume of 1 ml contain­
ing 60 mM triethanolamine- HCl buffer (pH 7.6), 90 mM KCl, 9 mM MgSO-», 0.3 
mM ADP, 2.1 mM NADH, 5 U malate dehydrogenase and 5 U lactate dehydro­
genase. The absorbance at 340 nm was measured in a Zeiss PMQ-3 spectropho­
tometer and, after a constant absorbance was reached, 5 U pyruvate kinase were 
added. The phosphoenolpyruvate concentration in the incubation mixture was 
calculated from the decrease in absorbance produced by addition of pyruvate 
kinase. Assays were performed in duplicate. Blanks were incubated in the ab­
sence of homogenate. Activities were expressed as nmol phosphoenolpyruvate 
formed/min per mg protein. 
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6.2.5.3. F r u c t o s e - 1 , 6 - d i p h o s p h a t a s e 
Principle 
Fructose- 1,6-diphosphatase was assayed according to Underwood and News-
holme (1965) according to the reactions: 
fructose-1.6-diphosphatase (1) Fructose-1,6-diphosphate + H2O
 + + ·• fructose-6-phosphate + Pi 
glucosephosphdte-isomerasc (2) Fructose-6-phosphate »- glucose-6-phosphate 
(3) Glucose-6-phosphate + NADP* — • — «- 6-phosphogluconolactone + NADPH + H + 
dehydrogenase 
The rate of formation of fructose-6-phosphate in reaction (1) was determined 
spectrophotometrically by following the rate of NADP+ reduction at 340 nm in 
the presence of excess glucosephosphate isomerase and glucose-6-phosphate 
dehydrogenase. Corrections were made for activities of aspecific phosphatases by 
measuring the activity with and without 0.3 mM AMP in the incubation mixture. 
At this concentration of AMP the activity of fructose-1,6-diphosphatase was 
completely inhibited (Taketa and Pogell, 1965). The difference between the rate 
of NADP+ reduction in the absence or presence of 0.3 mM AMP represents 
the activity of fructose-1,6-diphosphatase. 
Assay 
The incubation mixture contained 50 mM Tris-HCl (pH 7.5), 5 mM MgSOa, 0.1 
mM EDTA, 0.4 mM NADP + , 0.1 mM fructose- 1,6-diphosphate, 3.5 U glucose-
phosphate isomerase, 1.4 U glucose-6-phosphate dehydrogenase in a final 
volume of 2.5 ml. After addition of 60μ1 homogenate ( 5 % w/v) the absorbance at 
340 nm was registered during 10 min in a Gary 118 spectrophotometer. To a se­
cond cuvette, containing 2.5 ml incubation mixture, 10 μ\ 75 mM AMP were 
added. After addition of 60 μΐ homogenate the absorbance was registered during 
10 min. Assays were performed in duplicate and activities were expressed as nmol 
NADPH formed/min per mg protein. 
6.2.5.4. G l u c o s e - 6 - p h o s p h a t a s e 
Principle 
Glucose-6-phosphatase activity was determined according to Harper ( 1962). The 
reaction involved is: 
67 
glucose- 6- phosph at ase 
Glucose-6-phosphate + H2O • glucose + Pi 
The formed inorganic phosphate was measured colorimetrically. 
Assay 
All solutions and glassware used were as free as possible from inorganic phospha­
te. The incubation mixture contained 50 mM citric acid-NaOH (pH 6.5), 40 mM 
glucose-6-phosphate and 100 μΐ 5% (w/v) homogenate in a final volume of 200 
μ\. Incubation was performed at 370C for 15 min and terminated by addition of 2 
ml 0.6 M trichloric acetic acid. 
After centrif ugation for 10 min at 3,000 χ g 1 ml of the supernatant was added to 5 
ml 2 mM ammoniummolybdate in 0.25 M H2SO4. After mixing 1 ml reduction 
solution (0.55 M NaHSOs, 15 mM NaiSOs, and 42 mM l-amino-2-naphtoI-
4-sulphonic acid) was added. After 30 min at room temperature the absorbance 
was measured at 700 nm in a Сагу 118 spectrophotometer against a blank, 
containing 1 ml of a mixture of 200μ10.1 M citrate buffer (pH 6.5) and 2 ml 0.6 M 
trichloric acetic acid, 5 ml 2 mM ammoniummolybdate, and 1 ml of the above 
mentioned reduction solution. An enzyme and a reagent blank were prepared 
by omission of glucose-6-phosphate or homogenate, respectively. The absorban-
ces of enzyme- and reagent blanks were substracted from the sample absorban-
ces and the activity of glucose-6-phosphatase was calculated with the aid of a 
standard solution containing 0.5 mM KH2PO4 in 0.18 M H2SO4. 
Assays were performed in duplicate and activities expressed as nmol Pi for-
med/min per mg protein. 
6.2.6. Amino acids 
Plasma amino acids were determined with a Biotronik LC 6000 amino acid 
analyzer using a method according to the manufacturer with minor modifications. 
Deproteinization of the samples was performed by precipitation with sulfosalicy-
lic acid (6.25%). 
6.2.7. Glycogen 
Glycogen content of the liver was determined according to Keppler and Decker 
(1962). The following reactions are involved: 
amvloglucosidase 
(1) Glycogen + (n-1) H2O : •• π glucose 
,,> г.. ..™ hexokinase , , , 
(2) Glucose + ATP „ , , »• glucose-6-phosphate + A DP 
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filucose-6-phosphate -(3) Glucose-6-phosphate + NADP+ ^ • • ·• 6-phosphogluconolactone + NADPH + H + 
Glycogen is enzymatically hydrolyzed to glucose by the enzyme amyloglucosidase 
according to reaction (1). Glucose is determined according to reaction (2) and 
(3), using hexokinase and glucose-6-phosphate dehydrogenase, by measurement 
of the formed NADPH. 
Assay 
A 50 μΐ sample of (20% w/v) liver homogenate in 0.6 M perchloric acid was 
neutralized with 25 μΐ 1 M КНСОз after which 0.5 ml 0.2 M sodium acetate buf­
fer (pH 4.8), containing 10 U amyloglucosidase, were added. 
The mixtures were incubated in a shaking water-bath at 40oC for 2 h. Blanks were 
incubated in the absence of amyloglucosidase. Incubations were terminated by 
addition of 250μΐ 0.6 perchloric acid, after which the test tubes were placed in ice. 
After 10 min 0.5 ml of the mixture were neutralized with 125 μ\ 1 M КНСОз, 
placed again in ice and centrifugated for 10 min at 900 χ g. 200 μΐ of the 
supernatant were added to a microcuvette, containing 0.8 ml 0.3 M 
triethanolamine- HCl (pH 7.5), 5 mM MgSO-», 1.25 mM ATP, and 1.13 mM 
NADP+. After mixing, 1 U glucose-6-phosphate dehydrogenase was added and 
the absorbance at 340 nm was measured. Thereafter, 1.5 U hexokinase were 
added. The reaction was completed after 10-15 min and the absorbance was 
measured again. From the difference between both absorbance values the hepatic 
glycogen content was calculated and expressed as^mol glucosyl glucose units per 
g liver. 
6.2.8. Carnitine 
Principle 
Carnitine content of liver was assayed according to Parvin and Pande (1977). 
Liver homogenate was incubated in 0.1 M КОН to hydrolyze acylcarnitines and 
acetylcarnitine. After neutralization, carnitine was assayed with carnitine acetyl 
transferase and [1-14C] acetyl-CoA according to the reaction: 
carnitine acetyl transferase , „ , 
Carnitine + [l-^C] acetyl-CoA »- [1-,4C] acetyl-carnitine + CoA 
After completion of the reaction the formed [14C] acetylcarnitine was separated 
from the excess of [14C] acetyl-CoA with active charcoal. 
Thereafter, the formed [ 1 4C] acetylcarnitine was measured in a liquid scintillation 
counter. 
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Preparation of liver samples for the carnitine assay 
Liver samples were prepared according to Borum et al. (1977) as follows. 
Liver was homogenized in water (20% w/v) with a motor-driven teflon-glass 
Potter-Elvehjem type homogenizer (5 strikes, 800 rpm) in an ice-bath. 
A 200 μΐ sample of the homogenate was mixed with 5μ14 M КОН and placed in a 
water-bath for 30 min at 40°C. Thereafter 0.6 ml 0.6 M perchloric acid was added 
and after mixing the tubes were placed in ice for 30 min. After centrifugation at 
9,000 χ g for 2.5 min, a 0.5 ml portion of the supernatant was neutralized with 60 
μΐ 4 M КОН and placed in ice again for 30 min. After centrifugation for a second 
time at 9,000 χ g for 2.5 min the supernatant was used for the carnitine assay. 
Assay 
A 50 μ\ portion of the supernatant was incubated in a total volume of 200 μΐ, 
containing 0.2 M potassium phosphate, 0.025 mM[l- ,4C]acetyl-CoA(0.05f¿ Ci) 
and 2 U carnitine acetyl transferase. The final pH was 7.4. Incubation was 
performed at 250C for 1 h. Blanks, in which supernatant was replaced by water, 
and standard solutions containing 1 to 5 nmoles carnitine were assayed at the 
same time. Incubations were terminated by addition of 0.6 ml of a charcoal 
suspension. The suspension was prepared by suspending 8 g charcoal in a mixture 
of 109 ml ethanol, 2.5 ml of 14 M orthophosphoric acid and 8.5 ml water. When 
the suspension was used it was stirred vigorously with a magnetic bar. After 
addition of the charcoal the tubes were placed in ice and mixed three times at 
about 10 min intervals. Thereafter, centrifugation was performed at 9,000 χ g for 
5 min. A 400 μ\ portion of the clear supernatant was transferred to a 20 ml 
counting vial, 10 ml Instagel were added and the radioactivity was measured in a 
Searle Mark III liquid scintillation counter. Carnitine concentration was calcula­
ted from a standard curve and expressed as nmol carnitine per mg protein. 
6.2.9. Long chain free fatty acids 
Principle 
Long chain free fatty acids (FFA) were assayed according to Ho (1970). The 
procedure consists of two major steps: 
1. Extraction of the plasma sample with Dole's extraction mixture (isopropa-
nol/heptane/0.5 M sulfuric acid 40:10:1, v/v) (Dole and Meinertz, 1960) to 
deproteinize the plasma and to extract the total amount of long chain FFA and 
phospholipids in the heptane/iso-propanol phase. Thereafter, the phospholipids 
are separated from long chain FFA by binding them to silicic acid. 
2. Assay of long-chain FFA in the heptane/iso-propanol phase with 6 3 Ni as 
tracer. 
In 1956 Ayer showed that Cu, Ni or Co form with long-chain FFA a chloroform 
soluble complex. So, an aliquot of the heptane/isopropanol phase is diluted with 
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chloroform and mixed thoroughly with 6 3Ni (КОз)2, dissolved in a saturated 
aqueous solution of sodium sulfate. After separation of the two phases, an aliquot 
of the organic phase is mixed with Instagel and counted in a liquid scintillation 
counter. Standard solutions of palmitic acid in heptane are treated in the same 
way. The amount of plasma long-chain FFA is calculated with help of these 
standard solutions. 
Extraction procedure 
A plasma sample of 10^1 was extracted in a polyethylene micro test tube with 50 
μΐ of Dole's extraction mixture. After adequate mixing, 100μΐ of heptane and 100 
μΐ of distilled water were added. After mixing again, the heptane layer was 
separated from the alcoholic water phase by centrifugation at 300 g. 50^1 of the 
heptane layer were transferred to another test tube containing approximately 5 
mg of silicic acid. Thereafter, 50 μΐ chloroform were added quickly. The tube 
contents were mixed and centrifuged. 50 μ 1 of silicic acid treated organic solution 
were used in duplicate for the FFA assay. 
Preparation of the 63Ni reagent 
" N i C b was converted to 6 3Ni (МОз)2 with help of Dowex 50-W χ 8 (100-200 
mesh) cation exchange resin and nitric acid, and freeze-dried afterwards. A 
solution of 2.0 ^Ci of 6 3Ni (N03)2 in 10μΙ solution of saturated sodium sulfate, 
containing 0.14 M acetic acid and 2 mM Ni-nitrate, was mixed with saturated 
aqueous potassium sulfate solution and triethanol-amine in a ratio of 100:85:15, 
v/v. The 6 3 Ni (КОз)2 reagent was freshly prepared before use. 
Assay 
50 μ\ of the silicic acid treated plasma extract or standard solution of palmitic acid 
in heptane, containing 1-4 nmol palmitic acid, were mixed with 100^1 of chloro­
form/heptane mixture (55:45, v/v) or 100^1 of chloroform/heptane mixture (4:1, 
v/v) respectively. Thereafter, 10 μΐ of the 6 3Ni reagent were added and the tubes 
were stoppered. They were mixed thoroughly on a Vortex mixer for 30 sec and 
centrifugated for 5 min at 400 χ g. The plastic tubes were cut just above the liquid 
level and 50 ^1 of the upper (organic) layer were transferred to a 20 ml glass vial 
without touching the inner walls of the tubes. 10 ml of Instagel were added and the 
vials were counted in a Searle Mark III liquid scintillation counter. Counts were 
corrected for the reagent blank. The amount of long chain FFA was calculated 
from the standard palmitic acid solutions and expressed as mmol FF A/1 plasma. 
6.2.10. Fatty acid oxidation rate 
Palmitate oxidation rate was determined radiochemically at 370C in 25 mM 
sucrose, 30 mM КС 1,25 mM Tris-НС 1 (pH 7.4), 10 mM potassium phosphate, 5 
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mM MgCh, 1 т М EDTA, 5 т М ATP, 1 т М N A D + , 25 μΜ cytochrome с, 0 1 
т М СоА, 0 5 т М L-malate and 0 5 т М L-carnitine (van Hinsbergh et a l , 
1978) Incubation was carried out in a final volume of 0 5 ml containing 100^1 
600 χ g supernatant prepared from a 5% (w/v) homogenate of liver in SET 
buffer (0 25 M sucrose, 2 mM EDTA, 10 mM Tris, pH 7 4) After 5-10 min 
preincubation the reaction was started by addition of 120 μΜ [U-1 4C] palmitate 
complexed to dialyzed fatty acid-free albumin (molar ratio 5·1, specific activity 
2μ€ι/μπιο1) After 30 mm the oxidation was stopped by addition of 0 2 ml 3 M 
perchloric acid and followed by incubation for 75 mm at 0oC 1 4 C02 produced was 
trapped in 0 2 ml ethanolamine-ethyleneglycol (1 2, v/v). The acid incubation 
mixture was centnfuged and 0 15 ml supernatant was assayed for radioactivity by 
liquid scintillation counting in 10 ml Aquasol 1 4 C02 radioactivity was measured 
in 0 4% Ommfluor in toluene-methanol (2 1, v/v) 
6 2 11 Specific activity of glucose 
To assay the specific activity of glucose in the glucose turnover experiments, a 50 
μί sample of the solution prepared as described in section 6 1 4 was brought on a 
0 5 ml column of Dowex 1-X8 anion exchange resin with a capacity of 1 2 
meq/ml Thereafter the column was eluted with 5 portions of 0 5 ml water The 
eluate was collected in a 20 ml incubation flask, mixed with 10 ml Instagel, and 
counted in a Searle Mark III liquid scintillation counter With this method glucose 
was completely eluted from the resin, but labelled intermediates, formed during 
glycolysis, were bound to the ion exchange resin With the known dilution factors 
of the blood samples and the blood glucose concentrations, the specific activity of 
blood glucose was calculated 
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Chapter 7. 
EXPERIMENTAL INTRAUTERINE GROWTH RETARDATION 
IN THE RAT; EVALUATION OF THE WIGGLESWORTH MODEL 
7.1. Introduction 
The model of ligation of the uterine artery of one of both uterine horns, as 
described by Wigglesworth (1964), is frequently used in metabolic investigations 
on the newborn rat that is small for gestational age. Animals from the opposite, 
untouched, uterine horn or normal newborn animals are taken as controls. Using 
this experimental model, newborn rats that are small for gestational age are 
produced which show lower blood glucose levels (Nitzan and Groffman, 1970, 
1971a; Chanez et al., 1971; Levitsky et al., 1976), lower fat and protein content 
of the body (Hohenhauer and Oh, 1969), an increase in total body water (Hohen-
hauer and Oh, 1969) and lower liver glycogen content (Nitzan and Groffman, 
1970,1971b). In Wigglesworth's model, unilateral ligation of one of both uterine 
vessels is performed on the 17th day of gestation, after the dam is anesthetized 
with ether and the abdomen is opened by a midline incision. In this way, blood 
flow to one uterine horn is reduced, resulting in a considerably reduced birth 
weight of the animals from this horn. Levitsky et al. (1977) suggested that the 
fetuses of an exposed and manipulated uterine horn may not truly serve as 
controls for the fetuses of the experimental horn, since both groups have been 
subjected to stress by operation and anesthesia of the dam. Another important 
factor may be that reduction of blood flow to one uterine horn results in an 
increased flow to the opposite horn, thus inducing a new metabolic or hormonal 
state in this horn. Therefore, the animals from the contralateral horn in the 
classical Wigglesworth model would not be the most satisfactory controls for the 
newborns from the ligated horn that are small for gestational age. 
In order to find a better control we measured birth weight and blood glucose 
levels during the first 6 h after delivery of newborns from unoperated rats, from 
both horns in the Wigglesworth model, and from sham-operated dams. 
7.2. Materials and Methods 
Female albino Wistar rats, weighing 150-200 g, were fed ad libitum. They were 
mated between 9 and 12 a.m. and conception was confirmed by the vaginal smear 
method. On the 17th day of gestation, at 4 p.m., the right uterine artery was 
ligated according to Wigglesworth (1964) under light ether anesthesia. The 
opposite uterine artery was untouched. In a control group no operation took 
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place, and in another group sham operation was performed on the 17th day of 
gestation. Under light ether anesthesia a midline incision was made, the uterus 
exposed and immediately replaced in the abdominal cavity, after which the 
abdomen was closed. On the 21st day of gestation, at 9 a.m., the fetuses from all 
dams were delivered by caesarean section after the mother had been killed by a 
blow on the head and cervical dislocation. After clamping the umbilical cords and 
weighing, the newborn rats were transferred to the incubator. Temperature was 
kept at 370C and humidity at about 65 %. After delivery of the whole litter, one or 
two animals from both horns and from control and sham litters were exsanguin­
ated by cardiac puncture (0 h). This was performed with a sharp heparinized 
capillary. Blood was collected in test tubes, containing fluoride. The same proce­
dure was performed on other animals at 1, 3 and 6 h after delivery. Blood from 
each newborn rat was analyzed separately; blood glucose was measured by the 
glucose-oxidase method. 
Statistical analysis was performed on the mean birth weight of litters ("litter 
weight"). Differences in litter weight between two independent groups were 
tested with Student's t-test when the F-test for comparing group variances gave 
no significant result (P>0.05); otherwise the Welch test was used. The difference 
in mean birth weight of the ligated horn and the corresponding contralateral horn 
was tested with Student's t-test for paired samples. The Kruskal-Wallis test was 
used ( a = 0.025) to test the hypothesis of no difference in glucose values 
between the 4 groups at each of 4 sampling times. If at least one of these tests gave 
a significant result, it was concluded that the course of the glucose concentration 
until 6 h after birth was different for the 4 groups. For each sampling time, if 
P<0.05, this difference was specified by applying Wilcoxon's two-sample test ( α 
= 0.025) on each pair of groups. 
7.3. Results 
Mean birth weight of individual animals and mean litter weight calculated from 
mean weights of individuals within litters or horns in the 4 groups are shown in 
Table 7.1. The variation of litter weight represented by the SD value is signifi­
cantly larger (P<0.005) in ligated and contralateral horns than in normal litters 
and litters of sham-operated dams; variation of weight in normal litters and litters 
of sham-operated dams does not differ significantly (P>0.10). The weight of 
animals in normal litters is significantly larger than the weight in litters of sham-
operated dams and in contralateral horns (P<0.05); the weight in litters of 
sham-operated dams and contralateral horns does not differ significantly 
(P>0.50). Comparison of the weight in ligated horns with that in the correspon­
ding contralateral horns was possible for 25 litters; the weight in ligated horns is 
significantly smaller than the weight in contralateral horns (one-sided 
P<0.0005), and standard deviations are in good agreement with each other. Fig. 
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7.1 shows a newborn rat from a ligated horn and a control littermate. In order to 
define criteria for intrauterine growth retardation, birth weights of normal ani-
mals were analysed. Assuming a normal distribution of birth weight, it was 
computed that the 90% confidence limit of the 10th centile was 3.95; a newborn 
rat weighing 3.95 g or more was considered to be appropriate for gestational age. 
The 90% confidence limit of the 7.5th centile was 3.88; therefore, a newborn rat 
weighing 3.85 gor less was considered to be small for gestational age. This implied 
that the birth weight of newborn rats that are small for gestational age was at least 
15% lower than the mean birth weight of rats from normal litters. For blood 
glucose determination, only rats weighing 3.85 g or less from the ligated horns 
were used and, from contralateral horns, litters of sham-operated dams and 
normal litters, only those rats weighing 3.95 g or more. 
Furthermore, rats were only used when at least 4 animals, fulfilling these birth 
weight criteria, were available from one litter or one horn to diminish variations 
between litters. The ligated horns and contralateral horns were from different 
litters. 
In Table 7.2 mean blood glucose levels at 0, 1,3 and 6 h after delivery are shown. 
The results of statistical analysis are presented in Table 7.3. 
At birth, there is no significant difference between blood glucose levels in animals 
from litters of sham-operated dams and from ligated horns and between animals 
from normal litters and from contralateral horns. Animals from normal litters 
have higher glucose levels at 0 and 1 h after delivery, in comparison with animals 
from litters of sham-operated dams and ligated horns. 
From 3 h after delivery, blood glucose levels in animals from litters of sham-
operated dams rise significantly more rapidly than those in animals from ligated 
horns. Blood glucose levels in newborns from normal litters and from contralate-
ral horns do not differ until 6 h after birth, when the former become higher. 
Animals from ligated horns show significantly lower blood glucose levels than 
animals from normal litters and from contralateral horns at birth and up to 6 h 
after birth. 
Fig. 7.1. Intrauterine growth-retarded newborn rat and control littermate 
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Table 7 1 Birth weight of newborn rats 
Group Birth weight*(g) (mean ± SD) Litter weight**(g) (mean ± SD) 
(no of animals in parentheses) (no of litters or horns in 
parentheses) 
Normal litters 4 51 ± 0 39 (473) 4 54 ± 0 28 (47) 
Contralateral horns 4 28 ± 0 53 (143) 4 34 ± 0 51 (34) 
Ligated horns 3 65 + 0 59(104) 3 75 ± 0 49 (28) 
Sham litters 4 36 ± 0 37 (185) 4 38 ± 0 27 (21) 
*Of individual animals 
""Calculated from mean weights of individuals within litters or horns 
Table 7 2 Plasma glucose 
Group Time after delivery (h) 
0 1 
Normal litters (31) 4 17 ± 0 90 3 60 ± 1 57 2 73 ± 1 23 4 32 ± 0 92 
Contralateral horns (23) 4 13 ± 1 51 3 42 ± 2 09 2 53 ± 1 24 3 38 ± 1 09 
Ligated homs (14) 2 81 ± 1 40 2 10 ± 1 16 1 69 ± 1 13 2 76 ± 1 24 
Sham litters (19) 3 26 ± 1 23 2 06 ± 1 13 2 34 ± 0 94 3 88 ± 0 93 
Values are given in mmol/1 as means ± SD of the number of litters or horns between parentheses 
Table 7 3 Statistical results of glucose measurements (P values) 
Time after delivery (h) 
Kruskal-Wallis test 0 004 0 002 0 037 0 001 
Wilcoxon test 
Normal vs sham 0 009,S<N 0 001,S<N 0 430,NS 0 097,NS 
Normal vs ligated* 0 001,L<N 0 002 )L<N 0 002,L<N 0 000,L<N 
Normal vs contralateral 0 760,NS 0 656,NS 0 600,NS 0 0 0 2 ^ < Ν 
Sham vs ligated' 0 150,NS 0 558,NS 0 022,L<S 0 007,L<S 
Sham vs contralateral 0 055,NS 0 033,NS 0 820,NS 0 022,Ы8 
Contralateral vs ligated* 0 010,L<C 0 034,NS 0 017,L<C 0 066,NS 
N = normal litters, С = contralateral horns, L = ligated horns, S = sham litters, NS = not signifi­
cantly different 
* One-sided Ρ values 
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7.4. Discussion 
We confirmed the validity of the procedure of Wigglesworth (1964) to produce 
newborn rats that are small for gestational age, which show a pronounced neo-
natal hypoglycemia. In the classical experimental model, animals from contrala-
teral horns of the same dams in which one uterine artery was ligated are mostly 
used as controls. Levitsky et al. (1977) recently showed that maternal stress, in-
duced, for example, by sham operation on the 17th day of gestation, induces fetal 
stunting and may be associated with alterations in the glycémie response to 
fasting. They found a significant reduction in exsanguinated body weight in the 
off-spring after sham operation in the dam. 
In our newborns from sham-operated dams, birth weight reduction was also 
significant. The weight gradient in the fetuses in the ligated horns, with increasing 
birth weight from the proximal site of ligation to the distal one along the uterine 
artery, may explain the greater variability of litter weight of ligated horns. The 
greater variation of litter weight in the contralateral horns could perhaps indicate 
that ligation of one uterine artery has, in fact, an effect on the birth weights of 
animals from the contralateral uterine horn due to alterations in blood flow. 
Blood glucose concentrations show the well-known pattern of a decrease during 
the first few hours after birth, followed by an increase (Cake et al., 1971 ; Girard et 
al., 1973; Snell and Walker, 1973). The increase at 3 h after birth is thought to be 
mainly the result of gluconeogenesis (Yeung and Oliver, 1967; Girard et al., 
1975). The lower blood glucose concentration at 0 and 1 h in animals from litters 
of sham operated dams indicates an effect of the sham procedure on the glucose 
metabolism in the newborns. Levitsky et al. (1977) found no difference in blood 
glucose value at birth, but a significantly lower value at 4 h after birth in animals 
from sham-operated dams. 
If the fetuses in the contralateral horns of the Wigglesworth model were only 
affected by the maternal stress of operation and anesthesia, one would expect the 
same blood glucose levels in animals from contralateral horns and in animals from 
sham litters. In fact, we found higher glucose concentrations in animals from 
contralateral horns during the first few hours after delivery. This indicates that the 
animals from the contralateral horns are not completely comparable with animals 
from litters of sham-operated dams. 
We conclude that, in experiments of intrauterine growth retardation with the 
Wigglesworth model, the fetuses from the opposite, non-ligated horns are not the 
most suited control animals, because of the effects of the ligation procedure in the 
opposite horn on growth and metabolism in these animals. Animals from sham-
operated mothers are to be preferred as controls, the only difference between 
animals from ligated horns and from litters of sham-operated mothers being 
reduction in uterine blood flow in the former. 
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7.5. Summary 
The validity of the Wigglesworth experimental model to produce newborn rats 
that are small for gestational age by ligation of one of both uterine vessels was 
confirmed Newborn rats from the opposite horns are used as controls in the 
classical model. 
It is concluded from this study that newborns from sham-operated dams are more 
satisfactory controls for newborn rats that are small for gestational age from 
hgated horns 
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Chapter 8. 
GLUCONEOGENIC KEY ENZYMES IN NORMAL AND 
INTRAUTERINE GROWTH-RETARDED NEWBORN RATS 
8.1. Introduction 
Neonatal hypoglycemia is frequently observed in small-for-gestational-age 
(SGA) infants (Pagliara et al., 1973; Cornblath and Schwartz, 1976) and rats 
(Chanez et al., 1971 ;Nitzan and Groffman, 1971;Levitsky etal., 1976; Kolléeet 
al., 1979). The etiology of this hypoglycemia is not completely understood. 
Before birth, nutrients are supplied by the maternal circulation across the placen-
ta. Blood glucose levels in the fetus reflect those in the maternal circulation. In 
utero, glucose is the most important fuel (Girard, 1975a). Towards the end of 
gestation, large amounts of glycogen accumulate in liver of all species investigated 
(Shelley, 1961). Glucose is the major precursor for fetal glycogen (Ballard and 
Oliver, 1964). In the fetus, enzymes of glycogenolysis (Phosphorylase and 
glucose-6-phosphatase) have a low activity (Dawkins, 1963). At birth, abrupt 
changes in energy supply occur (Girard et al., 1975b). Before suckling, the 
newborn is completely dependent on his own metabolic mechanisms to provide 
energy fuels. These mechanisms include glycogenolysis and gluconeogenesis from 
several substrates. In the newborn rat, during the first 24 h of life, hepatic 
glycogen content decreases from 10 to 1% of wet weight (Shelley, 1961). In fetal 
rat liver, gluconeogenesis is absent (Ballard and Oliver, 1963; Vernon et al., 
1968). After birth an increase of the phosphoenolpyruvate carboxykinase activity 
occurs, together with the appearance of gluconeogenesis (Girard et al., 1973a, b; 
Snell and Walker, 1973; Girard et al., 1975c). Several authors (Ballard and 
Philippidis, 1971; Exton, 1972) speculate that phosphoenolpyruvate carboxyki-
nase is the key regulatory enzyme in liver gluconeogenesis. In the first 3 h after 
birth, the newborn rat shows a decrease of blood glucose levels followed by an 
increase between 3 and 6 h after birth, even when food is withheld (Dawkins, 
1963; Girard et al., 1973b; Snell and Walker, 1973; Levitsky et al., 1976). The 
pronounced neonatal hypoglycemia in SGA newborns could be explained in 
several ways. Diminished glycogen storage or delayed gluconeogenesis could 
contribute to the development of hypoglycemia. It was suggested that gluconeo-
genesis is deficient in the first period after birth in SGA infants (Dacou-
Voutetakis et al., 1973; Pagliara et al., 1973; Haymond et al., 1974; Mestyán et 
al., 1975) and rats (Chanez et al., 1971; Nitzan and Groffman, 1971). 
The purpose of this study was to investigate whether the more pronounced 
hypoglycemia in SGA rats could be explained on the basis of lower activities of 
gluconeogenic key enzymes. SGA newborn rats were obtained by ligation of one 
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of both uterine arteries according to Wigglesworth (Wigglesworth, 1964). We 
compared the enzyme activities in their livers with those in the liver of animals 
from normal and sham-operated litters, and from non-ligated contralateral horns. 
In a previous paper (Kollée et al., 1979) it was shown that newborn rats obtained 
from sham-operated dams might be considered as a better control group for the 
SGA animals from the ligated horns. 
8.2. Materials and Methods 
Experimental procedures 
Female albino Wistar rats, weighing 150-200 g, were fed ad libitum. They were 
mated between 9 and 12 a.m. and conception was confirmed by the vaginal smear 
method. Surgical procedures were as described previously (Kollée et al., 1979). 
Ligation of the uterine artery of one of both uterine horns was performed on the 
17th day of gestation under ether anesthesia. The fetuses were delivered by 
caesarean section at 9 a.m. on the 21st day of gestation after the mother had been 
killed by a blow on the head and cervical dislocation. Spontaneous delivery in the 
rat occurs after about 21.5 days of gestation; so, the fetuses were delivered about 
12 h premature. They were placed in an incubator; temperature was kept at 370C 
and humidity at about 65%. After delivery of the whole litter, one or two animals 
from both horns were exsanguinated by cardiac puncture and the livers excised as 
soon as possible (0 h). Only animals in good clinical condition were used. The 
livers were immediately put in liquid nitrogen and stored at -70oC until determi-
nation of the activities of the 4 gluconeogenic key enzymes was performed. Under 
these conditions enzyme activities remained constant. The same procedure was 
carried out on littermates at 1, 3 and 6 h after delivery. Generally, rats were only 
used when at least 4 animals were available from one litter or one horn, fulfilling 
birth weight criteria described previously (Kollée et al., 1979): newborn rats 
weighing 3.85 g or less were considered to be small for gestational age, and rats 
weighing 3.95 g or more were considered to be appropriate for gestational age. 
Assay procedures 
Each liver was homogenized (5% w/v) in ice-cold 2 mM EDTA, 5 mM Tris-HCl 
buffer (pH 7.4) in a Potter-Elvehjem homogenizer and centrifuged at 600 xg for 
10 min at 40C. The supernatant was used for assay of the enzyme activities. 
Generally, activities of all enzymes were not determined in the same liver. 
Incubation temperature was 37°C. Pyruvate carboxylase (EC 6.4.1.1.) activity 
was determined according to Utter and Keech (1963), using a regenerating 
system for acetyl-CoA as proposed by Henning and Seubert (1964). Phospho-
enolpyruvate carboxykinase (EC 4.1.1.32), fructose-1,6-diphosphatase (EC 
3.1.3.11), and glucose-6-phophatase (EC 3.1.3.9) activities were measured ac-
cording to Harper (1962), Underwood and Newsholme (1965), and Flores and 
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Alleyne (1971), respectively. Protein was measured according to Lowry et al. 
(1951). 
Statistical analysis 
At each sampling time the test of Kruskal-Wallis was used ( a = 0.025) to state a 
difference in enzyme activity between the 4 groups of animals. If at least one 
significant difference was found it was concluded that the course of enzyme 
activity until 6 h after birth was different in the 4 groups. For each sampling time, 
if P<0.05, this difference was specified by applying Wilcoxon's two-sample test 
( a = 0.025) on each pair of groups. 
8.3. Results 
In Table 8.1, the activities of the 4 gluconeogenic key enzymes are shown in liver 
of newborns from the 4 groups at 0, 1, 3 and 6 h after birth. 
Pyruvate carboxylase activity was significantly lower until 6 h after birth in 
newborns from ligated horns only in comparison with those from sham litters 
(P<0.009). 
Statistical analysis did not reveal any significant difference in the patterns of 
phosphoenolpyruvate carboxykinase activity between the 4 groups of newborn 
rats at 0 and 1 h after delivery; thereafter, the activity of this enzyme increased 
more rapidly in newborns from sham litters in comparison with those from the 3 
other groups. Enzyme activity in animals from ligated horns was significantly 
lower compared with sham litters only at 3 h (P = 0.011). 
Fructose- 1,6-diphosphatase activity in the liver of animals from ligated horns was 
lower than in the liver of animals from sham litters or contralateral homs, but only 
the former difference was significant at each sampling time (P<0.001). The diffe-
rences between enzyme activities in animals from normal litters and ligated horns 
were also significant (P<0.007). 
Glucose-6-phosphatase activity was not different between the 4 groups immedia-
tely after birth. From 1 to 6 h after delivery, this activity was significantly lower in 
the liver of animals from ligated horns than in the liver of animals from sham 
litters (P<0.002). 
8.4. Discussion 
Our results concerning the activities of gluconeogenic key enzymes in normal 
newborn rats are comparable with values reported in the literature. Pyruvate 
carboxylase activity is present in fetal rat liver (Yeunget al., 1967; Chang, 1977), 
but its activity increases after birth. Activities of this enzyme have not been 
reported in SGA rats before. We found no difference in enzyme activity between 
newborns from ligated horns and newborns from contralateral horns. If, however, 
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Table 8 1 Gluconeogenic key enzyme activities in liver of newborn rats 
Enzyme 
Pyruvate 
carboxylase 
Group 
normal litters 
contralateral horns 
ligated horns * 
sham litters 
( 7) 
(10) 
(19) 
(13) 
Time after delivery (h) 
0 
39 2 ± 9 0 
38 6 ± 9 1 
31 5 ± 124 
42 8 ± 9 5 
1 
35 9 + 
38 1 ± 
29 1 ± 
38 9 ± 
4 4 
9 7 
8 2 
8 4 
3 
36 5 ± 5 7 
38 5 ± 10 3 
34 2 ± 9 0 
4 1 4 + 1 0 5 
6 
40 2 ± 
36 6 ± 
31 6 ± 
45 1 ± 
8 8 
7 1 
7 0 
9 5 
Phosphocnolpy-
ruvate carboxy-
kinase 
normal litters 
contralateral horns 
ligated horns 
sham litters (1 
(1 
(1 
(12) 
4 55 ± 0 98 
3 84 + 1 181) 
3 88 ± 1 20 
4 42 ± 1 43 
4 35 ± 1 36 
3 85 ± 145') 
3 71 ± 142 
4 63 ± 1 03 
6 70 ± 1 57 
5 58 ± 2 01 
5 65 ± 2 08 
9 61 ± 3 47 
9 22 ± 2 08 
8 01 ± 3 17 
9 5 0 ± 3 912) 
14 3 7 ± 4 39 
Fructose-1,6-di-
phosphatase 
normal litters 
contralateral horns 
ligated horns *, ** 
sham litters 
(1 
(1 
(12) 
(1 
25 7 ± 4 2 
24 5 ± 3 8 
20 5 ± 3 6') 
30 4 ± 4 9 
27 2 ± 5 8 
25 4 ± 6 8 
195 ± 3 6 
30 8 ± 3 2 
26 8 ± 3 9 
26 3 ± 5 7 
20 2 ± 3 5 
32 5 ± 3 1 
29 4 ± 4 8 
25 2 ± 8 2 
205 ± 4 I2) 
35 6 ± 4 9 
Glucosc-6-phos-
phatase 
normal litters 
contralateral horns 
ligated horns * 
sham litters 
(H) 
(11) 
(12) 
(11) 
17 1 ± 
18 9 ± 
18 4 ± 
23 6 + 
5 7 
6 6 
5 32) 
5 3 
24 6 ± 112 
24 1 ± 6 8 
19 9 ± 5 7 
30 6 ± 8 1 
31 1 ± 11 9 
36 2 ± 12 3 
26 4 ± 7 8 
45 2 ± 10 5 
46 6 ± 13 6 
49 3 ± 14 1 
44 5 ± 11 92) 
70 5 ± 16 7 
00 
Number of litters or horns between parentheses, with the exception of ') = 10 and 2) = 11 
All values are means ± SD and expressed as nmol/min/mg protein 
* Course of activities significantly different from those in sham litters P-values are given m the text 
** Course of activities significantly different from those in normal litters P-value is given in the text 
newborn animals from sham-operated dams are taken as controls, the activity of 
pyruvate carboxylase in SGA newborn rats is significantly lower at 0-6 h. 
Cytosolic phosphoenolpyruvate carboxykinase activity is low at birth and increa-
ses rapidly within a few hours (Girard et al., 1973a; Snell and Walker, 1973; 
Pearce et al., 1974; Girard et al., 1975c). Our results are comparable with this 
pattern, but the increase of phosphoenolpyruvate carboxykinase activity within 6 
h of birth was only one-third of that reported in the literature. This may be due to 
the premature delivery, since there is a time-lag in development of the activity of 
this enzyme (Di Marco et al., 1976). In our study the animals were delivered 12 h 
prematurely. In SGA newborn rats we found the same developmental pattern as 
in animals from normal litters and sham litters and contralateral horns. Only at 3 h 
was hepatic enzyme activity in SGA newborn rats significantly lower in compari-
son with rats from sham-operated mothers. Recently, Pollak et al. (1979) repor-
ted a lower activity of cytosolic phosphoenolpyruvate carboxykinase in SGA rats 
in comparison with sham controls at 4 h of age. 
Fructose-1,6-diphosphatase activity is present in late fetal life in the rat, but 
increases dramatically from a few days before birth to peak values at about the 
10th day of postnatal life (Yeung et al., 1967; Vernon and Walker, 1968; Räihä 
and Lindros, 1969; Chanez et al., 1971; Schaub et al., 1972). In SGA newborn 
rats, a slight delay in the development of enzyme activity from birth until 3 days of 
age was reported (Chanez et al., 1971; Siegel et al., 1979) as compared with 
normal rats. The results of fructose tolerance tests in SGA infants suggested that 
hypoglycemia in those infants could be caused by a decreased activity of 
fructose- 1,6-diphosphatase (Rautenbach and Beyreiss, 1976). Our results show a 
lower activity in SGA newborns in the first 6 h after delivery as compared with 
rats from all other groups. 
Glucose-6-phosphatase activity is present in rat liver in late fetal life, and increa-
ses after birth (Vernon and Walker, 1968; Chanez et al., 1971; Schaub et al., 
1972; Girard et al., 1973a). Premature delivery does not influence this pattern. 
We confirmed that in SGA newborn rats the developmental pattern is the same as 
in normal newborn rats (Chanez et al., 1971; Siegel et al., 1979), as well as in 
animals from contralateral horns. In comparison with newborn rats from sham 
litters, however, the enzyme activity in SGA newborn rats is significantly lower. 
When the experimental model of Wigglesworth is used, newborn rats from sham 
litters should be preferred as control animals over animals from the opposite 
non-ligated horns (Kollée et al., 1979). In comparison with sham controls, SGA 
rats have markedly lower activities of fructose-1,6-diphosphatase, glucose-6-
phosphatase and pyruvate carboxylase during the period in which hepatic gluco-
neogenesis in the rat appears to rise. In comparison with rats from contralateral 
horns, however, SGA rats show only a lower activity of fructose-1,6-
diphosphatase. 
The lower activity of more than one of the gluconeogenic key enzymes could play 
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a role in defective gluconeogenesis in SGA individuals after birth More impor­
tant than the lower specific activities of these enzymes might be lower total 
activities of these gluconeogenic enzymes in liver The liver protein content 
expressed per g wet weight is unchanged in SGA rats (Roux et a l , 1970), whereas 
the liver weight is severely reduced (Wigglesworth, 1964) Brain weight is spared 
( Wigglesworth, 1964), resulting in a high brain/liver weight ratio In this perspec­
tive lower total hepatic enzyme activities could contribute to the development of 
neonatal hypoglycemia in SGA rats Further studies are needed to investigate the 
significance of these findings for the human newborn 
8.5. Summary 
Intrauterine growth retardation was induced in rats by ligation of the artery of one 
of both uterine horns Activities of pyruvate carboxylase, phosphoenolpyruvate 
carboxykinase, fructose-1,6-diphosphatase and glucose-6-phosphatase in liver 
were measured at 0, 1, 3 and 6 h after delivery in newborn rats from normal and 
sham-operated litters, and from ligated and contralateral uterine horns Lower 
activities of fructose-1,6-diphosphatase were found in small-for-gestational age 
animals in comparison with animals from contralateral horns. When small-for-
gestational-age animals were compared with animals from sham litters (which 
could be regarded as more satisfactory controls) the activities of two other 
gluconeogenic enzymes (pyruvate carboxylase and glucose-6-phosphatase) ap­
peared to be lower as well 
It is concluded that a delay in the development of these gluconeogenic enzymes 
could play a role in neonatal hypoglycemia in small-for-gestational-age rats. 
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Chapter 9. 
SUBSTRATES FOR GLUCOSE HOMEOSTASIS IN THE 
EARLY NEONATAL PERIOD 
9.1. Introduction 
As outlined in chapter 4, the most important substrates for glucose homeostasis in 
the early neonatal period are glycogen, amino acids and fatty acids. Glycogen 
depletion occurs soon after birth in both IUGR and control newborn rats (Chanez 
et al., 1971). Plasma amino acids accumulate in the neonatal period in IUGR rats. 
The data are, however, limited. Roux and Jahchan (1974) measured amino acid 
concentrations from birth till 35 days of life with intervals of at least 1 day in 
suckling animals after natural delivery. Manniello et al. (1977) measured amino 
acid concentrations at birth and at 2-4 h after birth in fasted animals, delivered by 
caesarian section. Insufficient availability or oxidation of fatty acids could contri-
bute to the development of neonatal hypoglycemia in IUGR (Ferré et al., 1978a). 
Some data from the literature, described in chapter 5, point to this possibility. 
Fatty acid oxidation capacity of the liver and its carnitine content have not yet 
been investigated in IUGR. 
In this chapter we present the results of our investigations on substrate availability 
during the early neonatal period in newborn rats from normal and sham-operated 
litters and in animals from ligated and contralateral horns. 
We measured hepatic glycogen and carnitine content, serum concentrations of 
amino acids and free fatty acids, and fatty acid oxidation rate in liver homogena-
tes. 
9.2. Materials and methods 
The experimental animal model and the biochemical methods were described in 
chapter 6. Birth weight criteria were defined in chapter 7. Except for glycogen and 
carnitine concentration measurements, only uterine horns or litters were used in 
which at least 4 fetuses, fulfilling the birth weight criteria, were present. This 
allowed sampling of littermates in each experiment to diminish the effect of 
variability between litters. Blood samples were not pooled. 
Glycogen content of the liver was determined at birth (0 h) and at 3 and 6 h after 
birth. Amino acid analyses were performed and free fatty acid levels determined 
in blood samples of newborn rats at birth, and at 1, 3 and 6 h after birth. Hepatic 
fatty acid oxidation was measured in liver homogenates of 1 h old animals. 
Hepatic carnitine content was measured in newborn animals at birth (0 h). 
The Kruskal-Wallis test was applied ( a =0.025; for carnitine a =0.05) to state 
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differences between the 4 groups of animals. Differences were specified by 
applying Wilcoxon's two-sample test ( α =0.025; for carnitine a =0.05) on each 
pair of groups. 
9.Э. Results 
Hepatic glycogen content is shown in Table 9.1 and Fig. 9.1. 
Table 9.1 Hepatic glycogen content during the early neonatal period 
Group Time after delivery (h) 
0 
Normal litters 
Contralateral horns 
Ligated horns 
Sham litters 
507 ± 43 (8) 
592 ± 55 (9) 
415 ± 97 (15) 
581 ± 71 (9) 
453 ± 42 (8) 
469 ± 40 (8) 
378 ± 63 (9) 
514 ± 91 (8) 
326 ± 52 (8) 
351 ± 79 (8) 
224 ± 89 (9) 
377 ± 84 (8) 
Values are given in nmol glucosyl glucose U/g liver as means ± SD; the number of animals is 
indicated between parentheses. 
Hepatic glycogen content in animals from ligated horns is significantly lower than 
in animals from normal litters, sham litter» and contralateral horns at each 
sampling time (P<0.009). At birth, the glycogen content in liver of newborns 
from contralateral horns is higher than in liver of normal newborns (P=0.009). 
hepatic glycogen 
(j-imol glucosyl g l u c o s e u n i t s / g liver ) 
700-1 
• normal litters 
о s h a m litters 
Δ l igated horns 
A contralateral horns 
0 3 6 
time after delivery(h) 
Fig. 9.1. Hepatic glycogen content during the early neonatal period 
Serum free fatty acid concentrations are shown in Table 9.2 and the results of 
statistical analysis in Table 9.3. 
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Free fatty acid concentrations did not change during the 6 h period after delivery 
in animals from ligated and contralateral horns A small increase occurred in 
animals from normal and sham litters. Striking differences in the concentrations, 
however, were found between some groups. The concentrations were signifi­
cantly higher in animals from contralateral uterine horns than in animals from the 
other 3 groups The P-value of 0.029 for the difference between ligated and 
contralateral horns is also the minimal P-value when comparing two samples with 
four observations each (from both groups one horn was removed because the 
opposite horn was present in the other group) Free fatty acid concentrations in 
animals from ligated horns were significantly higher than in animals from sham 
litters. 
Table 9 2 Serum free fatly acid levels during the early neonatal period 
Group Time after delivery (h) 
0 1 
Normal litters (5) 0 23 ± 0 05 0 26 ± 0 06 0 36 ± 0 02 0 37 ± 0 07 
Contralateral horns (5) 1 08 ± 0 16 0 89 ± 0 10 1 03 ± 0 18 1 03 ± 0 10 
Ligated horns (5) 0 43 ± 0 18 0 43 ± 0 06 0 45 ± 0 14 0 42 ± 0 12 
Sham litters (5) 0 16 ± 0-08 0 16 ± 0 07 0 24 ± 0 04 0 19 ± 0 04 
Values are given in mmol/l as means ± SD, the number of litters or horns is indicated between 
parentheses 
Table 9 3 Statistical analysis of f ree fatty acid determinations (P-values) 
Kruskal-Walhs test 
Wilcoxon's test 
Normal vs sham 
Normal vs ligated 
Normal vs contralateral 
Sham vs ligated 
Sham vs contralateral 
Contralateral vs ligated 
Time after delivery (h) 
0 
0 004 
0 222, NS 
0 032, NS 
0 008, N < C 
0,016, S<L 
0 008, S<C 
0 029, L<C* 
1 
0 002 
0 044, NS 
0 016, N < L 
0 008, N < C 
0 008, S<L 
0 008, S<C 
0 029, L < C * 
3 
0 0 0 1 
0 008 
0 222, 
0 008, 
0012, 
0 008, 
0 029, 
S<N 
NS 
N < C 
S<L 
S<C 
L<C» 
6 
0 002 
0 008, 
0 599, 
0 008, 
0 008, 
0 008, 
0 029, 
S<N 
NS 
N < C 
S < L 
S<C 
L < C * 
N = normal litters, С = contralateral horns L = ligated horns, S = sham litters, NS = not signifi­
cantly different 
* 0 029 is the minimal P-value See text 
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Hepatic carnitine content at birth is shown in Table 9.4. The carnitine content of 
the liver is significantly higher in animals from ligated horns than in animals from 
sham litters and contralateral horns. 
Table 9 4 Hepatic carnitine content at birth 
Group Carnitine content 
Normal litters (4) 3 82 ± 1 00 
Contralateral horns (4) 3 84 ± 0 51 
Ligated horns (5) 5 15 ± 0 36 
Sham litters (4) 3 82 ± 0 43 
Values are given in nmol/mg protein as means ± SD, the number of animals is indicated between 
parentheses 
The rates of hepatic fatty acid oxidation are shown in Table 9.5. No difference 
was found in the palmitate oxidation rates between the 4 groups. 
Table 9 5 Hepatic fatty acid oxidation in I h old newborn rats 
Group Oxidation rate 
Normal litters ( 6 ) 0 470 ± 0 058 
Contralateral horns ( 5 ) 0 535 ± 0 064 
Ligated horns ( 6 ) 0 573 ± 0 172 
Sham litters (10) 0 530 1 0 157 
Values are given in nmol palmitate/min per mg protein as means ± SD, the number of animals is 
indicated between parentheses 
The concentrations of individual serum amino acids in the 4 groups of animals are 
shown in Tables 9.6 - 9.9. 
The concentration of all amino acids measured, except for taurine, glycine, citrul-
line and cystine, decreased after delivery in all groups of animals examined. The 
cystine concentration was higher in animals from ligated and contralateral horns 
than in animals from normal and sham litters at I and 3 h after delivery. Phenyl-
alanine concentrations were higher in the operated groups of animals, especially 
in the animals from ligated horns. 
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Table 9 6 Serum ammo acid concentrations in animals from normal litters 
Time after delivery (h) 
0 1 3 6 
Taurine 
Threonine 
Senne 
Glycine 
Alanine 
Citrullme 
Valine 
Cystine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Ornithine 
Lysine 
979 
222 
474 
550 
875 
74 
435 
22 
156 
127 
263 
207 
184 
100 
1138 
± 
+ 
+ 
+ 
+ 
± 
+ 
+ 
+ 
+ 
+ 
± 
+ 
± 
+ 
125 
67 
69 
110 
114 
27 
97 
5 
27 
47 
75 
54 
42 
16 
232 
1071 ± 
123 ± 
295 ± 
500 ± 
703 ± 
70 ± 
278 ± 
13 ± 
105 ± 
50 ± 
110 ± 
156 ± 
102 ± 
80 ± 
881 ± 
186 
25 
61 
116 
102 
27 
68 
1 
20 
19 
41 
57 
17 
30 
176 
745 
93 
217 
483 
361 
61 
229 
16 
77 
44 
96 
133 
86 
45 
618 
± 
+ 
+ 
± 
+ 
+ 
± 
± 
+ 
+ 
+ 
+ 
± 
+ 
+ 
286 
11 
32 
78 
58 
35 
23 
4 
7 
22 
23 
50 
10 
25 
113 
1228 ± 248 
129 ± 18 
261 ± 35 
652 ± 87 
418 ± 93 
71 ± 3 5 
231 ± 23 
13 ± 5 
109 ± 29 
68 ± 3 
117 ± 13 
127 ± 22 
136 ± 26 
58 ± 38 
666 ± 98 
Values are given m/vmol/l as means ± SD of 5 litters. 
Table 9 7 Serum ammo acid concentrations in animals from contralateral horns 
Time after delivery (h) 
0 1 3 6 
Taurine 
Threonine 
Serine 
Glycine 
Alanine 
Citrullme 
Valine 
Cystine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Ornithine 
Lysine 
954 
370 
556 
1136 
1069 
59 
544 
34 
149 
164 
335 
221 
243 
167 
1373 
± 
+ 
± 
± 
+ 
± 
+ 
± 
± 
± 
+ 
+ 
+ 
+ 
+ 
304 
82 
84 
225 
144 
14 
60 
19 
32 
33 
45 
69 
51 
58 
154 
808 
211 
300 
922 
765 
59 
348 
31 
99 
63 
157 
150 
144 
117 
1035 
± 
+ 
± 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
± 
+ 
± 
124 
35 
65 
131 
261 
17 
82 
15 
42 
45 
78 
58 
43 
58 
183 
783 
154 
232 
853 
386 
47 
276 
26 
76 
57 
122 
144 
124 
67 
780 
± 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
± 
+ 
+ 
+ 
+ 
+ 
+ 
269 
30 
38 
128 
59 
16 
33 
15 
23 
16 
13 
41 
21 
26 
126 
754 ± 
175 ± 
259 ± 
1003 ± 
427 ± 
61 ± 
286 ± 
30 ± 
95 ± 
83 ± 
144 ± 
148 ± 
176 ± 
77 ± 
783 ± 
167 
58 
45 
149 
72 
22 
44 
20 
30 
9 
17 
48 
24 
31 
79 
Values are given in^mol/1 as means ± SD The number of horns was 11, except for taunne (8), 
cystine (9) and methionine (10) 
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Table 9.8 Serum ammo acid concentrations in animals from ligated horns 
Time after delivery (h) 
0 1 3 6 
Taurine 
Threonine 
Senne 
Glycine 
Alanine 
Citrulline 
Valine 
Cystine 
Methionine 
Isoleucme 
Leucine 
Tyrosine 
Phenylalanine 
Ornithine 
Lysine 
667 ± 
298 ± 
539 ± 
944 ± 
1317 ± 
54 ± 
505 ± 
37 ± 
162 ± 
155 ± 
331 ± 
179 ± 
258 ± 
122 ± 
1180 ± 
139 
38 
107 
182 
273 
13 
53 
21 
64 
20 
37 
40 
36 
36 
178 
818 
240 
345 
1087 
1176 
59 
417 
48 
136 
97 
232 
163 
208 
102 
1143 
+ 
+ 
+ 
+ 
+ 
+ 
± 
± 
+ 
+ 
+ 
± 
± 
± 
± 
108 
108 
147 
256 
513 
21 
165 
33') 
85 
81 
162 
62 
94 
46 
344 
781 ± 
157 ± 
240 ± 
926 ± 
963 ± 
61 ± 
321 ± 
37 ± 
113 ± 
64 ± 
174 ± 
161 ± 
183 ± 
54 ± 
850 ± 
252 
77 
67 
303 
914 
17 
101 
31 
59 
29 
111 
66 
58 
19 
244 
829 ± 288 
157 ± 30 
300 ± 98 
1061 ± 235 
540 ± 243 
61 ± 15 
290 ± 52 
26 ± l l 2 ) 
104 ± 25 
80 ± 17 
139 ± 33 
146 ± 27 
204 ± 40 
70 ± 43 
871 ± 164 
Values are given in ^mol/1 as means ± SD. The number of horns was 10, except for taurine (8). 
1) = 9 animals 
2) = 8 animals 
Table 9.9 Serum amino acid concentrations in animals from sham litters 
Time after delivery (h) 
0 1 3 6 
Taurine 
Threonine 
Serine 
Glvcine 
Alanine 
Citrulline 
Valine 
Cystine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Ornithine 
Lysine 
819 
231 
509 
555 
1051 
55 
490 
17 
150 
126 
259 
206 
202 
134 
1246 
± 
+ 
+ 
± 
+ 
+ 
+ 
+ 
± 
+ 
+ 
+ 
+ 
+ 
+ 
113 
75 
120 
93 
145 
1 
101 
9 
8 
34 
73 
26 
18 
14 
186 
918 
133 
334 
475 
876 
57 
327 
8 
105 
47 
126 
146 
128 
100 
994 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
± 
245 
53 
83 
78 
268 
8 
75 
4 
17 
30 
73 
22 
42 
55 
221 
842 
90 
227 
491 
536 
46 
262 
9 
86 
34 
94 
129 
104 
54 
697 
+ 
± 
± 
+ 
+ 
± 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
± 
179 
18 
44 
66 
287 
19 
33 
2 
13 
9 
31 
26 
25 
38 
145 
767 ± 
94 ± 
228 ± 
565 ± 
442 ± 
52 ± 
271 + 
15 ± 
102 ± 
62 ± 
123 ± 
135 ± 
146 ± 
59 ± 
694 ± 
178 
15 
13 
55 
143 
15 
32 
4 
6 
7 
14 
23 
15 
23 
77 
Values are given in fimol/l as means ± SD of 5 litters. 
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Gluconeogenic amino acids enter the metabolic pathways at specific steps, as 
shown in Fig. 9.2. We summed the most important amino acids entering at the 
level of pyruvate (alanine, serine, glycine, threonine) and show the individual and 
summed values for each experimental group of animals in Table 9.10. 
Significant differences were found in the gluconeogenic amino acids threonine 
and glycine at all sampling times and in alanine at birth. The results of this statis­
tical evaluation are shown in Tables 9.11, 9.12 and 9.13 for threonine, glycine, 
and the summed values of glycine, threonine, alanine and serine respectively. 
Glycine and threonine concentrations were higher in animals from ligated horns 
compared to animals from sham and normal litters. Alanine concentration was 
higher at birth in animals from ligated horns compared to animals from normal 
litters (P = 0.003); the difference between the alanine concentration in animals 
from ligated horns and from sham litters was not significant (P = 0.075). When 
the 4 gluconeogenic amino acids, which enter the metabolic pathway at pyruvate, 
are summed the total concentration is significantly higher in animals from ligated 
homs compared to animals from sham-operated or normal litters. The difference 
between ligated and contralateral horns is, however, not significant. 
g l u c o s e 
phosphoenol pyruvate 
PEPck {alanine gfycine 
threonine 
[proline 
J glutan 
> glu tar 
I histidme 
phenylalanine »• f u m a r a t e a-ketoglutarate ·« Nalutam'ic acid 
succinyl - CoA 
ь 
methionine 
valine 
isoleucme 
Fig. 9.2. Gluconeogenic amino acids entering the metabolic pathway (adapted from Haymond et 
al., 1974) 
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Table 9 10 Serum concentrations of gluconeogenic ammo acids, entering the metabolic pathway 
at pyruvate 
Ammo acid 
Group 
Alanine 
Normal litters 
Contralateral horns 
Ligated horns 
Sham litters 
Senne 
Normal litters 
Contralateral horns 
Ligated horns 
Sham litters 
Glycine 
Normal litters 
Contralateral homs 
Ligated horns 
Sham litters 
Threonine 
Normal litters 
Contralateral horns 
Ligated horns 
Sham litters 
Summed values 
Normal litters 
Contralateral horns 
Ligated horns 
Sham litters 
Time after delivery (h) 
0 
875 ± 114 
1069 ± 144 
1317 ± 273 
1051 ± 145 
474 ± 69 
556 ± 84 
539 ± 107 
509 ± 120 
550 ± 110 
1136 ± 2 2 5 
944 ± 182 
555 ± 93 
222 ± 67 
370 ± 82 
298 ± 38 
231 ± 75 
2121 ± 306 
3132 ± 467 
3098 ± 420 
2345 ± 388 
1 
703 ± 102 
765 ± 261 
1176 ± 513 
876 ± 268 
295 ± 61 
300 ± 65 
345 ± 147 
334 ± 83 
500 ± 116 
922 ± 131 
1087 ± 256 
475 ± 78 
123 ± 25 
211 ± 35 
240 ± 108 
133 ± 53 
1620 ± 282 
2198 ± 446 
2848 ± 939 
1819 ± 463 
3 
361 ± 
386 ± 
963 ± 
536 ± 
217 ± 
232 ± 
240 ± 
227 ± 
483 ± 
853 ± 
926 ± 
491 ± 
93 ± 
154 ± 
157 ± 
90 ± 
1154 ± 
1624 ± 
2287 ± 
1344 ± 
58 
59 
914 
287 
32 
38 
67 
44 
78 
128 
303 
66 
11 
30 
77 
18 
137 
197 
1317 
396 
6 
418 ± 93 
427 ± 72 
540 ± 243 
442 ± 143 
261 ± 35 
259 ± 45 
301 ± 98 
228 ± 13 
652 ± 87 
1003 ± 149 
1061 ± 235 
565 ± 55 
129 ± 18 
175 ± 58 
158 ± 30 
94 ± 15 
1461 ± 191 
1863 ± 233 
2059 ± 585 
1329 ± 178 
Values are given in //mol/l as means ± SD, the number of normal and sham litters was 5, the 
number of contralateral horns 11 and the number of ligated horns 10 
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Table 9 11 Statistical evaluation of threonine concentration measurements (P-values) 
Time after delivery (h) 
Kruskal-Wallis test 0 004 0 003 0 001 0 004 
Wilcoxon's test 
Normal vs sham 
Normal vs ligated 
Normal vs contra­
lateral 
Sham vs ligated 
Sham vs contra­
lateral 
Contralateral vs 
ligated 
1 000, NS 
0 040, NS 
0 013, N<C 
0 055, NS 
0 017, S<C 
0 027, NS 
0 835, NS 
0 008, N<L 
0 002, N<C 
0 040, NS 
0,013, S<C 
0 699, NS 
0 676, NS 
0 013, N<L 
0 002, N<C 
0 008, S<L 
0 003, S<C 
0 597, NS 
0 016, S<N 
0 075, NS 
0 113, NS 
0 001, S<L 
0 005, S<C 
0 550, NS 
N = normal litters, С = contralateral horns, L = ligated horns, S = sham litters, 
NS = not significantly different 
Table 9 12 Statistical evaluation of glycine concentration measurements (P-values) 
Time after delivery (h) 
Kruskal-Walbs test 0 000 0 000 0 000 0 000 
Wilcoxon's test 
Normal vs sham 
Normal vs ligated 
Normal vs contra­
lateral 
Sham vs ligated 
Sham vs contra­
lateral 
Contralateral vs 
ligated 
1 000, NS 
0 001, N<L 
0 002, N<C 
0 001,S<L 
0 002, S<C 
0 067, NS 
0 835, NS 
0 001, N<L 
0 002, N < C 
0 001,S<L 
0 002, S<C 
0 073, NS 
1 000, NS 
0 001, N<L 
0 002, N<C 
0 001,S<L 
0 002, S<C 
0 805, NS 
0 095, NS 
0 003, N<L 
0 002, N < C 
0 001,S<L 
0 002, S<C 
0 597, NS 
N = normal litters, С = contralateral horns, L = bgated horns, S = sham litters, NS = not signifi­
cantly different 
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Table 9 13 Statistical evaluation of the total values of glycine, threonine, alanine, and serine con­
centrations measured (P-values) 
Kruskal-Wallis test 
Wilcoxon's test 
Normal vs sham 
Normal vs ligated 
Normal vs contra­
lateral 
Sham vs ligated 
Sham vs. contra­
lateral 
Contralateral vs. 
ligated 
Time after delivery (h) 
0 
0 001 
0 403, NS 
0 001,N<L 
0 003, N<C 
0 001,S<L 
0 009, S<C 
0 805, NS 
1 
0 002 
0 403, NS 
0 001,N<L 
0 017, N<C 
0 008, S<L 
0 365, NS 
0 038, NS 
3 
0 002 
0 5 3 1 , 
0 008, 
0 002, 
0 028, 
0 079, 
0 032, 
NS 
N<L 
N<C 
NS 
NS 
NS 
6 
0 002 
0 403, NS 
0 019, N < L 
0 013, N < C 
0 008, S<L 
0 003, S<C 
0 699, NS 
N = normal litters, С = contralateral horns, L = ligated horns, S = sham litters, NS = not signi­
ficantly different 
9.4. Discussion 
Hepatic glycogen concentration shows a rapid fall in all groups of animals after 
birth. This was already found in the normal newborn rat (Dawkins, 1963; Cake et 
al., 1971; Girard et al., 1972; Snell and Walker, 1973; De Meyer et al., 1979; 
Bashan et al., 1979; Cuezva et al., 1980) and in the IUGR newborn rat (Chanez et 
al., 1971). Some discrepancy, however, exists in the literature about whether 
there is a lag period after birth before glycogenolysis takes place or not. In most 
reports, a lag period of at least 1 h was mentioned. The absence of a lag period, 
however, was reported in two recent papers (Bashan et al., 1979; Cuezva et al., 
1980). Our results point to initiation of glycogen breakdown between 0 and 3 h 
after delivery. At birth and up to 6 h after delivery, hepatic glycogen concentra­
tion in IUGR newborn rats is lower than in newborns from contralateral horns or 
sham litters. The total amount of glycogen stores will be more reduced because of 
the smaller liver weight in intrauterine growth-retarded newborn animals. Glyco­
gen depletion, as can be seen in Fig. 9.1, is similar in the 4 groups of animals. Thus 
it appears that at birth glycogen stores are lower in IUGR newborn rats, but that 
depletion of these glycogen stores takes place at a relatively normal rate. 
The large differences of the plasma free fatty acid concentrations between the 4 
groups are difficult to interpret. The concentrations are in the same order as 
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reported for normal newborn rats (Girard et al., 1973; Snell and Walker, 1973; 
Ferré et al., 1978b). The slight increase of the free fatty acid concentrations in 
animals from normal and sham litters during the 6 h period is in accordance with 
the findings of other authors (Girard et al., 1973; Snell and Walker, 1973). The 
absence of such an increase of free fatty acid concentrations in animals from 
ligated and contralateral horns could point to a delay in free fatty acid mobiliza-
tion in these animals. Chanez and Tordet-Caridroit (1972) found a delay of 12 h 
in animals from ligated and contralateral horns. Since free fatty acid mobilization 
in the unsuckled newborn rat results from lipolysis in brown adipose tissue, 
mainly in response to cold exposure, a more substantial increase of free fatty acid 
concentrations in normal and sham litters was presumably prevented in our 
experimental design by keeping the animals at thermal neutrality. We confirmed 
that free fatty acid concentrations are lower in IUGR newborn rats than in 
animals from contralateral horns, as reported previously (Roux et al., 1970; 
Chanez and Tordet-Caridroit, 1972). In comparison with animals from sham 
litters, however, we found elevated concentrations of free fatty acids in IUGR 
rats. We have no explanation for the low concentration in the animals from 
sham-operated litters. A similar result was obtained by Roux (personal commu-
nication). Whatever the meaning of the difference in free fatty acid concentra-
tions between the 4 groups may be, it seems to be clear from our data that the 
operation procedure has a marked effect on their concentrations in the fetal rat. 
Hormonal response to the experimental procedure (Levitsky et al., 1977) was not 
studied in our investigations. The elevated free fatty acid concentrations in 
animals from ligated and contralateral horns compared to those in normal and 
sham litters may be the result of increased lipolysis or decreased utilization. 
The concentrations of carnitine agree well with those from the literature 
(Robles-Valdesetal., 1976;Borum, 1978; Yeh and Zee, 1979). Carnitine, which 
can be synthesized in the liver, is required for transport of long chain fatty acids 
from the cytosol to the mitochondrial matrix and is thus of importance for 
adequate fatty acid oxidation and ketogenesis. Its availability could limit the 
transport of fatty acids into the mitochondria though fatty acid oxidation is not 
exclusively determined by the hepatic level of carnitine (Yeh and Zee, 1979). 
Hepatic carnitine content rises in pregnant rats and their fetuses around the time 
of parturition (Robles-Valdes et al., 1976). The explanation for our finding of a 
higher hepatic carnitine concentration in IUGR newborn rats immediately after 
birth as compared with the other groups of newborn animals remains unclear but 
excludes carnitine deficiency in IUGR newborn rats. A positive correlation 
between hepatic carnitine content and plasma ketone body concentrations in the 
perinatal period has been established (Robles-Valdes et al., 1976). We did not 
measure ketone body concentrations. Dahlquist and Persson (1976) found no 
differences in ketone body concentrations between intrauterine growth-retarded 
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and control animals on the day of birth, but they did not mention when the 
samples were taken. Our results show that the fatty acid oxidation capacity in the 
liver of IUGR newborn rats is normal. 
Limited data are available in the literature on serum amino acid concentrations in 
IUGR newborn rats (Roux and Jahchan, 1974; Manniello et al., 1977; Cresteil 
and Leroux, 1977). At birth, most gluconeogenic amino acid concentrations were 
in the same range in animals from ligated and contralateral horns (Roux and 
Jahchan, 1974; Manniello et al., 1977). Total amino acid concentration was 
reported to be higher in IUGR newborn rats compared to animals from the 
contralateral horns (Manniello et al., 1977). We found, however, that, except for 
alanine, there is no statistical difference in concentrations of gluconeogenic amino 
acids between animals from ligated and contralateral horns. Compared to animals 
from sham litters, however, the total concentration of the gluconeogenic amino 
acids, which enter the pathway at pyruvate, is higher in IUGR newborn rats from 
0-6 h after delivery (Table 9.13). Girard et al. (1975) reported that the concentra-
tions of most amino acids decline within a few hours after delivery in normal 
newborn rats. We observed this phenomenon in normal as well as in IUGR 
newborn rats. The exceptions are, as found by Girard, taurine, citrulline and cys-
tine. The sharp decline of the amino acid concentrations after birth is thought to 
be the result of the interruption of placental transfer, peripheral uptake and con-
version of gluconeogenic amino acids to glucose in the gluconeogenic pathway, 
which increases from 0-6 h after delivery in the newborn rat (Girard et al., 1975). 
Our observation that the phenylalanine concentration is elevated in intrauterine 
growth-retarded newborn rats is in accordance with the finding of Manniello et al. 
(1977). Since phenylalanine is not catabolized in the newborn rat, but is incorpo-
rated into protein (Cresteil and Leroux, 1977), this might reflect diminished 
protein synthesis after intrauterine growth retardation. 
9.5. Summary 
In this chapter the results of the determinations of some important substrates for 
glucose homeostasis in the 4 experimental groups of newborn rats from 0-6 h after 
birth are described. 
The glycogen concentration is the lowest in the liver of IUGR newborn rats. The 
decrease after delivery is rapid and similar in all groups and is initiated within 3 h 
after birth. Hepatic glycogen content is significantly lower in IUGR animals 
compared to animals from sham litters or contralateral horns from 0-6 h after 
delivery. The conclusion is that the diminished hepatic glycogen stores in IUGR 
newborn rats are depleted during the first period after delivery at a similar rate as 
in control animals. 
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Seram free fatty acid concentrations show striking differences between some 
groups. Compared to animals from sham litters, the lUGR newborn rats had 
higher free fatty acid concentrations during the period studied but, compared to 
animals from contralateral horns, the concentration of free fatty acids is lower. An 
increase of the free fatty acid concentration was found in animals from normal and 
from sham-operated mothers between 3-6 h after birth. Such an increase was 
absent in animals from hgated and contralateral horns. The results are consistent 
with a normal availability of free fatty acids at birth in IUGR rats. The absence of 
an increase from 3 h after birth in IUGR animals could point to a delay m free 
fatty acid mobilization during this period. 
Hepatic carnitine content at birth was significantly higher in IUGR animals 
compared to animals from the control groups. The possibility of a deficiency of 
carnitine, limiting fatty acid oxidation and gluconeogenesis, could thus be exclu­
ded. 
Measurements of fatty acid oxidation in liver homogenates of 1 h-old newborn 
rats showed a similar oxidation rate in animals of all groups and point to a normal 
enzymatic capacity for fatty acid oxidation in the liver of IUGR newborn rats. 
Serum amino acid analyses revealed a higher total concentration of the amino 
acids which enter the gluconeogenic pathway at pyruvate in IUGR animals 
compared to normal animals and animals from sham litters at birth and from 0-6 h 
after delivery, though in all groups of animals amino acid concentrations decrea­
sed markedly after delivery. No differences were noted in these values between 
animals from ligated and contralateral horns. 
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Chapter 10. 
GLUCOSE TURNOVER STUDIES IN THE EARLY NEONATAL 
PERIOD AFTER INTRAUTERINE GROWTH RETARD ΑΠΟΝ 
10.1. Introduction 
Hypoglycemia in newborn IUGR rats might be due to an impaired gluconeogene-
sis, as has been discussed in chapters 8 and 9, but could also result from an 
increased glucose utilization. In a steady state, production equals utilization and 
blood glucose concentrations will remain constant. The dynamics of glucose 
production and utilization can be studied by determination of the glucose turn­
over rate in vivo as defined by the amount of glucose which is utilized during a 
given time period. 
In this chapter, the results of glucose turnover studies in normal and IUGR new­
born rats will be presented. 
10.2. Theoretical approach to glucose turnover 
Glucose turnover studies are based on the dilution principle of Stewart-Hamilton 
as described by Shipley and colleages (Shipley et al., 1967; Shipley and Clark, 
1972). When a tracer dose of labelled glucose is injected in vivo, the specific 
activity of glucose will decrease as a result of dilution. Glucose and the injected 
tracer are metabolized and replaced by new, unlabelled, glucose. After disappea­
rance of all tracer glucose, tracer dose divided by the mean specific activity during 
the whole time period would represent approximately the total amount of glucose 
utilized in the pool during this period. When expressed per unit of time, it would 
represent the glucose turnover rate. 
A hypothetical curve of the specific activity (S) after injection of a tracer dose (d) 
against time is shown in Fig. 10.1. 
The turnover rate (R) would be: 
η
 d
 1 d u· U 
R =
 ΧΤτ
 X
 Υ
 =
 "A l n w h i c h 
A = the area under the curve 
T = whole time period 
A/T = mean specific activity 
To get precise results, the area under the curve must be known exactly. 
Numerous sequential blood samples would, therefore, be necessary. This is 
impossible in small animals like newborn rats. A method to reduce the number of 
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sampling times has, however, been described (Corney and Heath, 1970). The 
calculation of the area under the curve, with this method, has been worked out 
(Heath and Barton, 1973; Heath and Cunningham, 1975) for steady-state condi­
tions. 
103. Choice of sampling times and calculation method 
To study turnover rates in newborn rats it is inevitable to kill one animal for each 
specimen of blood. The biological variation of specific activities must thus be 
taken into account, and several animals from one litter should be killed at many 
sampling times to get the precise curve of the specific activity after tracer injec­
tion. However, it is desirable to minimize the number of animals used and to 
sample at as few time-points as possible. It was shown that systematic errors can 
be kept at about 2% by sampling at four properly chosen times per curve for 
glucose turnover studies instead of many sampling times (Corney and Heath, 
1970). The principles of the designed method are as follows. The general shape of 
the curve can be determined in a preliminary experiment. Then, the area under 
the curve can be divided into 8 equal portions by trial and error, e.g. by plotting on 
paper, cutting, and weighing (Fig. 10.1). Thus, the four areas between to and t2, ti 
and t4, t4 and te, and te and ω are equal and ti, ti, ts and t? exactly halve these 
areas, i.e. are at their centroids. Values of specific activity are experimentally 
obtained at ti, ta, ts and t?. A computer program can be used to calculate the four 
optimal sampling times from a preliminary experiment (Heath and Cunningham, 
1975). The glucose turnover rates can be calculated from the area under the curve 
and the total tracer dose injected. 
to t-i ta із Ц tg te t? t i m e t m i n ) 
Fig. 10.1. Curve of speafic activity after intravenous injection of a tracer dose of glucose 
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10.4. Choice of the label in glucose turnover studies 
The ideal label to use in glucose turnover measurements is one which is lost in an 
early stage of metabolism to avoid reincorporation into newly synthesized gluco-
se. [14C]glucose and carbon-2 or carbon-6 tritiated glucose are used mostly. 
When [14C]glucose is used, label will appear in all glycolytic and citric acid cycle 
intermediates and in CO2. The label may be reincorporated into new glucose 
and the glucose turnover rate will be underestimated (Dunn and Strahs, 1965; 
Dunn et al., 1967). For this reason [14C]glucose is not the most suitable tracer to 
study glucose turnover. When [2-3H]glucose is used, extensive exchange of the 
tritium with protons occurs at an early stage of glycolysis during isomerization be-
tween glucose-6-phosphate and fnictose-6-phosphate (Fig. 10.2) and only very 
small amounts of label are incorporated into glycogen (Katz and Dunn, 1967). 
When glycogenolysis occurs, glucose produced will be unlabelled and dilute the 
labelled blood glucose pool. As a result, not only gluconeogenesis but also glyco-
genolysis will be included in the calculated glucose turnover. [2-3H]glucose 
seems, therefore, to be well suited to study glucose turnover rates. An important 
disadvantage, however, became clear in recent years when the existence of "fu-
tile" or substrate cycles in metabolism was detected (Katz et al., 1975; Clark et 
al., 1975; Hers, 1976; Hue, 1976). Cyclic transformation of metabolites at the 
expense of ATP occurs in these cycles, which may play a regulatory role in glucose 
homeostasis by controlling substrate concentrations (Hers, 1976). One of these 
futile cycles operates between glucose and glucose-6-phosphate (Hue and Hers, 
1974; Clark et al., 1975) and considerable amounts of tritium at the 2-position 
may be lost at this step without net utilization of glucose (Hue and Hers, 1974). 
This can introduce a recycling error and overestimation of the glucose turnover 
rate by approximately 20% (Katz et al., 1976). Label from [6-3H]glucose is lost 
early in catabolism like that from [2-3H]glucose during isomerization between 
glucose-6-phosphate and fructose-6-phosphate, but the former tracer behaves in 
a different way. Its tritium label is incorporated into glycogen. As a result, glu-
cose production from glycogen does not markedly influence the glucose turnover 
rate, determined with [6-:'HJglucose, and therefore the glucose turnover rate 
refers only to gluconeogenesis. Overestimation of the turnover rate as a result of 
futile cycling is considerably less than when [2-3H]glucose is used (Hue and Hers, 
1974; Dunn et al., 1975). In our experiments in newborn rats we chose a sampling 
time of 6 h after delivery because at his time both gluconeogenesis and glyco-
genolysis are operative and contribute to the turnover of glucose in the newborn 
rat. [2-3H]glucose was selected as tracer because with the aid of this tracer the 
contributions both of gluconeogenesis and of glycogenolysis to the glucose turn-
over rate are measured. Since the investigations were performed to compare data 
from IUGR animals with those from control animals, the disadvantage of over-
estimation due to futile cycling was accepted. 
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Fig. 10.2. Fate of tracer after injection of [6-3H]glucose or [2-3H]glucose 
10.5. Materials and methods 
The experimental animal model was described in chapter 6. For each glucose 
turnover experiment, four newborn rats from one litter or one uterine horn were 
kept in an incubator at a temperature of 370C and a relative humidity of 65%. 
Birth weight criteria were as described in chapter 7. 
At the age of 6 h, the fasted animals were injected intraperitoneally with 5/Л of a 
solution of glucose in water, containing 4-5 /¿Ci [2-3H]glucose (specific activity 
17.9 Ci/mmol). Injection was performed with a Hamilton microliter syringe no 
701. Four animals were killed by decapitation after 3, 15, 45 and 130 min 
respectively. These sampling times were established* from preliminary experi-
ments by the method of Heath and Cunningham (1975). 
Blood samples were collected as described in section 6.1.4 and blood glucose 
concentration and the specific activity of glucose determined as described in 
sections 6.2.4 and 6.2.11, respectively. From the data on body weight, specific 
activity of glucose and tracer dose the glucose turnover rate was calculated* 
according to a procedure developed previously (Heath and Barton, 1973 ; Heath 
and Cunningham, 1975). 
10.6. Results 
Birth weight and blood glucose concentrations at the 4 sampling times after 
injection of the tracer are given in Table 10.1. Blood glucose concentrations are 
approximately constant during the time-course of the experiments, indicating 
steady-state conditions in which glucose production and utilization are in balance. 
* The calculations were carried out by Dr V.J. Cunningham, Medical Research Council Toxico-
logy Unit, Carshalton, Surrey, England. 
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Table IO I Birth weight and blood glucose concentrations after injection of [2-3H]glucose at 6 h 
after delivery 
Group 
Normal litters 
Contralateral horns 
Ligated horns 
Sham litters 
(5) 
(4) 
(4) 
(4) 
Birth weight 
(g) 
4 78 ± 0 31 
4 74 ± 0 27 
3 43 ± 0 38 
4 58 ± 0 50 
Blood glucose concentrations (mmol/1) 
Time after injection (mm) 
3 
4 52 ± 0 72 
3 21 ± 1 09 
3 31 ± 130 
4 29 ± 0 82 
15 
4 63 ± 0 33 
4 21 ± 0 53 
2 96 ± 2 08 
4 49 ± 0 95 
45 
5 29 ± 0 92 
3 65 ± 0 73 
3 45 ± 1 36 
4 34 ± 0 36 
130 
4 08 ± 0 42 
3 01 ± 0 88 
3 66 ± 1 76 
3 46 ± 0 43 
Mean blood glucose 
concentration (mmol/1) 
over expérimental period 
4 63 ± 0 49 
3 52 ± 0 68 
3 35 ± 1 42 
4 14 ± 0 55 
Values are given as means ± SD, the number of Utters or horns is indicated between parentheses 
An example of the course of the specific activity of glucose after injection of 
[2-3H]glucose, calculated from the data on the 4 sampling times, is given in Fig. 
10.3. 
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Fig. 10.3. Specific activity (dpm perumol glucose) after intraperitoneal injection of 5 /¿Ci [ 2 - ^ ] -
glucose into newborn rats at 6 h of age 
The glucose turnover rates calculated are shown in Table 10.2. Statistical analysis 
(Kruskal-Wallis test) did not reveal any significant differences (P = 0.35). 
Table 10.2 Glucose turnover rate m the fasted newborn rat at 6 h after delivery 
Group Glucose turnover rate 
Normal litters 
Contralateral horns 
Ligated horns 
Sham litters 
(5) 5 45 ± 0.31 
(4) 5.14 ± 0.51 
(3) 5.49 ± 0.29 
(4) 5.80 ± 0.52 
Values are given in ^ mol/min per 100 g body weight as means ± SD; the number of litters or horns 
is indicated between parentheses. 
10.7. Discussion 
Glucose production at 6 h after delivery in fasted newborn rats occurs from 
glycogenolysis and gluconeogenesis, both of which are operative at that time. As 
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described in section 10.4, with the use of [2-3H]glucose the contribution of 
glycogenolysis as well as gluconeogenesis to glucose production will be measured. 
Some data on glucose turnover rates in the early neonatal period are available. 
Snell and Walker (1973 a,b) measured, with [6-3H]glucose, glucose utilization 
and formation rates during the first 2 h and at 2 days after delivery in normal, 
fasted rats. They found a glucose formation rate of about 6 μτηοΐ/τηιτι per 100 g 
body weight during the first 2 h after delivery and of about 7.4 at 2 days of age. 
During the first hour after delivery, the glucose utilization rate exceeded the 
glucose formation rate and was about 15 /imol/min per 100 g body weight. At 2 
days of age glucose utilization was similar to glucose production. Girard and 
Guillet (1975) found, with [2-3H]glucose, a glucose turnover rate of about 7 
μτηοΐ/τηίη per 100 g body weight at birth, increasing to about 18^mol/min per 
100 g body weight at 6 h after birth. Our values of the glucose turnover rate of 
about 5^mol/min per 100 g body weight at 6 h after birth are in the same order as 
found in the newborn period by Snell and Walker (1973 a,b). They are, however, 
lower than those found by Girard and Guillet (1975) at 6 h after birth. The mean 
blood glucose concentrations, however, in their animals from the Sherman strain 
were distinctly higher than in our animals from the Wistar strain and their animals 
had been suckled whereas ours were starved from birth. 
We found no differences in glucose turnover rates between IUGR animals and 
animals of the other groups. Mean blood glucose concentrations in IUGR animals 
during the glucose turnover experiments at 6 h after delivery were lower than 
those in animals from sham-operated litters. The difference was, as contrasted 
with the observations in chapter 7, not significant. This might be explained by 
the small number of litters involved and the unusually high glucose concentrations 
in one of the 4 ligated horns. 
The results of the glucose turnover experiments must be interpreted cautiously, 
since the experiments were only performed at 6 h after delivery. We can assume 
that a higher glucose concentration in IUGR rats could be accompanied by a 
higher glucose turnover rate. It might be hypothesized that, although substantial 
glucose production from gluconeogenesis and glycogenolysis takes place in 
IUGR newborn rats after birth, this is inadequate to provide the amounts of 
glucose needed for utilization and, at the same time, elevate the glucose concen­
trations to normal values in the early neonatal period. An increased utilization of 
glucose may contribute to the lower blood glucose concentrations found in IUGR 
rats. 
10.8. Summary 
In this chapter, theoretical backgrounds of the glucose turnover measurement 
with labelled glucose and the results of our own investigations are described. 
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With [2-3H]glucose as a tracer, glucose turnover rates were calculated at 6 h after 
delivery in newborn rats from normal and sham-operated litters and from hgated 
and contralateral uterine horns. No differences were found. The results show that, 
in the IUGR rats, substantial glucose production from gluconeogenesis occurs at 
6 h after birth and suggest that a higher utilization of glucose might also contri­
bute to the lower blood glucose concentrations in the early neonatal period 
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Chapter И . 
GENERAL SURVEY AND CONCLUSIONS 
11.1. General survey 
Ligation of one of both uterine arteries in the rat (Wigglesworth, 1964), the 
experimental model used in our investigations, resembles intrauterine growth 
retardation from "subacute fetal distress" (Gruenwald, 1963) in the human fetus 
and newborn, which is frequently caused by vascular or placental disease of the 
mother and results in body wasting and low birth weight. One must, however, 
realize that intrauterine growth retardation in man may be caused by a variety of 
known and unknown factors (Lubchenco et al., 1968; Renfield, 1975). The 
Wigglesworth model is, nevertheless, a useful tool to study intrauterine growth 
retardation. 
Previously there was no doubt concerning the choice of controls in this experi­
mental model since the anatomy of the reproductive organs of the female rat 
offers the possibility to take control animals from the contralateral, non-ligated 
uterine horn of the same mother. After ligation of one uterine artery, however, 
circulatory changes might occur which affect blood flow to the contralateral 
uterine horn. Direct studies of the blood flow to the uterine horns in the Wiggles­
worth model would be worthwhile. Our finding that mean birth weight of animals 
from contralateral horns is significantly lower compared to mean birth weight of 
animals from normal litters (Table 7.1) points to a reduction in blood flow to the 
contralateral horns. We found a significantly larger standard deviation of birth 
weights of animals from ligated as well as from contralateral horns compared to 
animals from normal and sham litters (Table 7.1). Thus the ligation procedure 
affects the contralateral horns as well. Therefore animals from sham-operated 
mothers are more satisfactory controls for newborn rats that are intrauterine 
growth-retarded in the Wigglesworth model (chapter 7). Our further investiga­
tions were performed in animals from ligated homs, contralateral horns, sham 
litters and normal litters. 
Transient neonatal hypoglycemia occurred in all groups of newborn animals 
(Table 7.2), the lowest blood glucose concentration being reached at about 3 h 
after delivery. This is in agreement with the pattern of glucose concentrations 
after birth in the normal rat (Cake et al., 1971; Girard et al., 1973; Snell and 
Walker, 1973; Levitsky et al., 1976), described in chapter 4. In the normal 
newborn infant a comparable transient fall of the blood glucose concentration 
occurs within 4-6 h after delivery (Cornblath and Schwartz, 1976). 
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The intrauterine growth-retarded newborn rat differs from their controls from 
sham-operated dams in the lower blood glucose concentrations and the signifi-
cantly slower rise of the blood glucose concentrations between 3 and 6 h after 
delivery (Tables 7.2 and 7.3). As described in chapter 4, the rise of blood glucose 
concentrations after the transient hypoglycemic period depends on the glucose 
producing processes of glycogenolysis and gluconeogenesis. Hepatic glycogen 
stores are low in intrauterine growth-retarded newborn rats (Chanez et al., 1971 ; 
Table 9.1) and small-for-gestational-age newborn babies (Shelley, 1964). Mobi-
lization of hepatic glycogen stores starts within a few hours after birth in normal 
and in intrauterine growth-retarded newborn rats (Snell and Walker, 1973; 
Manniello et al., 1977a; Bashan et al., 1979; De Meyer et al., 1979; Table 9.1) 
around the time when the lowest blood glucose concentrations are reached. At 6 h 
after delivery, when the blood glucose concentration in normal newborn rats has 
reached its initial value again, 35-50% of the hepatic glycogen stores are deple-
ted. In intrauterine growth-retarded newborn rats glycogen breakdown contribu-
tes to the rise of blood glucose concentrations between 3 and 6 h after birth. 
However, in spite of the presence of about half of the original glycogen stores at 6 
h (Table 9.1), blood glucose concentrations in intrauterine growth-retarded rats 
still do not reach the values found in control animals (Table 7.2). 
Gluconeogenesis appears after birth in the rat (Girard et al., 1973; Snell and 
Walker, 1973; Girard et al., 1975). Several lines of evidence point to a delay in 
the development of the gluconeogenic capacity in intrauterine growth-retarded 
rats and small-for-gestational-age babies. 
Conversion of labelled alanine to glucose in liver slices of these rats is significantly 
lower compared to control animals (Nitzan and Groffman, 1971). An inverse 
correlation between plasma glucose and gluconeogenic amino acids was establish-
ed (Manniello et al., 1977b). In intrauterine growth-retarded newborn babies, a 
lack of glycémie response was noted after injection of alanine (Mestyán et al., 
1974; Sóvik and Finne, 1977) and hyperaminoacidemia occurs (Haymond et al., 
1974; Mestyán et al., 1975). 
If gluconeogenesis is indeed impaired in intrauterine growth-retarded newborns, 
what are the causes of this phenomenon? The enzymatic capacity for the gluco-
neogenic pathway appears, in normal rat and man, around birth (Chapter 4). The 
last gluconeogenic key enzyme which appears is cytosolic phosphoenolpyruvate 
carboxykinase, the activity of which is almost absent before birth. After delive-
ry, its activity increases within a few hours in rat liver (Girard et al., 1973; 
Pearce et al., 1974; Di Marco et al., 1976) and within a few days in human 
liver (Marsac et al., 1976). We observed lower activities of the four gluconeogenic 
key enzymes pyruvate carboxylase, phosphoenolpyruvate carboxykinase, fruc-
tose-1,6-diphosphatase and glucose-6-phosphatase from 0-6 h after delivery 
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in intrauterine growth-retarded newborn rats compared to controls from sham 
litters (Chapter 8). For phosphoenolpyruvate carboxykinase, which is the rate-
limiting gluconeogenic enzyme, the difference was, however, only statistically 
significant at 3 h. Pollak et al. (1979) found a significant difference of this enzyme 
at 4 h of age between intrauterine growth-retarded and control rats. 
Although the levels of enzyme activities are lower in intrauterine growth-
retarded animals, the pattern of development was similar to that in control 
animals (Chapter 8). It is unknown whether the lower activity of one of these 
different enzymes could be rate-limiting in the gluconeogenic pathway but the 
results of our study would fit into a delay of the development of the enzymatic 
capacity or into a secondary effect of a limited activation of the gluconeogenic 
process by other causes. 
Hormonal regulation of metabolic adaptation after birth is not completely under-
stood, but the rise in plasma glucagon levels after birth seems to play a major role 
in triggering gluconeogenesis (Snell and Walker, 1978). No differences in gluca-
gon and insulin levels after birth were found between intrauterine growth-
retarded and normal rats (Girard et al., 1976) and between small-for-
gestational-age and normal babies (Stanley et al., 1979). It is thus unlikely that 
inappropriate secretion of one of these hormones inhibits the development of 
gluconeogenesis after birth in the intrauterine growth-retarded newborn. 
Amino acids are the most important substrates for glucose production from 
gluconeogenesis. Limited availability of gluconeogenic substrates might result in 
decreased glucose production and it was suggested that this could influence 
glucose homeostasis in the newborn rat (Haymond et al., 1972 ; Ferré et al., 1978) 
and in the newborn baby (Sperling et al., 1974). This suggestion is not supported 
by the finding of accumulation of gluconeogenic amino acids after birth in 
intrauterine growth-retarded rats (Roux and Jahchan, 1974; Manniello et al., 
1977b; Chapter 9) and small-for-gestational-age babies (Haymond et al., 1974; 
Mestyán et al., 1975). This could point to a decreased utilization of amino acids 
for gluconeogenesis in intrauterine growth-retarded newborn animals. 
Fatty acid oxidation is necessary for gluconeogenesis by providing ATP, reducing 
equivalents and acetyl-CoA for pyruvate carboxylase activation (Ferré et al., 
1979; Sabel et al., 1979). The activities of enzymes for fatty acid oxidation 
increase markedly at birth in normal rat liver (Foster and Bailey, 1976). Free fatty 
acid concentrations in serum do not rise in the early neonatal period (Table 9.2) 
indicating a delay in fatty acid mobilization in the intrauterine growth-retarded 
rat. The increase of free fatty acid levels after birth is also smaller in small-for-
gestational-age newborn infants compared to normal newborns (Harris, 1974; de 
Leeuw and de Vries, 1976). 
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Because of the important role of carnitine in the mitochondrial transport of free 
fatty acids, hepatic carnitine concentration was studied. The liver of intrauterine 
growth-retarded newborn rats contained somewhat higher carnitine concentra-
tions compared to control animals (Table 9.4), excluding carnitine deficiency. 
The hepatic fatty acid oxidation rate in vitro is identical in intrauterine growth-
retarded newborn rats and control animals (Table 9.5). 
To gain more insight into the dynamics of glucose production and utilization at the 
time after birth when gluconeogenesis and glycogenolysis contribute to the nor-
malization of blood glucose concentrations glucose turnover rates were measured 
at 6 h after delivery (Chapter 9). The determinations were performed under 
steady-state conditions, in which glucose production equals glucose utilization. 
Glucose turnover rates were similar in intrauterine growth-retarded and control 
animals. Blood glucose concentrations in intrauterine growth-retarded animals at 
6 h after delivery are, however, lower compared to control animals (Chapter 7). 
So, in these animals, glucose production from glycogenolysis and gluconeogenesis 
must be inadequate to provide the amounts needed both for utilization of glucose 
and normalization of the blood glucose levels. Utilization of glucose might be 
increased in the early neonatal period in the intrauterine growth-retarded rats, as 
was found in the small-for-gestational-age newborn infant (Horváth et al., 1975 ; 
Roth, 1980). 
Not all the factors involved in the regulation of gluconeogenesis have been 
studied in this thesis. ATP/ADP ratios are low at birth, but increase shortly after 
birth (Ballard, 1971). The mitochondrial maturation of adenine nucleotide trans-
port and anion translocation (Sutton and Pollak, 1980) might limit gluconeogene-
sis. 
11.2. Summarizing conclusions 
Intrauterine growth-retardation in man by vascular disease of the mother can be 
mimiced by ligation of uterine arteries during the last part of gestation in the rat. 
Normalization of blood glucose levels after the initial fall within a few hours after 
delivery is impaired in the IUGR rat. Both glucogenolysis and gluconeogenesis 
contribute to the normalization of blood glucose concentrations since both pro-
cesses are operative in the newborn rat at that time. 
The pattern of glycogen breakdown in IUGR newborn rats is similar to that in 
control animals, but the amounts of glycogen per 100 g body weight metabolized 
are smaller. 
Several lines of indirect evidence support the concept of a diminished or delayed 
gluconeogenesis during the early neonatal period in IUGR rats. Lower acti-
vities of gluconeogenic key enzymes are present. Gluconeogenic amino acids are 
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present in serum in even higher concentrations compared to control animals. 
This excludes substrate deficiency but points to a decreased utilization. 
The hepatic capacity of fatty acid oxidation, a necessary energy source for 
gluconeogenesis, is normal in IUGR rats. The gradual increase of free fatty acids 
concentrations due to hpolysis might be delayed. A sufficient concentration of 
carnitine is present in the liver of IUGR newborn rats. 
Glucose turnover rates in the early neonatal period are identical in IUGR and 
control animals. So, substantial glucose production occurs in IUGR newborn rats 
but this is insufficient to increase blood glucose concentrations to normal levels at 
6 h after birth. 
It may be concluded from our investigations and the data from the literature that 
delayed or diminished gluconeogenesis most probably contributes to the occur­
rence of low blood glucose concentrations in the early neonatal period of the 
IUGR rat. The exact course of the impairement of gluconeogenesis remains, 
however, unclear. We could exclude diminished substrate availability, absence of 
gluconeogenic key enzymes, deficiency of hepatic carnitine or impaired fatty acid 
oxidation capacity as primary causes. 
The results of our investigations, although restricted to the rat, might be of value 
for the understanding of the etiology of disturbances in carbohydrate metabolism 
in small-for-gestational-age newborn infants. 
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SAMENVATTING 
Het in dit proefschrift beschreven onderzoek is gericht op de glucose stofwisseling 
in de neonatale periode bij intrauteriene groeiachterstand. 
Bij 1.5-2% van alle pasgeborenen treedt intrauteriene groeiachterstand op. Het 
kind heeft dan een te laag geboortegewicht in relatie tot de zwangerschapsduur en 
vertoont typische kenmerken, welke het gevolg zijn van ondervoeding tijdens het 
verblijf in de baarmoeder. Op de klinische aspecten hiervan wordt ingegaan in 
Hoofdstuk 1. Een van de gevolgen van intrauteriene groeiachterstand is het 
frequent optreden van te lage bloedglucose spiegels in de neonatale periode. Bij 
deze zg. "dysmature" pasgeborenen is behandeling met glucose infusen vaak 
noodzakelijk om hersenbeschadiging door glucosegebrek te voorkomen. De 
klinische aspecten van de hypoglycémie bij dysmaturiteit worden beschreven in 
Hoofdstuk 2. 
Het onderzoek werd verricht met een dierexperimenteel model. Enkele diermo-
dellen waarbij artificieel een intrauteriene groeiachterstand kan worden opge-
wekt zijn beschreven in Hoofdstuk 3. Er werd gekozen voor een ratte-model 
omdat het rijpingspatroon van voor de glucose stofwisseling belangrijke enzym-
systemen bij rat en mens overeenkomsten vertoont. Door middel van het beper-
ken van de bloedstroom naar één van beide uterushoorns door operatieve 
ligatie van de arteria uterina op de 17e dag van de zwangerschap wordt een 
groeiachterstand opgewekt bij de in die uterushoorn aanwezige foetale ratten. 
Omzetting van in de lever opgeslagen glycogeen in glucose is een van de mecha-
nismen die, kort na de geboorte, er toe bijdragen dat voldoende glucose productie 
is verzekerd. Lange tijd werd aangenomen dat de geringere glycogeenvoorraad 
bij de dysmature pasgeborene de oorzaak was van de frequent optredende 
neonatale hypoglycémie in deze groep. Zoals in Hoofdstuk 4 nader wordt uiteen-
gezet speelt de gluconeogenese eveneens een belangrijke rol bij de glucose 
homeostase na de geboorte. 
Uit literatuurgegevens blijkt dat bij dysmature pasgeborenen de gluconeogenese 
mogelijk niet optimaal verloopt, ten gevolge waarvan een neonatale hypoglycé-
mie zou kunnen ontstaan (Hoofdstuk 5). 
Het dierexperimentele model werd op haar waarde getoetst, waarbij de volgende 
4 groepen pasgeboren ratten werden onderzocht op geboortegewicht en bloed-
glucose spiegels gedurende de eerste 6 uur na de geboorte: 
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1. Normale pasgeboren ratten, waarbij bij de moeder géén operatieve ingreep 
plaats vond. 
2. Ratten, bij de moeder waarvan op de 17e dag van de zwangerschap geope-
reerd werd doch waarbij de bloedvoorziening naar de uterus ongemoeid werd 
gelaten (sham-operatie). 
3. Ratten uit de uterushoorns, waarvan de bloedvoorziening door ligatie op 
de 17e dag beperkt werd. 
4. Ratten uit de niet-geligeerde uterushooms (aan de andere zijde van die waar 
wel ligatie had plaats gevonden). 
Alle dieren werden op de 21e (en laatste) dag van de zwangerschap via een 
keizersnede geboren. Ook bij de verdere experimenten werden deze 4 groepen 
pasgeboren ratten betrokken. Uit de onderzoeksresultaten bleek (Hoofdstuk 7) 
dat ligatie van de arteria uterina van één van beide uterushoorns eveneens 
gevolgen heeft voor de foetus in de andere uterushoorn. Bij toepassing van het 
gekozen model bleken de dieren uit de contralaterale uterushoorn minder ge-
schikt te zijn als controle-dieren dan de dieren bij de moeder waarvan een 
sham-operatie was uitgevoerd. In de geligeerde groep is de bloedglucose concen-
tratie in de onderzochte periode na de geboorte lager dan in de overige groepen. 
Bij alle dieren treedt na de geboorte een daling van de bloedglucose spiegel op, 
waarbij de laagste waarde ongeveer 3 uur na de geboorte wordt bereikt. De 
daarna optredende stijging van de bloedglucose spiegels verloopt in de geligeerde 
groep trager (Hoofdstuk 7). 
Op 4 tijdstippen na de geboorte (0, 1, 3 en 6 uur) werden de activiteiten van de 
vier sleutelenzymen van de gluconeogenese (pyruvaat-carboxylase, phospho-
enolpyruvaatcarboxykinase, fructose-1,6-diphosphatase en glucose-6-phospha-
tase) in de lever bepaald (Hoofdstuk 8). De activiteiten van deze enzymen, 
behoudens die van phosphoenolpyruvaatcarboxykinase, bleken in de geligeerde 
groep significant lager te zijn dan in de groep waarbij een sham-operatie werd 
uitgevoerd. 
Sommige aminozuren vormen belangrijke substraten voor de gluconeogenese. 
De serum aminozuur concentraties werden op genoemde tijdstippen bepaald om 
na te gaan of een verminderd aanbod van gluconeogenetische aminozuren (me-
de) oorzaak zou kunnen zijn voor het optreden van hypoglycémie in de dysma-
ture groep. De som van de concentraties van de gluconeogenetische aminozuren 
bleek bij de dieren uit de geligeerde groep significant te zijn verhoogd (Hoofdstuk 
9) hetgeen een gevolg kan zijn van een gestoorde gluconeogenese. 
De bevindingen betreffende het verloop van de enzymactiviteiten en de substra-
ten wijzen er op dat de gluconeogenese in de vroege neonatale periode inderdaad 
niet optimaal verloopt bij intrauterien opgetreden groeiachterstand. 
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Voor een optimaal verloop van de gluconeogenese is vetzuur oxydatie noodzake-
lijk. Het verloop van vrije vetzuur concentraties in het serum tijdens de eerste 6 
uur na de geboorte werden daarom eveneens onderzocht. Er werden grote 
verschillen tussen de 4 groepen gevonden doch vrije vetzuren bleken in de 
geligeerde groep in ruime mate beschikbaar. De capaciteit van de lever tot 
vetzuuroxydatie bleek in alle groepen gelijk te zijn. Voor het transport van vrije 
vetzuren naar de mitochondria, waar de vetzuuroxydatie plaats vindt, is carnitine 
noodzakelijk. Carnitine bleek in de geligeerde groep in voldoende concentratie in 
de lever aanwezig (Hoofdstuk 9). 
Teneinde enig inzicht te verkrijgen in de dynamiek van glucose productie en 
verbruik in de neonatale periode werden, met behulp van intraperitoneale injec-
tie van radioactief gemerkt (tritium) glucose, de "turnover" snelheden van glu-
cose bepaald op het tijdstip van 6 uur na de geboorte. Er werd in alle groepen 
eenzelfde turnover snelheid van glucose gevonden (Hoofdstuk 10). De gemid-
delde bloedglucose concentraties tijdens de glucose turnover experimenten wa-
ren in de geligeerde groep lager dan in de groep waarbij een sham-operatie had 
plaats gevonden. Het verschil is echter niet significant, hetgeen kan worden 
verklaard door het klein aantal nesten. Te verwachten zou zijn dat, bij onderzoek 
van een groter aantal nesten, het verschil significant zou zijn zoals ook het geval 
was bij de experimenten, beschreven in Hoofdstuk 7. Er kan dan worden gecon-
cludeerd dat er in ruime mate glucoseproductie via gluconeogenese plaats vindt 
doch dat dit niet geheel voldoende is om de behoeften voor glucose utilisatie te 
dekken en tevens de bloedglucose concentratie op een normaal peil te brengen. 
Samenvattend kunnen wij concluderen dat de gluconeogenese in de vroege 
neonatale periode na intrauterien opgetreden groeiachterstand bij de rat hoogst-
waarschijnlijk niet optimaal verloopt hoewel een aanzienlijke glucose productie 
plaats vindt. De juiste oorzaak blijft nog onopgehelderd, doch enkele mogelijke 
oorzaken konden worden uitgesloten. 
Toepassen van deze gegevens op het dysmature kind dient met de nodige reserve 
te geschieden. Niet alle van belang zijnde factoren werden nagegaan. 
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STELLINGEN 
I 
Snelle veranderingen in de bloeddruk spelen een rol bij het ontstaan van 
subependymaal en intraventriculair gelokaliseerde hersenbloedingen bij de 
kleinere prematuur. 
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II 
Een verhoogde excretie van pipecolinezuur is nog niet bewijzend voor de 
diagnose syndroom van Zellweger. 
Tnjbels, J M F. et al (1979). J. Inher. Metab. Dis. 2, 39-42. 
lil 
Er bestaan sterke aanwijzingen dat bij het syndroom van Zellweger de mole­
culaire membraanstructuur van spiermitochondriën een afwijkende samen-
stelling bezit. 
IV 
De grote spreiding van de plasma renine activiteit bij het jonge kind kan 
niet worden verklaard door de invloed van stress. 
Van Acker, K.J. et al. (1979). Kidney Int. 16, 196-203. 
V 
Ondanks de noodzakelijke ontwikkeling van gespecialiseerd babylance 
transport van zieke geborenen naar neonatale centra verdient transport van 
bedreigde ongeborenen naar perinatale centra de voorkeur. 
VI 
Behalve aan de rol van de ductus arteriosus zal waarschijnlijk ook aan de 
rol van de ductus venosus betekenis moeten worden toegekend in de patho-
fysiologie van de aanpassing aan het extra-uteriene leven. 
VII 
De huisarts dient op de hoogte te zijn van de betekenis van een positieve 
bevinding gedaan bij landelijke screening op aangeboren ziekten bij de pas-
geborene. 
Vili 
Bij de intensieve zorg voor pasgeborenen dient men zich ervan bewust te 
zijn dat ogenschijnlijk weinig ingrijpende handelingen toch een ongewenste 
daling van de artenele zuurstofspanning kunnen veroorzaken 
Long J G et al (1980) Pediatrics 65, 203-207 
IX 
De Dubowitz score dient te worden vervangen door een praktischer alter­
natief. 
X 
Misvormingen komen frequenter voor bij monozygote tweelingen dan bij 
dizygote tweelingen of eenlingen. 
Schinzel, A A G L et al (1979) J Pediat 95,921-930 
Livingston, J E en Poland, В J (1980) Teratology 21, 139-148 
XI 
Wanneer in de kwaliteit van het leven bedreigde pasgeborenen konden spre­
ken, zouden zij zelfs bewindslieden tot zwijgen kunnen brengen 
XII 
De huidige waardestijging van de cent geeft aan de betekenis van de uit­
drukking "je zou hem een cent geven" een andere nuance. 
XIII 
Je tèzko si pfedstavit, ze zpûsob odporu, ν Ceskoslovensku symbolizovanj 
postavou dobrého vojáka Svejka, by nèkdy zmizel ζ mysli ceského lidu 
L.A A. Kollée Nijmegen, 3 oktober 1980 
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